
<html lang="en"     class="pb-page"  data-request-id="157cf37e-94a1-4393-b944-1c34cca36956"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.5b00684;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2015.58.issue-17;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds" /></meta><meta name="dc.Creator" content="Fangrui  Wu" /></meta><meta name="dc.Creator" content="Hong  Jiang" /></meta><meta name="dc.Creator" content="Baisong  Zheng" /></meta><meta name="dc.Creator" content="Mari  Kogiso" /></meta><meta name="dc.Creator" content="Yuan  Yao" /></meta><meta name="dc.Creator" content="Chao  Zhou" /></meta><meta name="dc.Creator" content="Xiao-Nan  Li" /></meta><meta name="dc.Creator" content="Yongcheng  Song" /></meta><meta name="dc.Description" content="Somatic mutations of isocitrate dehydrogenase 1 (IDH1) at R132 are frequently found in certain cancers such as glioma. With losing the activity of wild-type IDH1, the R132H and R132C mutant protein..." /></meta><meta name="Description" content="Somatic mutations of isocitrate dehydrogenase 1 (IDH1) at R132 are frequently found in certain cancers such as glioma. With losing the activity of wild-type IDH1, the R132H and R132C mutant protein..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 26, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00684" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00684" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00684" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00684" /></link>
        
    
    

<title>Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00684" /></meta><meta property="og:title" content="Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0010.jpeg" /></meta><meta property="og:description" content="Somatic mutations of isocitrate dehydrogenase 1 (IDH1) at R132 are frequently found in certain cancers such as glioma. With losing the activity of wild-type IDH1, the R132H and R132C mutant proteins can reduce α-ketoglutaric acid (α-KG) to d-2-hydroxyglutaric acid (D2HG). The resulting high concentration of D2HG inhibits many α-KG-dependent dioxygenases, including histone demethylases, to cause broad histone hypermethylation. These aberrant epigenetic changes are responsible for the initiation of these cancers. We report the synthesis, structure–activity relationships, enzyme kinetics, and binding thermodynamics of a novel series of 2-thiohydantoin and related compounds, among which several compounds are potent inhibitors of mutant IDH1 with Ki as low as 420 nM. X-ray crystal structures of IDH1(R132H) in complex with two inhibitors are reported, showing their inhibitor–protein interactions. These compounds can decrease the cellular concentration of D2HG, reduce the levels of histone methylation, and suppress the proliferation of stem-like cancer cells in BT142 glioma with IDH1 R132H mutation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00684"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00684">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00684&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00684&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00684&amp;href=/doi/10.1021/acs.jmedchem.5b00684" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 6899-6908</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00680" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00709" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fangrui++Wu">Fangrui Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Jiang">Hong Jiang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Baisong++Zheng">Baisong Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mari++Kogiso">Mari Kogiso</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yuan++Yao">Yuan Yao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chao++Zhou">Chao Zhou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Nan++Li">Xiao-Nan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongcheng++Song">Yongcheng Song</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Pharmacology, <sup>‡</sup>Department of Pediatrics-Oncology, and <sup>§</sup>Dan L. Duncan Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div><div class="corresp-info"><strong>*</strong>Tel: 713-798-7415. E-mail: <a href="/cdn-cgi/l/email-protection#9ee7edf1f0f9defcfdf3b0fbfaeb"><span class="__cf_email__" data-cfemail="7009031f1e173012131d5e151405">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00684&amp;href=/doi/10.1021%2Facs.jmedchem.5b00684" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 6899–6908</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 17, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 May 2015</li><li><span class="item_label"><b>Published</b> online</span>26 August 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00684" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00684</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6899%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFangrui%2BWu%252C%2BHong%2BJiang%252C%2BBaisong%2BZheng%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D17%26contentID%3Dacs.jmedchem.5b00684%26title%3DInhibition%2Bof%2BCancer-Associated%2BMutant%2BIsocitrate%2BDehydrogenases%2Bby%2B2-Thiohydantoin%2BCompounds%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6908%26publicationDate%3DSeptember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00684"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2880</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00684" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fangrui&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Baisong&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Mari&quot;,&quot;last_name&quot;:&quot;Kogiso&quot;},{&quot;first_name&quot;:&quot;Yuan&quot;,&quot;last_name&quot;:&quot;Yao&quot;},{&quot;first_name&quot;:&quot;Chao&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Xiao-Nan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yongcheng&quot;,&quot;last_name&quot;:&quot;Song&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;6899-6908&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00684&quot;},&quot;abstract&quot;:&quot;Somatic mutations of isocitrate dehydrogenase 1 (IDH1) at R132 are frequently found in certain cancers such as glioma. With losing the activity of wild-type IDH1, the R132H and R132C mutant proteins can reduce α-ketoglutaric acid (α-KG) to d-2-hydroxyglutaric acid (D2HG). The resulting high concentration of D2HG inhibits many α-KG-dependent dioxygenases, including histone demethylases, to cause broad histone hypermethylation. These aberrant epigenetic changes are responsible for the initiation of these cancers. We report the synthesis, structure–activity relationships, enzyme kinetics, and binding thermodynamics of a novel series of 2-thiohydantoin and related compounds, among which several compounds are potent inhibitors of mutant IDH1 with Ki as low as 420 nM. X-ray crystal structures of IDH1(R132H) in complex with two inhibitors are reported, showing their inhibitor–protein interactions. These compounds can decrease the cellular concentration of D2HG, reduce the levels of histone methylation, and suppress &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00684&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00684" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00684&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00684" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00684&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00684" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00684&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00684&amp;href=/doi/10.1021/acs.jmedchem.5b00684" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00684" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00684" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00684%26sid%3Dliteratum%253Aachs%26pmid%3D26280302%26genre%3Darticle%26aulast%3DWu%26date%3D2015%26atitle%3DInhibition%2Bof%2BCancer-Associated%2BMutant%2BIsocitrate%2BDehydrogenases%2Bby%2B2-Thiohydantoin%2BCompounds%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D17%26spage%3D6899%26epage%3D6908%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/jmcmar.2015.58.issue-17/20150910/jmcmar.2015.58.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Somatic mutations of isocitrate dehydrogenase 1 (IDH1) at R132 are frequently found in certain cancers such as glioma. With losing the activity of wild-type IDH1, the R132H and R132C mutant proteins can reduce α-ketoglutaric acid (α-KG) to <span class="smallcaps smallerCapital">d</span>-2-hydroxyglutaric acid (D2HG). The resulting high concentration of D2HG inhibits many α-KG-dependent dioxygenases, including histone demethylases, to cause broad histone hypermethylation. These aberrant epigenetic changes are responsible for the initiation of these cancers. We report the synthesis, structure–activity relationships, enzyme kinetics, and binding thermodynamics of a novel series of 2-thiohydantoin and related compounds, among which several compounds are potent inhibitors of mutant IDH1 with <i>K</i><sub>i</sub> as low as 420 nM. X-ray crystal structures of IDH1(R132H) in complex with two inhibitors are reported, showing their inhibitor–protein interactions. These compounds can decrease the cellular concentration of D2HG, reduce the levels of histone methylation, and suppress the proliferation of stem-like cancer cells in BT142 glioma with IDH1 R132H mutation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62016" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62016" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Isocitrate dehydrogenase (IDH) catalyzes oxidative decarboxylation of isocitric acid (ICT) to α-ketoglutaric acid (α-KG) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A), which is one of the key reactions in the tricarboxylic acid cycle.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Among the three isoforms of IDH in humans, frequent somatic mutations of IDH1 have recently been found in certain cancers.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2-4)</a> Particularly noted is that ∼75% of lower grade (grade II and III) gliomas, the most common form of brain tumors, contain IDH1 mutations.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Although growing relatively slowly, these gliomas are invasive and eventually develop to become secondary glioblastoma multiforme (GBM, grade IV glioma), a highly malignant tumor with 5-year survival rates of <10%. Distinct from many other mutations, the mutation site in IDH1 is always located in the R132 residue, with R132H being predominant (∼93%). IDH mutations (including IDH1 and IDH2) have also been found in ∼20% acute myeloid leukemia (AML) and ∼50% of certain sarcomas.<a onclick="showRef(event, 'ref4 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref7">(4, 7)</a> Moreover, clinical data suggest the IDH mutation is an early event in cancer initiation and development.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reactions catalyzed by (A) wild-type IDH1, (B) mutant IDH1, and (C) α-KG-dependent histone demethylases. D2HG, the product of mutant IDH1, inhibits α-KG-dependent histone demethylases, resulting in histones with more methylated lysine residues. (D) The structures of three known inhibitors of mutant IDH1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Biochemically, all of the characterized mutant IDH1 proteins in cancer almost lose the wild-type (WT) enzyme activity. However, these mutant enzymes can reduce α-KG to <span class="smallcaps smallerCapital">d</span>-2-hydroxyglutaric acid (D2HG), using NADPH as the cofactor (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B).<a onclick="showRef(event, 'ref4 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref4 ref8 ref9">(4, 8, 9)</a> This new function causes a high concentration of D2HG to be accumulated in cancer cells (as well as in patient plasma). D2HG was found to be an inhibitor of many α-KG-dependent dioxygenases, including the JmjC family of histone demethylases (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>C).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> This inhibitory activity leads to genome-wide hypermethylation of histones in IDH mutated cancers.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Given the crucial roles of histone lysine methylation in gene regulation as well as cancer initiation, the observed aberrant epigenetic changes were hypothesized to be responsible for the initiation and/or maintenance of the IDH mutated cancers.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a></div><div class="NLM_p last">As representatively shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>D, three chemo-types of inhibitors (<b>1</b>–<b>3</b>) of mutant IDH1 have been reported.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18">(14-18)</a> These compounds can reduce the cellular levels of D2HG, showing on-target activity in cells. Compounds <b>1</b> and <b>2</b> can also inhibit proliferation of IDH1 mutated cancer cells,<a onclick="showRef(event, 'ref15 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref17">(15, 17)</a> demonstrating that mutant IDH1 is a drug target for these cancers. Here, we report the synthesis and structure–activity relationships (SAR) of a series of 2-thiohydantoin-containing compounds as a new chemo-type of inhibitor of mutant IDH1. X-ray crystallographic, enzyme kinetics, and binding thermodynamics studies of selected compounds showed the binding structures and the mode of action. Biological activity testing demonstrated these compounds can reduce cellular concentration of D2HG, inhibit histone lysine methylation, and impair the self-renewal ability of IDH1 mutated glioma cells.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis and Structure–Activity Relationship Studies</h3><div class="NLM_p">Recombinant human IDH1 R132H mutant protein was expressed in <i>E. coli</i> and purified with a series of column chromatography, using our previously reported methods.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> The activity and inhibition of IDH1(R132H) were determined based on initial linear consumption of NADPH (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B) monitored at 340 nm, where NADPH has the maximal optical absorption. Through compound screening using our published biochemical method,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> 3-benzyl-5-(3,4-dihydroxybenzylidene)-2-thiohydantoin (<b>4</b>)was identified to be an inhibitor of IDH1(R132H) with a <i>K</i><sub>i</sub> value of 4.7 μM against the substrate α-KG. This compound is of interest since it possesses good inhibitory activity and is amenable to medicinal chemistry studies.<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0011.gif" alt="" id="GRAPHIC-d1831e345-autogenerated" /></img></span></div><div class="NLM_p">Medicinal chemistry was performed with modifications on the 3-substituent (-R<sup>1</sup>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), 5-substituent (-R<sup>2</sup>, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), and the 2-thiohydantoin core (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) of compound <b>4</b>. These compounds were efficiently synthesized using a general method as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Glycine was reacted with R<sup>1</sup> isothiocyanate, and the resulting thiourea product was cyclized in the presence of sulfuric acid to give 3-R<sup>1</sup>-substituted 2-thiohydantoin. The condensation reaction of a 2-thiohydantoin (or related heterocyclic) compound with an aldehyde in the presence of sodium acetate in refluxing acetic acid gave an R<sup>2</sup>-substituted 5-methylene-2-thiohydantoin compound in 60–90% yield. The synthesis and characterization of compounds <b>4</b>–<b>41</b> are described in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>, Experimental Section.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and <i>K</i><sub>i</sub> Values of 5- or 6-Substituted Compounds against IDH1(R132H)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0008.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0009.gif" alt="" id="fx3" /></img><div></div></div><figure id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures and Activities of Compounds <b>35</b>–<b>41</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Method<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) R<sup>1</sup>NCS, KOH, H<sub>2</sub>O-EtOH; (ii) H<sub>2</sub>SO<sub>4</sub>, acetone; (iii) an aldehyde, e.g., 6-methoxynicotinaldehyde, NaOAc, HOAc, reflux; (iv) HCl, reflux.</p></p></figure><div class="NLM_p">Compound <b>5</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) having a 3,4-dimethoxyphenyl group was found to be inactive (<i>K</i><sub>i</sub> > 50 μM) against IDH1(R132H). Similarly, compounds <b>6</b> and <b>7</b>, which contain the same R<sup>2</sup> group of 3,4-dimethoxyphenyl, are also inactive. This observation suggests that at least one of the two −OH groups in compound <b>4</b> is important for the activity. Indeed, after removal of the methyl groups of <b>6</b> and <b>7</b>, the corresponding hydroxyl compounds <b>8</b> and <b>9</b> can inhibit the mutant enzyme with <i>K</i><sub>i</sub> values of 16.7 and 13.4 μM, respectively, although they are ∼3-fold less active than compound <b>4</b> (R<sup>1</sup> = benzyl), which should be due to a different R<sup>1</sup> group (i.e., phenyl and 4-OH-benzyl for <b>8</b> and <b>9</b> versus benzyl in <b>4</b>).</div><div class="NLM_p">Because undesirable properties associated with the 3,4-dihydroxyphenyl (catechol-containing) group, which is a strong metal chelator and is easily oxidized, compounds <b>10</b>–<b>12</b> were synthesized in an effort to find another R<sup>2</sup> group that has comparable or improved activity. Compound <b>10</b> with a 3-pyridinyl and compound <b>11</b> with a 2-methoxy-5-pyridinyl group have one and two H-bond acceptors. Both compounds are inactive. However, compound <b>12</b> with a 2-pyridinone-5-yl group possesses a good inhibitory activity with a <i>K</i><sub>i</sub> value of 4.8 μM against IDH1(R132H), showing activity comparable to that of compound <b>4</b>.</div><div class="NLM_p">Next, compounds <b>13</b>–<b>20</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) were synthesized to optimize the R<sup>1</sup> group. Although compounds <b>13</b>, <b>15</b>, and <b>17</b> containing a 2-methoxy-5-pyridinyl R<sup>2</sup> group are still moderate or weak inhibitors of IDH1(R132H) with <i>K</i><sub>i</sub> values of 9.2, 25, and 7.8 μM, their activities are superior to that of compound <b>11</b> (<i>K</i><sub>i</sub> > 50 μM), suggesting a smaller R<sup>1</sup> group (i.e., -Et in <b>13</b>, -Me in <b>15</b>, and -H in <b>17</b>) is more favorable. The demethylated compounds <b>14</b>, <b>16</b>, and <b>18</b> (with a 2-pyridinone-5-yl R<sup>2</sup> group) were found to possess strong activities. While compound <b>14</b> with an -Et R<sup>1</sup> group has a <i>K</i><sub>i</sub> of 3.6 μM, compounds <b>16</b> and <b>18</b> with a -Me and -H R<sup>1</sup> group, respectively, showed potent inhibitory activities with <i>K</i><sub>i</sub> values of 750 and 420 nM. The increasing activities of compounds <b>12</b>, <b>14</b>, <b>16</b>, and <b>18</b> suggest a SAR trend for the R<sup>1</sup> group of Bn < Et < Me < H, with small substituents Me and H being most favorable. Compounds <b>19</b> and <b>20</b> were synthesized to find if a carboxyl group or its ester is a good R<sup>1</sup>. However, none of these compounds is active.</div><div class="NLM_p">Compounds <b>21</b>–<b>34</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) were synthesized to investigate the SAR for the R<sup>2</sup> group. Compound <b>21</b> with an <i>N</i>-methyl substituent on the 2-pyridinone ring was found to have a slight improved activity with a <i>K</i><sub>i</sub> of 470 nM, as compared with <b>16</b>. However, an <i>N</i>-benzyl substituent considerably reduces the inhibitory activity of compound <b>22</b> (<i>K</i><sub>i</sub> = 4.6 μM). Compound <b>23</b> and its demethylated compound <b>24</b>, which have an O atom (or -OH) attached to N1 of the pyridine-2-one ring, also show decreased activities (<i>K</i><sub>i</sub> = 4.3 and 5.9 μM, respectively). Compounds with other pyridinyl R<sup>2</sup> substituents were synthesized for SAR studies. Compounds <b>25</b> and <b>26</b> containing 2-methoxy-pyridin-3-yl and pyridine-2-one-3-yl group, respectively, were found to have very weak or no inhibitory activity (<i>K</i><sub>i</sub> ≥ 25 μM) against IDH1(R132H). Compound <b>27</b> with a 6-methoxypyridin-2-yl R<sup>2</sup> group is inactive, while the demethylated compound <b>28</b> has a modest activity (<i>K</i><sub>i</sub> = 11.3 μM). Compounds bearing a 4-pyridinyl R<sup>2</sup> group are of interest. Although compound <b>29</b> with a 4-pyridinyl group is inactive (<i>K</i><sub>i</sub> > 50 μM), compounds <b>30</b> and <b>31</b> having 2-methoxy-4-pyridinyl and pyridin-2-one-4-yl groups are good inhibitors with <i>K</i><sub>i</sub> values of 2.6 and 9.2 μM, respectively. In addition, compound <b>30</b> is the only -OMe containing compound that is considerably more active than its -OH analogue <b>31</b>, suggesting a more hydrophobic group might be favorable at this position, and several compounds were therefore synthesized. Loss of activity for compound <b>32</b> indicates the 3-bromo-4-pyridinyl R<sup>2</sup> group is disfavored, while compound <b>33</b> bearing the 3-phenyl-4-pyridinyl group showed good inhibitory activity (<i>K</i><sub>i</sub> = 5.6 μM). Similarly, compound <b>34</b> having a 2,5-substituted furan R<sup>2</sup> group also exhibited a good <i>K</i><sub>i</sub> of 3.2 μM.</div><div class="NLM_p">The SAR studies described above show that a good R<sup>2</sup> group requires a strong H-bond acceptor (e.g., the 4-O atom in 4 and 2-O in <b>12</b>, <b>14</b>, <b>16</b>, <b>18</b>, <b>21</b>, <b>22</b>, and <b>24</b>) at the <i>para</i>-position. The potent activity of compound <b>21</b> (as well as that of <b>22</b>) indicates that an H-bond donor (e.g., 3-OH in 4 and 1-NH in pyridin-2-one containing compounds) is not essential.</div><div class="NLM_p last">SARs for the 2-thiohydantoin ring were investigated, and the results are shown in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>. We synthesized compounds <b>35</b> and <b>36</b> with a 2-thioxothiazolidin-4-one core structure, <b>37</b> and <b>38</b> with a hydantoin, and compound <b>39</b> with a 2-amino-imidazol-4-one core. The activities of compounds <b>35</b> and <b>36</b> (<i>K</i><sub>i</sub> = > 50 and 3.1 μM, respectively) are significantly lower than those of the corresponding 2-thiohydantoin compounds <b>17</b> and <b>18</b> (<i>K</i><sub>i</sub> = 7.8 and 0.42 μM), showing that -NH- at the 1-position of the ring is more favorable than -S-. Complete loss of activity for compounds <b>37</b> and <b>38</b> was unexpected, indicating that the 2-carbonyl O atom of the hydantoin ring is highly disfavored, as compared to the corresponding S atom of 2-thiohydantoin ring in <b>17</b> and <b>18</b>. Similarly, compound <b>39</b> having an -NH<sub>2</sub> at this position is also inactive. In compound <b>40</b>, the methyl group attached to the S atom causes the compound to completely lose the inhibitory activity against IDH1(R132H). Moreover, adding a methyl group to the N3 atom of the 2-thiohydantoin ring in compound <b>41</b> (<i>K</i><sub>i</sub> = 16.5 μM) resulted in a 22-fold activity reduction, as compared to that of compound <b>16</b> (<i>K</i><sub>i</sub> = 0.75 μM).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Activity against R132C and WT IDH1</h3><div class="NLM_p">Compounds <b>16</b>, <b>18</b>, and <b>22</b> were selected to be tested for their abilities to inhibit the R132C (a frequent mutation in leukemia and sarcoma) mutant as well as WT IDH1. These two recombinant IDH1 proteins were also expressed in <i>E. coli</i> and purified with our previously reported methods.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> The activity and inhibition of IDH1(R132C) were determined in a manner similar to those of the R132H mutant protein. For WT IDH1, the reaction rate was calculated based on the production of NADPH (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B), resulting in an increase of optical density at 340 nm.</div><div class="NLM_p">As can be seen in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, these three compounds were found also to be inhibitors of IDH1(R132C). While compound <b>18</b> is the most potent inhibitor of IDH1(R132H) (<i>K</i><sub>i</sub><sup>R132H</sup> = 0.42 μM), it is less inhibitory against the R132C mutant protein with a <i>K</i><sub>i</sub> of 2.3 μM. Compound <b>16</b> exhibited a <i>K</i><sub>i</sub> value of 1.2 μM against IDH1(R132C), which is, however, comparable to that against IDH1(R132H) (<i>K</i><sub>i</sub><sup>R132H</sup> = 0.75 μM). In addition, compound <b>22</b> showed a less inhibitory activity against IDH1(R132C) with a <i>K</i><sub>i</sub> of 12.5 μM. These three compounds have moderate to good selectivity for the mutant IDH1 enzymes. Compounds <b>16</b>, <b>18</b>, and <b>22</b> were found to be relatively weak inhibitors of WT IDH1, with <i>K</i><sub>i</sub> values of 8.8, 10.3, and 32.9 μM, respectively. Thus, compound <b>16</b> shows selectivity indices of 11.7 and 7.3 (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) for the R132H and R132C mutant protein, respectively. Compound <b>18</b> was found to be 24.5- and 4.5-fold more active for the R132H and R132C mutants, as compared to the WT enzyme. Similarly, compound <b>22</b> possesses selectivity indices of 7.2- and 2.6-fold for the inhibition of R132H and R132C, respectively.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Activity (<i>K</i><sub>i</sub>, μM) and Selectivity of Compounds <b>16</b>, <b>18</b>, and <b>22</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">selectivity Index</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">R132H</th><th class="colsep0 rowsep0" align="center">R132C</th><th class="colsep0 rowsep0" align="center">WT</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub><sup>WT</sup>/<i>K</i><sub>i</sub><sup>R132H</sup></th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub><sup>WT</sup>/<i>K</i><sub>i</sub><sup>R132C</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">0.75 ± 0.39</td><td class="colsep0 rowsep0" align="left">1.2 ± 0.3</td><td class="colsep0 rowsep0" align="left">8.8 ± 0.4</td><td class="colsep0 rowsep0" align="left">11.7</td><td class="colsep0 rowsep0" align="left">7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">0.42 ± 0.21</td><td class="colsep0 rowsep0" align="left">2.3 ± 0.7</td><td class="colsep0 rowsep0" align="left">10.3 ± 0.5</td><td class="colsep0 rowsep0" align="left">24.5</td><td class="colsep0 rowsep0" align="left">4.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">4.6 ± 0.7</td><td class="colsep0 rowsep0" align="left">12.5 ± 0.7</td><td class="colsep0 rowsep0" align="left">32.9 ± 1.2</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">2.6</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> X-ray Crystallography</h3><div class="NLM_p">X-ray crystallography was used to find how these novel 2-thiohydantoin inhibitors bind to IDH1(R132H). We determined the tertiary structures of IDH1(R132H) in complex with NADPH and compounds <b>16</b> and <b>22</b> to a resolution of 3.2 Å, similar to those reported previously.<a onclick="showRef(event, 'ref16 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref19">(16, 19)</a> Statistics for diffraction data and structural refinement are in <a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf" class="ext-link">Table S1</a>. As shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A and <a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf" class="ext-link">Figure S1</a>, the protein IDH1(R132H) was found to crystallize as a homodimer with one NADPH molecule cocrystallized in each protein subunit. Only one molecule of the 2-thiohydantoin inhibitor <b>16</b> (or <b>22</b>) can be found in the protein homodimer, based on the electron density and omit maps (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B,C and <a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf" class="ext-link">Figure S2</a>). These observations were also found in our previous structures of IDH1(R132H) in complex with 1-hydroxypyridinone inhibitors (e.g., compound <b>2</b>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structures of IDH1(R132H):inhibitor complexes. (A) The overall structure of IDH1(R132H) in complex with compound <b>16</b> (ball and stick model) and NADPH (tube model). (B) The 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map of IDH1(R132H):<b>16</b> at the inhibitor-binding site, contoured at 1σ. (C) The <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> omit map of IDH1(R132H):<b>16</b>, contoured at 3σ. (D) The superimposed structures of IDH1(R132H) (electrostatic surface model) in complex with <b>16</b> (with C atoms in green) and <b>22</b> (in pink). (E) The close-up views of compound <b>16</b> and (F) compound <b>22</b> in IDH1(R132H). The protein backbones are shown as blue lines and H-bonds as purple dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds <b>16</b> and <b>22</b> are located deeply inside a cleft between the two protein homodimers (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D), sitting in a pocket surrounded by residues Thr77, Ser94, Asn96, Gly97, Arg100, Asn101, Arg109, and NADPH. <a class="ref internalNav" href="#fig2" aria-label="Figures 2">Figures 2</a>E and <a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf" class="ext-link">S3A</a> show the close-up view of the binding site and the ligand-protein interactions of compound <b>16</b>. The almost flat inhibitor molecule lies on a “bed surface” composed of Gly97, Asn96, and Ser94, with the distance between the two almost parallel planes being ∼3.3–3.6 Å. The two partially negatively charged O atoms of <b>16</b> form three H-bonds as well as electrostatic interactions with the positively charged side chains of Arg100 and Asn101. The S atom of compound <b>16</b> was found to have favorable, mostly hydrophobic interactions with Thr77 and NADPH. <a class="ref internalNav" href="#fig2" aria-label="Figures 2">Figures 2</a>F and <a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf" class="ext-link">S3B</a> show the binding site and the ligand–protein interactions of compound <b>22</b>. The conjugated rings of 2-thiohydantoin and pyridinone adopt a similar binding pose as observed for compound <b>16</b>, having favorable interactions with Gly97, Asn96, and Ser94. In addition, the two O atoms of <b>22</b> also have three H-bond and electrostatic interactions with Arg100 and Asn101. Therefore, it appears that these two types of common interactions between the protein and compounds <b>16</b> and <b>22</b> provide the majority of binding affinity for these inhibitors. The 2-thiohydantoin ring of compound <b>22</b> was found to orientate slightly differently from that of compound <b>16</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D), with, for example, the distance between the two S atoms being ∼2.2 Å. While such a movement for <b>22</b> causes the loss of the interactions between the S atom and NADPH and Thr77, it renders the 3-methyl group of <b>22</b> to have van der Waals interactions with the side chain of Arg109. The benzyl group of compound <b>22</b> bends and inserts into a deep side-pocket, having mostly hydrophobic interactions with the side chains of Lys93, Gly97, and Thr98 (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D and F).</div><div class="NLM_p">Previous crystallographic studies showed that unlike the WT protein, the R132H IDH1 mutant has two ligand binding sites.<a onclick="showRef(event, 'ref16 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref19">(16, 19)</a> Site I is where ICT as well as 1-hydroxypyridinone inhibitors (e.g., compound <b>2</b>) bind to IDH1(R132H). The binding site II is the catalytically active site where the substrate α-KG is located.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> It is also noted that the two binding sites in IDH1(R132H) do not coexist. A large protein conformational change occurs to switch the two ligand binding sites in IDH1(R132H) that recognize a different ligand (e.g., ICT versus α-KG). However, in the WT IDH1, there is only one ligand binding site that corresponds to site II in IDH1(R132H).</div><div class="NLM_p">Superposition of the crystal structures of IDH1(R132H) in complex with ICT, α-KG, and compounds <b>16</b> and <b>22</b>, shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A, demonstrated that the two inhibitors occupy the ligand binding site I, the same location where ICT and 1-hydroxypyridinone inhibitors (e.g., <b>2</b>) are located in IDH1(R132H). α-KG is ∼6 Å away in binding site II. <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B shows the large protein conformational differences between the two binding states of IDH1(R132H). In addition, the binding poses of NADPH in the two structures also differ significantly (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Superimposed structures of IDH1(R132H):<b>16</b> (protein as blue lines) and IDH1(R132H):α-KG (protein as brown lines), showing the two ligand binding sites. Also aligned are the crystal structures of IDH1(R132H):ICT (with C atoms in gray) and :<b>22</b> (in purple), showing that both ligands are also located in the binding site I. (<b>B</b>) Superposition of the structures of IDH1(R132H):<b>16</b> (protein as blue ribbons) and IDH1(R132H):α-KG (as yellow ribbons), showing a large protein conformational difference. Compound <b>16</b> (C atoms in green) and α-KG (in brown) are shown as ball and stick models. In addition, the conformation as well as the binding site of NADPH of the two structures (tube models in green and brown, respectively) are also significantly different.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Enzyme Kinetic Studies</h3><div class="NLM_p">We also performed a steady-state enzyme kinetic study for the most potent compound <b>18</b>, with which an X-ray crystal structure of IDH1(R132H) cannot be obtained. Initial velocities of IDH1(R132H) were determined in the presence of increasing concentrations of compound <b>18</b>, the substrate α-KG, and cofactor NADPH. These data were imported into the program SigmaPlot and fitted to competitive, uncompetitive, and noncompetitive kinetic models, using a Lineweaver–Burk or Michaelis–Menten plot. The best model, as judged by the <i>R</i><sup>2</sup> and AICc values, showed the mode of action for the inhibitor. Thus, compound <b>18</b> was found to exert a competitive mode of action against the substrate α-KG, as shown in <a class="ref internalNav" href="#fig4" aria-label="Figures 4">Figures 4</a>A (competitive fitting) and <a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf" class="ext-link">S4A</a> (uncompetitive and noncompetitive fitting). In addition, compound <b>18</b> was determined to be a noncompetitive inhibitor against the cofactor NADPH (<a class="ref internalNav" href="#fig4" aria-label="Figures 4">Figures 4</a>B and <a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf" class="ext-link">S4B</a>). Moreover, enzyme kinetic results for compound <b>18</b> are in line with the crystal structure of compound <b>16</b> described above, which also suggests that it is competitive to α-KG and noncompetitive to NADPH.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Best fitting models for enzyme kinetic studies of compound <b>18</b>. (A) Competitive inhibition model with variable concentrations of α-KG using a Lineweaver–Burk plot and (B) a noncompetitive inhibition model with variable concentrations of NADPH using a Michaelis–Menten plot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Binding Thermodynamics Studies</h3><div class="NLM_p">We performed isothermal titration calorimetry (ITC) experiments to further characterize the binding as well as mode of action for compound <b>18</b>. First, binding thermodynamics of compound <b>18</b> to IDH1(R132H) (100 μM) without NADPH was investigated in 30 mM Tris buffer (pH 7.4) with 4 mM MgCl<sub>2</sub> and 150 mM NaCl at 298 K. Use of a relatively high concentration of the protein was because of the small amount of heat generated for the binding. As shown representatively in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A, the binding of <b>18</b> to IDH1(R132H) alone was slightly exothermic (Δ<i>H</i> = −1.5 kJ/mol) with a <i>K</i><sub>a</sub> (affinity constant) value of 1.68 × 10<sup>5</sup> M<sup>–1</sup>, or a <i>K</i><sub>d</sub> (dissociate constant) value of 5.9 μM. This equals a Δ<i>G</i> value of −29.8 kJ/mol, showing the binding is mostly entropy driven (with a calculated Δ<i>S</i> of 95.0 J K<sup>–1</sup> mol<sup>–1</sup>). Next, binding of compound <b>18</b> to IDH1(R132H) (133 μM) in the presence of NADPH (300 μM) was found to be slightly more exothermic (Δ<i>H</i> = −2.5 kJ/mol) with a <i>K</i><sub>d</sub> value of 8.9 μM (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). Comparable <i>K</i><sub>d</sub> values as well as similar thermodynamics for these two experiments suggest that the binding of compound <b>18</b> to IDH1(R132H) is not significantly affected by NADPH. These two molecules could bind to different binding sites in the protein. Third, compound <b>18</b> was titrated into IDH1(R132H) (100 μM) with NADPH (300 μM) and α-KG (300 μM). As shown representatively in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C, the observed binding affinity of <b>18</b> to the protein (<i>K</i><sub>d</sub> = 46.0 μM) was found to be reduced by ∼5-fold in the presence of α-KG, suggesting that inhibitor <b>18</b> and α-KG are competitive to each other. These results are consistent with the enzyme kinetics data as well as the X-ray crystallographic studies of compounds <b>16</b> and <b>22</b>.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative ITC results and fitting curves for (A) compound <b>18</b> binding to IDH1(R132H) (100 μM); (B) <b>18</b> binding to IDH1(R132H) (100 μM) in the presence of NADPH (300 μM); and (C) <b>18</b> binding to IDH1(R132H) (100 μM) in the presence of NADPH (300 μM) and α-KG (300 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Biological Activity Evaluation</h3><div class="NLM_p">First, we tested if the most potent inhibitors <b>16</b> and <b>18</b> inhibit mutant IDH1 enzymes in vivo (cells) using human fibrosarcoma cell line HT1080, which harbors R132C mutation of IDH1, as a cell model. Thus, HT1080 cells in an exponential growth phase were treated with increasing concentrations of compounds <b>16</b> and <b>18</b> for 2 days, after which the concentrations of D2HG were determined by HPLC-MS using our previous method.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> As can be seen in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A, treatment with compounds <b>16</b> and <b>18</b> significantly reduced the production of D2HG, showing that these inhibitors are cell membrane permeable and on-target in cells.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular activity of mutant IDH1 inhibitors. (A) Treatment of compounds <b>16</b> and <b>18</b> caused significantly reduced amount of D2HG in HT1080 cells. (B) Treatment of <b>18</b> significantly reduced methylation levels on histone lysine residues in HT1080 cells, while inactive compound <b>20</b> did not significantly affect histone methylation levels. (<b>C</b>) Treatment of compounds <b>18</b>, <b>16</b>, and <b>1</b> inhibited neurosphere formation of BT142 glioma cells with IDH1 R132H mutation but (D) did not affect neurosphere formation of BXD-3752 glioma cells without an IDH1 mutation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Upon confirming their ability to inhibit cellular mutant IDH1, we next investigated whether the activity can alter levels of histone methylation. Since D2HG broadly inhibits α-KG-dependent histone lysine demethylases,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> it is expected that treatment with inhibitors of mutant IDH1 can restore the activity of these histone demethylases and therefore reduce the levels of histone lysine methylation. HT1080 cells were treated with compound <b>18</b> for 4 days. Histone proteins from both control and treated cells were extracted and subjected to Western blot analysis, probed by specific antibodies of human histone H3, trimethylated and dimethylated histone H3 lysine 4 (H3K4me3 and H3K4me2), dimethylated histone H3 lysine 27 (H3K27me2), and dimethylated histone H4 lysine 20 (H4K20me2). As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B, compound <b>18</b> was found to significantly reduce the methylation levels of these histone lysine residues in a dose dependent manner. To further confirm that the effects were due to the inhibition of mutant IDH1, inactive compound <b>20</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was used in the experiments, and it did not significantly reduce D2HG (data not shown) as well as histone lysine methylation levels in HT1080 (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B). These results show that by reducing the cellular concentration of D2HG, the inhibitors of mutant IDH1 can maintain the functions of histone demethylases and reverse the histone hypermethylation phenotype in HT1080 with IDH1 R132C mutation.</div><div class="NLM_p">Compounds <b>16</b> and <b>18</b> were next tested for their in vitro antitumor activity, together with potent known inhibitor <b>1</b> as a comparison. These three compounds were found to have no or negligible activity (EC<sub>50</sub> > 50 μM) against the proliferation of MCF-7 (breast), A549 (lung) cancer cells, and WI-38 normal fibroblast cells. In addition, compounds <b>1</b>, <b>16</b>, and <b>18</b> did not significantly inhibit the growth of HT1080 cells (EC<sub>50</sub> > 50 μM). These results showed that these potent inhibitors of mutant IDH1 do not have general cytotoxicity. Lack of growth inhibition against these tumor and normal cells also suggests that compounds <b>16</b> and <b>18</b> do not appear to affect critical cellular metabolism and signaling pathways, showing possibly good selectivity, although an enzyme selectivity profiling needs to be done for future studies.</div><div class="NLM_p">We further tested whether these compounds inhibit cancer stem cells (CSC) containing an IDH1 mutation. CSCs represent a small fraction of cancer cells that possess certain stem cell traits including the ability to self-renew and differentiate. Studies have found that only CSCs can generate new tumors when transplanted into a new host.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In the perspective of cancer treatment, CSCs are more resistant to chemotherapies and are also believed to be responsible for tumor relapse and metastasis. It is therefore of importance to find that compounds have selective activity against CSCs. To this end, patient sample derived BT142 glioma cells<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> bearing IDH1 R132H mutation were cultured in serum-free media and grew as “neurospheres”, which are colonies of cells with a diameter of 30–300 μm. Stem-like glioma cells are found to be enriched in these neurospheres.<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> BXD-3752 glioma cells<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> without an IDH1 mutation were included as a control cell model. As shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C, compounds <b>16</b> and <b>18</b> were able to significantly inhibit the proliferation of BT142 glioma stem-like cells, although these compounds are noncytotoxic to normal and malignant cancer cells. However, compounds <b>16</b> and <b>18</b> did not have activity against the proliferation of BXD-3752 glioma stem-like cells (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D), showing that their anti-CSC activity is selective for IDH1 mutated cancer cells. Moreover, 2-thiohydantoin inhibitors <b>16</b> and <b>18</b> exerted comparable anti-CSC activity to that of known inhibitor <b>1</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C and D). Compound <b>1</b> can inhibit the growth of IDH1 mutated BT142 glioma stem-like cells but did not affect BXD-3752 cells without IDH1 mutation. These results from the two chemo-types of inhibitors (i.e., compounds <b>1</b>, <b>16</b> and <b>18</b>) show that the function of mutant IDH1 seems of importance for maintenance of glioma stem cells bearing an IDH1 mutation. However, presumably due to the presence of other gene mutations, inhibition of mutant IDH1 alone does not significantly affect proliferation of the bulk of nonstem like cancer cells, such as those in HT1080. This probably explains the reason why these mutant IDH1 inhibitors did not affect the overall proliferation rate of HT1080 but impaired self-renewal ability of the HT1080 stem-like cells.</div><div class="NLM_p last">Although 2-thiohydantoin and related compounds have been reported to be associated with a number of other biological activities and implicated as promiscuous inhibitors,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> our SAR studies showed this is unlikely to be the case because our compounds showed a wide range of activity (<i>K</i><sub>i</sub>: 0.4 to >50 μM) as well as several SARs for inhibition of IDH1(R132H). Enzyme kinetics and ITC studies also suggested that compound <b>18</b> is a competitive inhibitor of IDH1(R132H) against the substrate α-KG. Our X-ray crystallographic investigation further revealed the exact binding structures of compounds <b>16</b> and <b>22</b> in IDH1(R132H), which could serve as a useful platform for more rational inhibitor design and development.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Genetic studies have shown frequent mutations of IDH are found in certain cancers, especially in gliomas. Biochemical studies have revealed that the mutant IDH enzymes can reduce α-KG, an important cellular metabolite, to D2HG, which inhibits histone lysine demethylation. Further biological and pharmacological studies demonstrated that mutant IDH1 is a viable drug target for these cancers. However, there have been limited chemotypes of inhibitors of mutant IDH1.</div><div class="NLM_p last">Several series of 5-substituted 2-thiohydantoin and related compounds were synthesized, among which several compounds were found to be potent and selective inhibitors of mutant IDH1 with <i>K</i><sub>i</sub> values as low as 420 nM. SAR studies of these compounds showed that the (1) 2-thiohydantoin ring is the most favorable core, (2) a small substituent, such as -H or -Me, is more favored at the 3-position, and that (3) 2-pyridinone-5-yl group at the 5-postion is the most potent for the inhibition of mutant IDH1. X-ray crystallographic studies revealed the binding structures of compounds <b>16</b> and <b>22</b> in IDH1(R132H), providing a platform for further structure-based inhibitor design. Enzyme kinetics as well as binding thermodynamics studies indicated that the most potent inhibitor <b>18</b> is a competitive inhibitor with respect to the substrate α-KG and exerts a noncompetitive mode of action to the cofactor NADPH. Cell biology studies showed that mutant IDH1 inhibitors <b>16</b> and <b>18</b> can lower the concentrations of D2HG in HT1080 cells. These compounds can also reverse the hypermethyled phenotype of histones and selectively suppress the self-renewal ability of glioma stem-like cells with IDH1 R132H mutation. These compounds are therefore novel chemical probes for studies of mutant IDH1 in cancer and represent a new scaffold for drug discovery targeting IDH1 mutated cancers.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents were purchased from Alfa Aesar (Ward Hill, MA) or Aldrich (Milwaukee, WI). Compounds were characterized by <sup>1</sup>H NMR on a Varian (Palo Alto, CA) 400-MR spectrometer, and the identities of selected compounds <b>16</b>, <b>18</b>, and <b>22</b> were confirmed with high resolution mass spectra (HRMS) using a ThermoFisher LTQ-Orbitrap mass spectrometer. Compound purity was monitored by a Shimadzu Prominence HPLC with a Phenomenex C18 column (4.6 × 250 mm, methonal/H<sub>2</sub>O 60:40, monitored at 254 and 280 nm). The purities of all compounds were found to be >95%.</div><div class="NLM_p">The synthesis and characterization of compounds <b>4</b>–<b>41</b> can be found in the <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>, Experimental Section.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Expression, Purification, and Inhibition of Human WT and Mutant IDH1</h3><div class="NLM_p last">Expression, purification, and inhibition of the WT, R132H, and R132C IDH1 enzymes followed our previously published methods.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> Enzyme inhibition assay for IDH1(R132H) and IDH1(R132C) was performed in a 96-well microplate in 50 mM HEPES buffer (pH 7.5) containing the enzyme (100 nM), 4 mM MgCl<sub>2</sub>, 100 μM NADPH, and increasing concentrations of an inhibitor. Upon incubation for 5 min, α-KG (1 mM) was added to initiate the reaction. The optical absorbance of each well was monitored every 30 s at 340 nm with a Beckman DTX-880 microplate reader. The inhibition assay of WT IDH1 was carried out in 50 mM HEPES buffer containing the enzyme (30 nM), 4 mM MgCl<sub>2</sub>, 1 mM NADP<sup>+</sup>, an inhibitor, and 200 μM sodium (<span class="smallcaps smallerCapital">d</span>)-isocitrate. The reaction was monitored by an increase in optical absorbance at 340 nm. The data were imported into Prism (version 5.0, GraphPad), and IC<sub>50</sub> values were calculated by using standard dose–response curve fitting. For compounds with IC<sub>50</sub>s ≫ [enzyme], <i>K</i><sub>i</sub> was calculated using the Cheng–Prusoff equation <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + [S]/<i>K</i><sub>m</sub>), where [S] is the concentration of α-KG (1 mM), and <i>K</i><sub>m</sub> is the literature value of 0.965 mM for R132H and 0.295 mM for R132C. For compounds with IC<sub>50</sub> values < 1 μM, <i>K</i><sub>i</sub> values were determined with the Morrison tight inhibition modeling in Prism. The reported results are the average from at least three independent experiments.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Crystallization and Structure Determination</h3><div class="NLM_p last">IDH1(R132H) (10 mg/mL) was crystallized together with 2 mM compounds <b>2</b> or <b>3</b>, 10 mM NADPH, and 10 mM CaCl<sub>2</sub> in a solution of 1.75 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> and 0.1 M NaOAc (pH 5.6). Prism-like single crystals appeared in ∼5 days. Diffraction data were collected using a Rigaku FR-E+ SuperBright X-ray source at Baylor College of Medicine and processed with the program HKL2000.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The initial structure was obtained by molecular replacement using the program Phaser,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> with the coordinates of 3MAP as a target. Structural refinement was performed using the program Refmac<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> or PHENIX.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The coordinates of IDH1(R132H) in complex with <b>16</b> and <b>22</b> were deposited into Protein Data Bank as entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XRX">4XRX</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XS3">4XS3</a>, respectively.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Steady-State Kinetic Study</h3><div class="NLM_p last">A steady-state kinetic inhibition experiment was conducted by measuring the initial velocities of reactions catalyzed by IDH1(R132H) while varying the concentrations of compound <b>18</b>, α-KG, and NADPH. Data were imported into SigmaPlot (version 13, Systat Software, Inc.) and fitted to competitive, noncompetitive, and uncompetitive inhibition models. The best kinetic models were determined by the highest <i>R</i><sup>2</sup> and lowest AICc values. Lineweaver–Burk or Michaelis–Menten plots were generated by Sigmaplot.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Isothermal Titration Calorimetry Study</h3><div class="NLM_p last">ITC experiments were performed using a Nano ITC LV (190 μL) instrument from TA Instruments (New Castle, DE) at 298 K. A 190 μL solution containing specified concentrations of IDH1(R132H), NADPH, and α-KG in 30 mM Tris-HCl buffer (pH 7.4) with 4 mM MgCl<sub>2</sub> and 150 mM NaCl was added into the sample cell. Compound <b>18</b> (1 mM) in the same buffer solution (50 μL) was transferred into the syringe of the instrument. Upon reaching temperature equilibrium, 25 injections (2 μL each) of the inhibitor were used for the titration. ITC data were then imported into NanoAnalyze software (TA Instruments, New Castle, DE). The titration baseline was corrected, and the Δ<i>H</i> and <i>K</i><sub>a</sub> values for the binding of the inhibitor were obtained by fitting into the independent model in the software. All experiments were repeated for at least one time to ensure that the reported data are reliable.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cell Culture and Growth Inhibition for Cells That Attach to a Plate</h3><div class="NLM_p last">Five thousand to 10<sup>5</sup> cells/well were inoculated into each well of a 96-well plate and cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37 °C in a 5% CO<sub>2</sub> atmosphere with 100% humidity. Upon culturing overnight for cell attachment, increasing concentrations of a compound were added and incubated for 48–96 h. Cell viability was then assessed with an MTT assay.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> D2HG Production Inhibition in HT1080 Cells</h3><div class="NLM_p last">Inhibition of cellular mutant IDH1 was determined following our previous protocol.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Then, 10<sup>5</sup> HT1080 cells/well were cultured in DMEM containing 10% dialyzed FBS and treated with increasing concentrations of an inhibitor for 48 h. Medium was collected, diluted with MeOH (8 mL), and centrifuged (20,000 rpm for 3 min). D2HG in the supernatant was determined by HPLC-MS using our previously published methods.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Inhibition of the Proliferation of Glioma Stem-Like Cells</h3><div class="NLM_p last">Two glioma cells BT142 and BXD-3752 were cultured as neurospheres in serum-free cell growth media at 37 °C in a 5% CO<sub>2</sub> atmosphere with 100% humidity as described previously.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Then, 2000 cells/well were added into 96-well plates and treated with increasing concentrations of a compound for 14 days. Cell viability was determined by Cell Counting Kit-8 (Dojindo Molecular Technologies, Rockville, MD) according to the manufacturer’s instructions.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00684">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00684" class="ext-link">10.1021/acs.jmedchem.5b00684</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Compound synthesis and characterization</p><p class="last">(<a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings spreadsheet</p><p class="last">(<a href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf">jm5b00684_si_001.pdf (966.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_002.csv">jm5b00684_si_002.csv (2.1 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b00684" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40485" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40485" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongcheng Song</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology, ‡Department of Pediatrics-Oncology, and §Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d242e32333a1d3f3e3073383928"><span class="__cf_email__" data-cfemail="18616b77767f587a7b75367d7c6d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fangrui Wu</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology, ‡Department of Pediatrics-Oncology, and §Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Jiang</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology, ‡Department of Pediatrics-Oncology, and §Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Baisong Zheng</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology, ‡Department of Pediatrics-Oncology, and §Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mari Kogiso</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology, ‡Department of Pediatrics-Oncology, and §Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuan Yao</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology, ‡Department of Pediatrics-Oncology, and §Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chao Zhou</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology, ‡Department of Pediatrics-Oncology, and §Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Nan Li</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacology, ‡Department of Pediatrics-Oncology, and §Dan L. Duncan
Cancer Center, Baylor College of Medicine, 1 Baylor Plaza, Houston, Texas 77030, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>F.W., H.J., and B.Z. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1831e1973-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72110" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72110" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by a grant (RP140469) from Cancer Prevention and Research Institute of Texas (CPRIT) and a grant (R01NS080963) from the National Institute of Neurological Disorders and Stroke (NINDS/NIH) to Y.S.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i25" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i25"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i26" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i26"> Abbrevations Used</h2><tr><td class="NLM_term">α-KG</td><td class="NLM_def"><p class="first last">α-ketoglutaric acid</p></td></tr><tr><td class="NLM_term">D2HG</td><td class="NLM_def"><p class="first last"><span class="smallcaps smallerCapital">d</span>-2-hydroxyglutaric acid</p></td></tr><tr><td class="NLM_term">ICT</td><td class="NLM_def"><p class="first last">isocitric acid</p></td></tr><tr><td class="NLM_term">IDH</td><td class="NLM_def"><p class="first last">isocitrate hydrogenase</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">isothermal titration calorimetry</p></td></tr><tr><td class="NLM_term">R132H</td><td class="NLM_def"><p class="first last">Arg132 mutation to His</p></td></tr><tr><td class="NLM_term">R132C</td><td class="NLM_def"><p class="first last">Arg132 mutation to Cys</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span> </span><span class="NLM_article-title">Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">33946</span><span class="NLM_x">–</span> <span class="NLM_lpage">33957</span><span class="refDoi"> DOI: 10.1074/jbc.M404298200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1074%2Fjbc.M404298200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=15173171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=33946-33957&author=X.+Xuauthor=J.+Zhaoauthor=Z.+Xuauthor=B.+Pengauthor=Q.+Huangauthor=E.+Arnoldauthor=J.+Ding&title=Structures+of+human+cytosolic+NADP-dependent+isocitrate+dehydrogenase+reveal+a+novel+self-regulatory+mechanism+of+activity&doi=10.1074%2Fjbc.M404298200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Cytosolic NADP-dependent Isocitrate Dehydrogenase Reveal a Novel Self-regulatory Mechanism of Activity</span></div><div class="casAuthors">Xu, Xiang; Zhao, Jingyue; Xu, Zhen; Peng, Baozhen; Huang, Qiuhua; Arnold, Eddy; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">33946-33957</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Isocitrate dehydrogenases (IDHs) catalyze the oxidative decarboxylation of isocitrate to α-ketoglutarate, and regulation of the enzymic activity of IDHs is crucial for their biol. functions.  Bacterial IDHs are reversibly regulated by phosphorylation of a strictly conserved serine residue at the active site.  Eukaryotic NADP-dependent IDHs (NADP-IDHs) have been shown to have diverse important biol. functions; however, their regulatory mechanism remains unclear.  Structural studies of human cytosolic NADP-IDH (HcIDH) in complex with NADP and in complex with NADP, isocitrate, and Ca2+ reveal three biol. relevant conformational states of the enzyme that differ substantially in the structure of the active site and in the overall structure.  A structural segment at the active site that forms a conserved α-helix in all known NADP-IDH structures assumes a loop conformation in the open, inactive form of HcIDH; a partially unraveled α-helix in the semi-open, intermediate form; and an α-helix in the closed, active form.  The side chain of Asp279 of this segment occupies the isocitrate-binding site and forms hydrogen bonds with Ser94 (the equiv. of the phosphorylation site in bacterial IDHs) in the inactive form and chelates the metal ion in the active form.  The structural data led us to propose a novel self-regulatory mechanism for HcIDH that mimics the phosphorylation mechanism used by the bacterial homologs, consistent with biochem. and biol. data.  This mechanism might be applicable to other eukaryotic NADP-IDHs.  The results also provide insights into the recognition and specificity of substrate and cofactor by eukaryotic NADP-IDHs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomJaUxoQoMZ7Vg90H21EOLACvtfcHk0lhv1JTKO-8a0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs70%253D&md5=79474e467a8cca43c26551c86745b3e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404298200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404298200%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520human%2520cytosolic%2520NADP-dependent%2520isocitrate%2520dehydrogenase%2520reveal%2520a%2520novel%2520self-regulatory%2520mechanism%2520of%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D33946%26epage%3D33957%26doi%3D10.1074%2Fjbc.M404298200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leary, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angenendt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankoo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallia, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busam, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekleab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartigan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strausberg, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinjo, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karchin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmigiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span> </span><span class="NLM_article-title">An integrated genomic analysis of human glioblastoma multiforme</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1812</span><span class="refDoi"> DOI: 10.1126/science.1164382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1126%2Fscience.1164382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=18772396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2008&pages=1807-1812&author=D.+W.+Parsonsauthor=S.+Jonesauthor=X.+Zhangauthor=J.+C.+Linauthor=R.+J.+Learyauthor=P.+Angenendtauthor=P.+Mankooauthor=H.+Carterauthor=I.+M.+Siuauthor=G.+L.+Galliaauthor=A.+Oliviauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=S.+Keirauthor=T.+Nikolskayaauthor=Y.+Nikolskyauthor=D.+A.+Busamauthor=H.+Tekleabauthor=L.+A.+Diazauthor=J.+Hartiganauthor=D.+R.+Smithauthor=R.+L.+Strausbergauthor=S.+K.+Marieauthor=S.+M.+Shinjoauthor=H.+Yanauthor=G.+J.+Rigginsauthor=D.+D.+Bignerauthor=R.+Karchinauthor=N.+Papadopoulosauthor=G.+Parmigianiauthor=B.+Vogelsteinauthor=V.+E.+Velculescuauthor=K.+W.+Kinzler&title=An+integrated+genomic+analysis+of+human+glioblastoma+multiforme&doi=10.1126%2Fscience.1164382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">An Integrated genomic analysis of human glioblastoma multiforme</span></div><div class="casAuthors">Parsons, D. Williams; Jones, Sian; Zhang, Xiaosong; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Mankoo, Parminder; Carter, Hannah; Siu, I.-Mei; Gallia, Gary L.; Olivi, Alessandro; McLendon, Roger; Rasheed, B. Ahmed; Keir, Stephen; Nikolskaya, Tatiana; Nikolsky, Yuri; Busam, Dana A.; Tekleab, Hanna; Diaz, Luis A., Jr.; Hartigan, James; Smith, Doug R.; Strausberg, Robert L.; Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba; Yan, Hai; Riggins, Gregory J.; Bigner, Darell D.; Karchin, Rachel; Papadopoulos, Nick; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">5897</span>),
    <span class="NLM_cas:pages">1807-1812</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review based on author's research.  Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer.  To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, detd. the presence of amplifications and deletions using high-d. oligonucleotide arrays, and performed gene expression analyses using next-generation sequencing technologies in 22 human tumor samples.  This comprehensive anal. led to the discovery of a variety of genes that were not known to be altered in GBMs.  Most notably, we found recurrent mutations in the active site of isocitrate dehydrogenase 1 (IDH1) in 12% of GBM patients.  Mutations in IDH1 occurred in a large fraction of young patients and in most patients with secondary GBMs and were assocd. with an increase in overall survival.  These studies demonstrate the value of unbiased genomic analyses in the characterization of human brain cancer and identify a potentially useful genetic alteration for the classification and targeted therapy of GBMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFSe-eB8psp7Vg90H21EOLACvtfcHk0lhv1JTKO-8a0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrE&md5=88c9e87c4b9dc8ebedcaa2b5d9f3ce13</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164382%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DJ.%2BC.%26aulast%3DLeary%26aufirst%3DR.%2BJ.%26aulast%3DAngenendt%26aufirst%3DP.%26aulast%3DMankoo%26aufirst%3DP.%26aulast%3DCarter%26aufirst%3DH.%26aulast%3DSiu%26aufirst%3DI.%2BM.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26aulast%3DOlivi%26aufirst%3DA.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DKeir%26aufirst%3DS.%26aulast%3DNikolskaya%26aufirst%3DT.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DBusam%26aufirst%3DD.%2BA.%26aulast%3DTekleab%26aufirst%3DH.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DHartigan%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BR.%26aulast%3DStrausberg%26aufirst%3DR.%2BL.%26aulast%3DMarie%26aufirst%3DS.%2BK.%26aulast%3DShinjo%26aufirst%3DS.%2BM.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DAn%2520integrated%2520genomic%2520analysis%2520of%2520human%2520glioblastoma%2520multiforme%26jtitle%3DScience%26date%3D2008%26volume%3D321%26spage%3D1807%26epage%3D1812%26doi%3D10.1126%2Fscience.1164382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span> </span><span class="NLM_article-title">Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/j.ccr.2010.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1016%2Fj.ccr.2010.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=21251613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvValsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=17-30&author=W.+Xuauthor=H.+Yangauthor=Y.+Liuauthor=Y.+Yangauthor=P.+Wangauthor=S.+H.+Kimauthor=S.+Itoauthor=C.+Yangauthor=M.+T.+Xiaoauthor=L.+X.+Liuauthor=W.+Q.+Jiangauthor=J.+Liuauthor=J.+Y.+Zhangauthor=B.+Wangauthor=S.+Fryeauthor=Y.+Zhangauthor=Y.+H.+Xuauthor=Q.+Y.+Leiauthor=K.+L.+Guanauthor=S.+M.+Zhaoauthor=Y.+Xiong&title=Oncometabolite+2-hydroxyglutarate+is+a+competitive+inhibitor+of+alpha-ketoglutarate-dependent+dioxygenases&doi=10.1016%2Fj.ccr.2010.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases</span></div><div class="casAuthors">Xu, Wei; Yang, Hui; Liu, Ying; Yang, Ying; Wang, Ping; Kim, Se-Hee; Ito, Shinsuke; Yang, Chen; Wang, Pu; Xiao, Meng-Tao; Liu, Li-xia; Jiang, Wen-qing; Liu, Jing; Zhang, Jin-ye; Wang, Bin; Frye, Stephen; Zhang, Yi; Xu, Yan-hui; Lei, Qun-ying; Guan, Kun-Liang; Zhao, Shi-min; Xiong, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-30</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: IDH1 and IDH2 mutations occur frequently in gliomas and acute myeloid leukemia, leading to simultaneous loss and gain of activities in the prodn. of α-ketoglutarate (α-KG) and 2-hydroxyglutarate (2-HG), resp.  Here we demonstrate that 2-HG is a competitive inhibitor of multiple α-KG-dependent dioxygenases, including histone demethylases and the TET family of 5-methylcytosine (5mC) hydroxylases. 2-HG occupies the same space as α-KG does in the active site of histone demethylases.  Ectopic expression of tumor-derived IDH1 and IDH2 mutants inhibits histone demethylation and 5mC hydroxylation.  In glioma, IDH1 mutations are assocd. with increased histone methylation and decreased 5-hydroxylmethylcytosine (5hmC).  Hence, tumor-derived IDH1 and IDH2 mutations reduce α-KG and accumulate an α-KG antagonist, 2-HG, leading to genome-wide histone and DNA methylation alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpry-WZlrav7Vg90H21EOLACvtfcHk0lilvPlwdK6Lvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvValsQ%253D%253D&md5=27f1e2d50b9dc1dd30bcc576d6318662</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DM.%2BT.%26aulast%3DLiu%26aufirst%3DL.%2BX.%26aulast%3DJiang%26aufirst%3DW.%2BQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DFrye%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DLei%26aufirst%3DQ.%2BY.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DZhao%26aufirst%3DS.%2BM.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DOncometabolite%25202-hydroxyglutarate%2520is%2520a%2520competitive%2520inhibitor%2520of%2520alpha-ketoglutarate-dependent%2520dioxygenases%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D17%26epage%3D30%26doi%3D10.1016%2Fj.ccr.2010.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittinger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkein, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1084/jem.20092506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1084%2Fjem.20092506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20142433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFGqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=339-344&author=S.+Grossauthor=R.+A.+Cairnsauthor=M.+D.+Mindenauthor=E.+M.+Driggersauthor=M.+A.+Bittingerauthor=H.+G.+Jangauthor=M.+Sasakiauthor=S.+Jinauthor=D.+P.+Schenkeinauthor=S.+M.+Suauthor=L.+Dangauthor=V.+R.+Fantinauthor=T.+W.+Mak&title=Cancer-associated+metabolite+2-hydroxyglutarate+accumulates+in+acute+myelogenous+leukemia+with+isocitrate+dehydrogenase+1+and+2+mutations&doi=10.1084%2Fjem.20092506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span></div><div class="casAuthors">Gross, Stefan; Cairns, Rob A.; Minden, Mark D.; Driggers, Edward M.; Bittinger, Mark A.; Jang, Hyun Gyung; Sasaki, Masato; Jin, Shengfang; Schenkein, David P.; Su, Shinsan M.; Dang, Lenny; Fantin, Valeria R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-344</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2), are present in most gliomas and secondary glioblastomas, but are rare in other neoplasms.  IDH1/2 mutations are heterozygous, and affect a single Arg residue.  Recently, IDH1 mutations were identified in 8% of acute myelogenous leukemia (AML) patients.  A glioma study revealed that IDH1 mutations cause a gain-of-function, resulting in the prodn. and accumulation of 2-hydroxyglutarate (2-HG).  Genotyping of 145 AML biopsies identified 11 IDH1 R132 mutant samples.  Liq. chromatog.-mass spectrometry metabolite screening revealed increased 2-HG levels in IDH1 R132 mutant cells and sera, and uncovered 2 IDH2 R172K mutations.  IDH1/2 mutations were assocd. with normal karyotypes.  Recombinant IDH1 R132C and IDH2 R172K proteins catalyze the novel NADP (NADPH)-dependent redn. of α-ketoglutarate (α-KG) to 2-HG.  The IDH1 R132C mutation commonly found in AML reduces the affinity for isocitrate, and increases the affinity for NADPH and α-KG.  This prevents the oxidative decarboxylation of isocitrate to α-KG, and facilitates the conversion of α-KG to 2-HG.  IDH1/2 mutations confer an enzymic gain of function that dramatically increases 2-HG in AML.  This provides an explanation for the heterozygous acquisition of these mutations during tumorigenesis.  2-HG is a tractable metabolic biomarker of mutant IDH1/2 enzyme activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8uyv8xo4qzLVg90H21EOLACvtfcHk0lilvPlwdK6Lvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFGqur0%253D&md5=7e900e78bc4b5a715c504272d6248551</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1084%2Fjem.20092506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20092506%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DS.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DCancer-associated%2520metabolite%25202-hydroxyglutarate%2520accumulates%2520in%2520acute%2520myelogenous%2520leukemia%2520with%2520isocitrate%2520dehydrogenase%25201%2520and%25202%2520mutations%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D339%26epage%3D344%26doi%3D10.1084%2Fjem.20092506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batinic-Haberle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations in gliomas</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span><span class="refDoi"> DOI: 10.1056/NEJMoa0808710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1056%2FNEJMoa0808710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=19228619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=765-773&author=H.+Yanauthor=D.+W.+Parsonsauthor=G.+Jinauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=W.+Yuanauthor=I.+Kosauthor=I.+Batinic-Haberleauthor=S.+Jonesauthor=G.+J.+Rigginsauthor=H.+Friedmanauthor=A.+Friedmanauthor=D.+Reardonauthor=J.+Herndonauthor=K.+W.+Kinzlerauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=D.+D.+Bigner&title=IDH1+and+IDH2+mutations+in+gliomas&doi=10.1056%2FNEJMoa0808710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations in gliomas</span></div><div class="casAuthors">Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Ahmed Rasheed, B.; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">765-773</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: A recent genomewide mutational anal. of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).  METHODS: We detd. the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system (CNS) tumors and 494 non-CNS tumors.  The enzymic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was detd. in cultured glioma cells that were transfected with these genes.  RESULTS: We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower-grade lesions.  Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid (R172) of the IDH2 gene.  Tumors with IDH1 or IDH2 mutations had distinctive genetic and clin. characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes.  Each of four tested IDH1 and IDH2 mutations reduced the enzymic activity of the encoded protein.  CONCLUSIONS: Mutations of NADP+-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMldYfHJnRn7Vg90H21EOLACvtfcHk0lhvz0-YAxr-cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D&md5=2b3b5db5e16f3714f3ed6cab86939031</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808710%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DKos%26aufirst%3DI.%26aulast%3DBatinic-Haberle%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DA.%26aulast%3DReardon%26aufirst%3DD.%26aulast%3DHerndon%26aufirst%3DJ.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520in%2520gliomas%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D765%26epage%3D773%26doi%3D10.1056%2FNEJMoa0808710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hartmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christians, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawrin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unterberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesseling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reifenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span> </span><span class="NLM_article-title">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1007/s00401-009-0561-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1007%2Fs00401-009-0561-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=19554337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A280%3ADC%252BD1MrpvVOqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2009&pages=469-474&author=C.+Hartmannauthor=J.+Meyerauthor=J.+Balssauthor=D.+Capperauthor=W.+Muellerauthor=A.+Christiansauthor=J.+Felsbergauthor=M.+Wolterauthor=C.+Mawrinauthor=W.+Wickauthor=M.+Wellerauthor=C.+Herold-Mendeauthor=A.+Unterbergauthor=J.+W.+Jeukenauthor=P.+Wesselingauthor=G.+Reifenbergerauthor=A.+von+Deimling&title=Type+and+frequency+of+IDH1+and+IDH2+mutations+are+related+to+astrocytic+and+oligodendroglial+differentiation+and+age%3A+a+study+of+1%2C010+diffuse+gliomas&doi=10.1007%2Fs00401-009-0561-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas</span></div><div class="casAuthors">Hartmann Christian; Meyer Jochen; Balss Jorg; Capper David; Mueller Wolf; Christians Arne; Felsberg Jorg; Wolter Marietta; Mawrin Christian; Wick Wolfgang; Weller Michael; Herold-Mende Christel; Unterberg Andreas; Jeuken Judith W M; Wesseling Peter; Reifenberger Guido; von Deimling Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Somatic mutations in the IDH1 gene encoding cytosolic NADP+-dependent isocitrate dehydrogenase have been shown in the majority of astrocytomas, oligodendrogliomas and oligoastrocytomas of WHO grades II and III.  IDH2 encoding mitochondrial NADP+-dependent isocitrate dehydrogenase is also mutated in these tumors, albeit at much lower frequencies.  Preliminary data suggest an importance of IDH1 mutation for prognosis showing that patients with anaplastic astrocytomas, oligodendrogliomas and oligoastrocytomas harboring IDH1 mutations seem to fare much better than patients without this mutation in their tumors.  To determine mutation types and their frequencies, we examined 1,010 diffuse gliomas.  We detected 716 IDH1 mutations and 31 IDH2 mutations.  We found 165 IDH1 (72.7%) and 2 IDH2 mutations (0.9%) in 227 diffuse astrocytomas WHO grade II, 146 IDH1 (64.0%) and 2 IDH2 mutations (0.9%) in 228 anaplastic astrocytomas WHO grade III, 105 IDH1 (82.0%) and 6 IDH2 mutations (4.7%) in 128 oligodendrogliomas WHO grade II, 121 IDH1 (69.5%) and 9 IDH2 mutations (5.2%) in 174 anaplastic oligodendrogliomas WHO grade III, 62 IDH1 (81.6%) and 1 IDH2 mutations (1.3%) in 76 oligoastrocytomas WHO grade II and 117 IDH1 (66.1%) and 11 IDH2 mutations (6.2%) in 177 anaplastic oligoastrocytomas WHO grade III.  We report on an inverse association of IDH1 and IDH2 mutations in these gliomas and a non-random distribution of the mutation types within the tumor entities.  IDH1 mutations of the R132C type are strongly associated with astrocytoma, while IDH2 mutations predominantly occur in oligodendroglial tumors.  In addition, patients with anaplastic glioma harboring IDH1 mutations were on average 6 years younger than those without these alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWtaE6XzJLN_6xYuD7tu2XfW6udTcc2eaJnG9PC6xAHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrpvVOqsA%253D%253D&md5=cf2e0709bbe2f6d49d466b7083f2e486</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00401-009-0561-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-009-0561-9%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DChristians%26aufirst%3DA.%26aulast%3DFelsberg%26aufirst%3DJ.%26aulast%3DWolter%26aufirst%3DM.%26aulast%3DMawrin%26aufirst%3DC.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DUnterberg%26aufirst%3DA.%26aulast%3DJeuken%26aufirst%3DJ.%2BW.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DType%2520and%2520frequency%2520of%2520IDH1%2520and%2520IDH2%2520mutations%2520are%2520related%2520to%2520astrocytic%2520and%2520oligodendroglial%2520differentiation%2520and%2520age%253A%2520a%2520study%2520of%25201%252C010%2520diffuse%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D2009%26volume%3D118%26spage%3D469%26epage%3D474%26doi%3D10.1007%2Fs00401-009-0561-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Amary, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacsi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berisha, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskandarpour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presneau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogendoorn, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirabosco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, A. M.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1002/path.2913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1002%2Fpath.2913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=21598255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVGms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2011&pages=334-343&author=M.+F.+Amaryauthor=K.+Bacsiauthor=F.+Maggianiauthor=S.+Damatoauthor=D.+Halaiauthor=F.+Berishaauthor=R.+Pollockauthor=P.+O%E2%80%99Donnellauthor=A.+Grigoriadisauthor=T.+Dissauthor=M.+Eskandarpourauthor=N.+Presneauauthor=P.+C.+Hogendoornauthor=A.+Futrealauthor=R.+Tiraboscoauthor=A.+M.+Flanagan&title=IDH1+and+IDH2+mutations+are+frequent+events+in+central+chondrosarcoma+and+central+and+periosteal+chondromas+but+not+in+other+mesenchymal+tumours&doi=10.1002%2Fpath.2913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumors</span></div><div class="casAuthors">Amary, M. Fernanda; Bacsi, Krisztian; Maggiani, Francesca; Damato, Stephen; Halai, Dina; Berisha, Fitim; Pollock, Robin; O'Donnell, Paul; Grigoriadis, Anita; Diss, Tim; Eskandarpour, Malihe; Presneau, Nadege; Hogendoorn, Pancras C.; Futreal, Andrew; Tirabosco, Roberto; Flanagan, Adrienne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">334-343</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Somatic mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 occur in gliomas and acute myeloid leukemia (AML).  Since patients with multiple enchondromas have occasionally been reported to have these conditions, we hypothesized that the same mutations would occur in cartilaginous neoplasms.  Approx. 1200 mesenchymal tumors, including 220 cartilaginous tumors, 222 osteosarcomas and another ∼750 bone and soft tissue tumors, were screened for IDH1 R132 mutations, using Sequenom mass spectrometry.  Cartilaginous tumors and chondroblastic osteosarcomas, wild-type for IDH1 R132, were analyzed for IDH2 (R172, R140) mutations.  Validation was performed by capillary sequencing and restriction enzyme digestion.  Heterozygous somatic IDH1/IDH2 mutations, which result in the prodn. of a potential oncometabolite, 2-hydroxyglutarate, were only detected in central and periosteal cartilaginous tumors, and were found in at least 56% of these, ∼40% of which were represented by R132C.  IDH1 R132H mutations were confirmed by immunoreactivity for this mutant allele.  The ratio of IDH1:IDH2 mutation was 10.6 : 1.  No IDH2 R140 mutations were detected.  Mutations were detected in enchondromas through to conventional central and dedifferentiated chondrosarcomas, in patients with both solitary and multiple neoplasms.  No germline mutations were detected.  No mutations were detected in peripheral chondrosarcomas and osteochondromas.  In conclusion, IDH1 and IDH2 mutations represent the first common genetic abnormalities to be identified in conventional central and periosteal cartilaginous tumors.  As in gliomas and AML, the mutations appear to occur early in tumorigenesis.  We speculate that a mosaic pattern of IDH-mutation-bearing cells explains the reports of diverse tumors (gliomas, AML, multiple cartilaginous neoplasms, haemangiomas) occurring in the same patient.  Copyright © 2011 Pathol. Society of Great Britain and Ireland.  Published by John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotnKlczQQ1mLVg90H21EOLACvtfcHk0ljy_7ahpTZ3ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVGms7c%253D&md5=59128645aa54d08a4251d8f763ccb28e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fpath.2913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2913%26sid%3Dliteratum%253Aachs%26aulast%3DAmary%26aufirst%3DM.%2BF.%26aulast%3DBacsi%26aufirst%3DK.%26aulast%3DMaggiani%26aufirst%3DF.%26aulast%3DDamato%26aufirst%3DS.%26aulast%3DHalai%26aufirst%3DD.%26aulast%3DBerisha%26aufirst%3DF.%26aulast%3DPollock%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DP.%26aulast%3DGrigoriadis%26aufirst%3DA.%26aulast%3DDiss%26aufirst%3DT.%26aulast%3DEskandarpour%26aufirst%3DM.%26aulast%3DPresneau%26aufirst%3DN.%26aulast%3DHogendoorn%26aufirst%3DP.%2BC.%26aulast%3DFutreal%26aufirst%3DA.%26aulast%3DTirabosco%26aufirst%3DR.%26aulast%3DFlanagan%26aufirst%3DA.%2BM.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520are%2520frequent%2520events%2520in%2520central%2520chondrosarcoma%2520and%2520central%2520and%2520periosteal%2520chondromas%2520but%2520not%2520in%2520other%2520mesenchymal%2520tumours%26jtitle%3DJ.%2520Pathol.%26date%3D2011%26volume%3D224%26spage%3D334%26epage%3D343%26doi%3D10.1002%2Fpath.2913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittinger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prins, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span><span class="refDoi"> DOI: 10.1038/nature08617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fnature08617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=19935646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=739-744&author=L.+Dangauthor=D.+W.+Whiteauthor=S.+Grossauthor=B.+D.+Bennettauthor=M.+A.+Bittingerauthor=E.+M.+Driggersauthor=V.+R.+Fantinauthor=H.+G.+Jangauthor=S.+Jinauthor=M.+C.+Keenanauthor=K.+M.+Marksauthor=R.+M.+Prinsauthor=P.+S.+Wardauthor=K.+E.+Yenauthor=L.+M.+Liauauthor=J.+D.+Rabinowitzauthor=L.+C.+Cantleyauthor=C.+B.+Thompsonauthor=M.+G.+van+der+Heidenauthor=S.+M.+Su&title=Cancer-associated+IDH1+mutations+produce+2-hydroxyglutarate&doi=10.1038%2Fnature08617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span></div><div class="casAuthors">Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun-Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7274</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers.  These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme's ability to catalyze conversion of isocitrate to α-ketoglutarate.  However, only a single copy of the gene is mutated in tumors, raising the possibility that the mutations do not result in a simple loss of function.  Here we show that cancer-assocd. IDH1 mutations result in a new ability of the enzyme to catalyze the NADPH-dependent redn. of α-ketoglutarate to R(-)-2-hydroxyglutarate (2HG).  Structural studies demonstrate that when arginine 132 is mutated to histidine, residues in the active site are shifted to produce structural changes consistent with reduced oxidative decarboxylation of isocitrate and acquisition of the ability to convert α-ketoglutarate to 2HG.  Excess accumulation of 2HG has been shown to lead to an elevated risk of malignant brain tumors in patients with inborn errors of 2HG metab.  Similarly, in human malignant gliomas harbouring IDH1 mutations, we find markedly elevated levels of 2HG.  These data demonstrate that the IDH1 mutations result in prodn. of the onco-metabolite 2HG, and indicate that the excess 2HG which accumulates in vivo contributes to the formation and malignant progression of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIgPaD-aavrVg90H21EOLACvtfcHk0ljy_7ahpTZ3ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE&md5=b8661605276da5cbd92641e45c5b8c87</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature08617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08617%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DM.%2BC.%26aulast%3DMarks%26aufirst%3DK.%2BM.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3Dvan%2Bder%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DCancer-associated%2520IDH1%2520mutations%2520produce%25202-hydroxyglutarate%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D739%26epage%3D744%26doi%3D10.1038%2Fnature08617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coller, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedvat, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1016/j.ccr.2010.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1016%2Fj.ccr.2010.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20171147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=225-234&author=P.+S.+Wardauthor=J.+Patelauthor=D.+R.+Wiseauthor=O.+Abdel-Wahabauthor=B.+D.+Bennettauthor=H.+A.+Collerauthor=J.+R.+Crossauthor=V.+R.+Fantinauthor=C.+V.+Hedvatauthor=A.+E.+Perlauthor=J.+D.+Rabinowitzauthor=M.+Carrollauthor=S.+M.+Suauthor=K.+A.+Sharpauthor=R.+L.+Levineauthor=C.+B.+Thompson&title=The+common+feature+of+leukemia-associated+IDH1+and+IDH2+mutations+is+a+neomorphic+enzyme+activity+converting+alpha-ketoglutarate+to+2-hydroxyglutarate&doi=10.1016%2Fj.ccr.2010.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate</span></div><div class="casAuthors">Ward, Patrick S.; Patel, Jay; Wise, David R.; Abdel-Wahab, Omar; Bennett, Bryson D.; Coller, Hilary A.; Cross, Justin R.; Fantin, Valeria R.; Hedvat, Cyrus V.; Perl, Alexander E.; Rabinowitz, Joshua D.; Carroll, Martin; Su, Shinsan M.; Sharp, Kim A.; Levine, Ross L.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-234</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The somatic mutations in cytosolic isocitrate dehydrogenase 1 (IDH1) obsd. in gliomas can lead to the prodn. of 2-hydroxyglutarate (2HG).  Here, the authors report that tumor 2HG is elevated in a high percentage of patients with cytogenetically normal acute myeloid leukemia (AML).  Surprisingly, less than half of cases with elevated 2HG possessed IDH1 mutations.  The remaining cases with elevated 2HG had mutations in IDH2, the mitochondrial homolog of IDH1.  These data demonstrate that a shared feature of all cancer-assocd. IDH mutations is prodn. of the oncometabolite 2HG.  Furthermore, AML patients with IDH mutations display a significantly reduced no. of other well characterized AML-assocd. mutations and/or assocd. chromosomal abnormalities, potentially implicating IDH mutation in a distinct mechanism of AML pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppKH_IGRymibVg90H21EOLACvtfcHk0ljy_7ahpTZ3ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWqtLg%253D&md5=cf235f63ccd050ff3b121b94d3c49b9e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DWise%26aufirst%3DD.%2BR.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DColler%26aufirst%3DH.%2BA.%26aulast%3DCross%26aufirst%3DJ.%2BR.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DHedvat%26aufirst%3DC.%2BV.%26aulast%3DPerl%26aufirst%3DA.%2BE.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520common%2520feature%2520of%2520leukemia-associated%2520IDH1%2520and%2520IDH2%2520mutations%2520is%2520a%2520neomorphic%2520enzyme%2520activity%2520converting%2520alpha-ketoglutarate%2520to%25202-hydroxyglutarate%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D225%26epage%3D234%26doi%3D10.1016%2Fj.ccr.2010.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Rourke, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">IDH mutation impairs histone demethylation and results in a block to cell differentiation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span><span class="refDoi"> DOI: 10.1038/nature10860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fnature10860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=22343901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=474-478&author=C.+Luauthor=P.+S.+Wardauthor=G.+S.+Kapoorauthor=D.+Rohleauthor=S.+Turcanauthor=O.+Abdel-Wahabauthor=C.+R.+Edwardsauthor=R.+Khaninauthor=M.+E.+Figueroaauthor=A.+Melnickauthor=K.+E.+Wellenauthor=D.+M.+O%E2%80%99Rourkeauthor=S.+L.+Bergerauthor=T.+A.+Chanauthor=R.+L.+Levineauthor=I.+K.+Mellinghoffauthor=C.+B.+Thompson&title=IDH+mutation+impairs+histone+demethylation+and+results+in+a+block+to+cell+differentiation&doi=10.1038%2Fnature10860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">IDH mutation impairs histone demethylation and results in a block to cell differentiation</span></div><div class="casAuthors">Lu, Chao; Ward, Patrick S.; Kapoor, Gurpreet S.; Rohle, Dan; Turcan, Sevin; Abdel-Wahab, Omar; Edwards, Christopher R.; Khanin, Raya; Figueroa, Maria E.; Melnick, Ari; Wellen, Kathryn E.; O'Rourke, Donald M.; Berger, Shelley L.; Chan, Timothy A.; Levine, Ross L.; Mellinghoff, Ingo K.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7390</span>),
    <span class="NLM_cas:pages">474-478</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in gliomas, acute myeloid leukemias (AML) and chondrosarcomas, and share a novel enzymic property of producing 2-hydroxyglutarate (2HG) from α-ketoglutarate.  Here we report that 2HG-producing IDH mutants can prevent the histone demethylation that is required for lineage-specific progenitor cells to differentiate into terminally differentiated cells.  In tumor samples from glioma patients, IDH mutations were assocd. with a distinct gene expression profile enriched for genes expressed in neural progenitor cells, and this was assocd. with increased histone methylation.  To test whether the ability of IDH mutants to promote histone methylation contributes to a block in cell differentiation in non-transformed cells, we tested the effect of neomorphic IDH mutants on adipocyte differentiation in vitro.  Introduction of either mutant IDH or cell-permeable 2HG was assocd. with repression of the inducible expression of lineage-specific differentiation genes and a block to differentiation.  This correlated with a significant increase in repressive histone methylation marks without observable changes in promoter DNA methylation.  Gliomas were found to have elevated levels of similar histone repressive marks.  Stable transfection of a 2HG-producing mutant IDH into immortalized astrocytes resulted in progressive accumulation of histone methylation.  Of the marks examd., increased H3K9 methylation reproducibly preceded a rise in DNA methylation as cells were passaged in culture.  Furthermore, we found that the 2HG-inhibitable H3K9 demethylase KDM4C was induced during adipocyte differentiation, and that RNA-interference suppression of KDM4C was sufficient to block differentiation.  Together these data demonstrate that 2HG can inhibit histone demethylation and that inhibition of histone demethylation can be sufficient to block the differentiation of non-transformed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxj9sZYgiJH7Vg90H21EOLACvtfcHk0ljTj28jfdgX1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKks74%253D&md5=d5bb18c8ef2bbd1d28540cf7dabc9b57</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature10860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10860%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DKapoor%26aufirst%3DG.%2BS.%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DEdwards%26aufirst%3DC.%2BR.%26aulast%3DKhanin%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DWellen%26aufirst%3DK.%2BE.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DD.%2BM.%26aulast%3DBerger%26aufirst%3DS.%2BL.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DIDH%2520mutation%2520impairs%2520histone%2520demethylation%2520and%2520results%2520in%2520a%2520block%2520to%2520cell%2520differentiation%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D474%26epage%3D478%26doi%3D10.1038%2Fnature10860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goenka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yilmaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabius, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guryanova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heguy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huse, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span> </span><span class="NLM_article-title">IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span><span class="refDoi"> DOI: 10.1038/nature10866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fnature10866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=22343889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=479-483&author=S.+Turcanauthor=D.+Rohleauthor=A.+Goenkaauthor=L.+A.+Walshauthor=F.+Fangauthor=E.+Yilmazauthor=C.+Camposauthor=A.+W.+Fabiusauthor=C.+Luauthor=P.+S.+Wardauthor=C.+B.+Thompsonauthor=A.+Kaufmanauthor=O.+Guryanovaauthor=R.+Levineauthor=A.+Heguyauthor=A.+Vialeauthor=L.+G.+Morrisauthor=J.+T.+Huseauthor=I.+K.+Mellinghoffauthor=T.+A.+Chan&title=IDH1+mutation+is+sufficient+to+establish+the+glioma+hypermethylator+phenotype&doi=10.1038%2Fnature10866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype</span></div><div class="casAuthors">Turcan, Sevin; Rohle, Daniel; Goenka, Anuj; Walsh, Logan A.; Fang, Fang; Yilmaz, Emrullah; Campos, Carl; Fabius, Armida W. M.; Lu, Chao; Ward, Patrick S.; Thompson, Craig B.; Kaufman, Andrew; Guryanova, Olga; Levine, Ross; Heguy, Adriana; Viale, Agnes; Morris, Luc G. T.; Huse, Jason T.; Mellinghoff, Ingo K.; Chan, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7390</span>),
    <span class="NLM_cas:pages">479-483</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Both genome-wide genetic and epigenetic alterations are fundamentally important for the development of cancers, but the interdependence of these aberrations is poorly understood.  Glioblastomas and other cancers with the CpG island methylator phenotype (CIMP) constitute a subset of tumors with extensive epigenomic aberrations and a distinct biol.  Glioma CIMP (G-CIMP) is a powerful determinant of tumor pathogenicity, but the mol. basis of G-CIMP remains unresolved.  Here we show that mutation of a single gene, isocitrate dehydrogenase 1 (IDH1), establishes G-CIMP by remodelling the methylome.  This remodelling results in reorganization of the methylome and transcriptome.  Examn. of the epigenome of a large set of intermediate-grade gliomas demonstrates a distinct G-CIMP phenotype that is highly dependent on the presence of IDH mutation.  Introduction of mutant IDH1 into primary human astrocytes alters specific histone marks, induces extensive DNA hypermethylation, and reshapes the methylome in a fashion that mirrors the changes obsd. in G-CIMP-pos. lower-grade gliomas.  Furthermore, the epigenomic alterations resulting from mutant IDH1 activate key gene expression programs, characterize G-CIMP-pos. proneural glioblastomas but not other glioblastomas, and are predictive of improved survival.  Our findings demonstrate that IDH mutation is the mol. basis of CIMP in gliomas, provide a framework for understanding oncogenesis in these gliomas, and highlight the interplay between genomic and epigenomic changes in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGkrX6t11CcLVg90H21EOLACvtfcHk0ljTj28jfdgX1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKktLc%253D&md5=4afa997b44a163435033c76b6d90b0b1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature10866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10866%26sid%3Dliteratum%253Aachs%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DGoenka%26aufirst%3DA.%26aulast%3DWalsh%26aufirst%3DL.%2BA.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DYilmaz%26aufirst%3DE.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DFabius%26aufirst%3DA.%2BW.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DKaufman%26aufirst%3DA.%26aulast%3DGuryanova%26aufirst%3DO.%26aulast%3DLevine%26aufirst%3DR.%26aulast%3DHeguy%26aufirst%3DA.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DL.%2BG.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DChan%26aufirst%3DT.%2BA.%26atitle%3DIDH1%2520mutation%2520is%2520sufficient%2520to%2520establish%2520the%2520glioma%2520hypermethylator%2520phenotype%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D479%26epage%3D483%26doi%3D10.1038%2Fnature10866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Prensner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Metabolism unhinged: IDH mutations in cancer</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1038/nm0311-291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fnm0311-291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=21383741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVGgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=291-293&author=J.+R.+Prensnerauthor=A.+M.+Chinnaiyan&title=Metabolism+unhinged%3A+IDH+mutations+in+cancer&doi=10.1038%2Fnm0311-291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism unhinged: IDH mutations in cancer</span></div><div class="casAuthors">Prensner, John R.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-293</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recently characterized IDH1 and IDH2 mutations in leukemia and glioblastoma have introduced a fascinating cancer-specific role for metabolic genes essential to cellular respiration.  Studies also link aberrant IDH1 and IDH2 activity to an altered metabolite profile, an observation that may have broad implications for both cancer epigenetics and clin. management of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpopuegY-UsALVg90H21EOLACvtfcHk0ljTj28jfdgX1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVGgtLw%253D&md5=6df1b41aab0341769974251276ba6dec</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnm0311-291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0311-291%26sid%3Dliteratum%253Aachs%26aulast%3DPrensner%26aufirst%3DJ.%2BR.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DMetabolism%2520unhinged%253A%2520IDH%2520mutations%2520in%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D291%26epage%3D293%26doi%3D10.1038%2Fnm0311-291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Garber, K.</span><span> </span><span class="NLM_article-title">Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span><span class="refDoi"> DOI: 10.1093/jnci/djq262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1093%2Fjnci%2Fdjq262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20576929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlegsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=926-928&author=K.+Garber&title=Oncometabolite%3F+IDH1+discoveries+raise+possibility+of+new+metabolism+targets+in+brain+cancers+and+leukemia&doi=10.1093%2Fjnci%2Fdjq262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Oncometabolite? IDH1 Discoveries Raise Possibility of New Metabolism Targets in Brain Cancers and Leukemia</span></div><div class="casAuthors">Garber, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">926-928</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Compared with normal cells, which primarily generate energy aerobically in mitochondria, most tumor cells rely more heavily on glycolysis (the anaerobic conversion of glucose to lactate) to generate energy.  Tumors also display other unique metabolic features.  But the discovery of a mutated metabolic enzyme was strong evidence that metabolic abnormalities play an important role in oncogenesis, and it set off a frantic effort to understand what the mutation was doing in such common and lethal cancers.  Answers have proven just as surprising as the initial discovery.  And the revelations, although incomplete and still controversial, are paving the way for drugs targeting mutant isocitrate dehydrogenase (IDH) and for diagnostic tests to identify patients likely to benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUWv5GxNnQqrVg90H21EOLACvtfcHk0lgq2deRwoUNmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlegsL0%253D&md5=66fe53c6c537f459144c907a59e47d90</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq262%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DK.%26atitle%3DOncometabolite%253F%2520IDH1%2520discoveries%2520raise%2520possibility%2520of%2520new%2520metabolism%2520targets%2520in%2520brain%2520cancers%2520and%2520leukemia%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2010%26volume%3D102%26spage%3D926%26epage%3D928%26doi%3D10.1093%2Fjnci%2Fdjq262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1021/ml300225h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300225h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=850-855&author=J.+Popovici-Mullerauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=J.+M.+Travinsauthor=S.+Yanauthor=F.+Zhaoauthor=S.+Grossauthor=L.+Dangauthor=K.+E.+Yenauthor=H.+Yangauthor=K.+S.+Straleyauthor=S.+Jinauthor=K.+Kuniiauthor=V.+R.+Fantinauthor=S.+Zhangauthor=Q.+Panauthor=D.+Shiauthor=S.+A.+Billerauthor=S.+M.+Su&title=Discovery+of+the+first+potent+inhibitors+of+mutant+IDH1+that+lower+tumor+2-HG+in+vivo&doi=10.1021%2Fml300225h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo</span></div><div class="casAuthors">Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Travins, Jeremy M.; Yan, Shunqi; Zhao, Fang; Gross, Stefan; Dang, Lenny; Yen, Katharine E.; Yang, Hua; Straley, Kimberly S.; Jin, Shengfang; Kunii, Kaiko; Fantin, Valeria R.; Zhang, Shunan; Pan, Qiongqun; Shi, Derek; Biller, Scott A.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">850-855</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a series of R132H IDH1 inhibitors from a high throughput screen led to the first potent mols. that show robust tumor 2-HG inhibition in a xenograft model.  Compd. 35 shows good potency in the U87 R132H cell based assay and ∼90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing.  The magnitude and duration of tumor 2-HG inhibition correlates with free plasma concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprvfJ98f1ns7Vg90H21EOLACvtfcHk0lgq2deRwoUNmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE&md5=eabdaa3351155971ed3feceace0d17c4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml300225h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300225h%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DTravins%26aufirst%3DJ.%2BM.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520inhibitors%2520of%2520mutant%2520IDH1%2520that%2520lower%2520tumor%25202-HG%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D850%26epage%3D855%26doi%3D10.1021%2Fml300225h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaskas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grommes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsoi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldrini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komisopoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedraza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kernytsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeber, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span> </span><span class="NLM_article-title">An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1126/science.1236062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1126%2Fscience.1236062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=23558169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=626-630&author=D.+Rohleauthor=J.+Popovici-Mullerauthor=N.+Palaskasauthor=S.+Turcanauthor=C.+Grommesauthor=C.+Camposauthor=J.+Tsoiauthor=O.+Clarkauthor=B.+Oldriniauthor=E.+Komisopoulouauthor=K.+Kuniiauthor=A.+Pedrazaauthor=S.+Schalmauthor=L.+Silvermanauthor=A.+Millerauthor=F.+Wangauthor=H.+Yangauthor=Y.+Chenauthor=A.+Kernytskyauthor=M.+K.+Rosenblumauthor=W.+Liuauthor=S.+A.+Billerauthor=S.+M.+Suauthor=C.+W.+Brennanauthor=T.+A.+Chanauthor=T.+G.+Graeberauthor=K.+E.+Yenauthor=I.+K.+Mellinghoff&title=An+inhibitor+of+mutant+IDH1+delays+growth+and+promotes+differentiation+of+glioma+cells&doi=10.1126%2Fscience.1236062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells</span></div><div class="casAuthors">Rohle, Dan; Popovici-Muller, Janeta; Palaskas, Nicolaos; Turcan, Sevin; Grommes, Christian; Campos, Carl; Tsoi, Jennifer; Clark, Owen; Oldrini, Barbara; Komisopoulou, Evangelia; Kunii, Kaiko; Pedraza, Alicia; Schalm, Stefanie; Silverman, Lee; Miller, Alexandra; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Rosenblum, Marc K.; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Brennan, Cameron W.; Chan, Timothy A.; Graeber, Thomas G.; Yen, Katharine E.; Mellinghoff, Ingo K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">626-630</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metab. of cancer cells for cancer therapy.  One potential drug target is isocitrate dehydrogenase 1 (IDH1), which is mutated in multiple human cancers.  Here, we examine the role of mutant IDH1 in fully transformed cells with endogenous IDH1 mutations.  A selective R132H-IDH1 inhibitor (AGI-5198) identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG).  Under conditions of near-complete R-2HG inhibition, the mIDH1 inhibitor induced demethylation of histone H3K9me3 and expression of genes assocd. with gliogenic differentiation.  Blockade of mIDH1 impaired the growth of IDH1-mutant-but not IDH1-wild-type-glioma cells without appreciable changes in genome-wide DNA methylation.  These data suggest that mIDH1 may promote glioma growth through mechanisms beyond its well-characterized epigenetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz81Au_Pr-4rVg90H21EOLACvtfcHk0lhAEV2ZHf5IhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D&md5=c4499103628349dcf9866c44924acf3c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.1236062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1236062%26sid%3Dliteratum%253Aachs%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DPalaskas%26aufirst%3DN.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DGrommes%26aufirst%3DC.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DTsoi%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DO.%26aulast%3DOldrini%26aufirst%3DB.%26aulast%3DKomisopoulou%26aufirst%3DE.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKernytsky%26aufirst%3DA.%26aulast%3DRosenblum%26aufirst%3DM.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DGraeber%26aufirst%3DT.%2BG.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DAn%2520inhibitor%2520of%2520mutant%2520IDH1%2520delays%2520growth%2520and%2520promotes%2520differentiation%2520of%2520glioma%2520cells%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D626%26epage%3D630%26doi%3D10.1126%2Fscience.1236062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anglin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1021/ml400036z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400036z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=542-546&author=B.+Zhengauthor=Y.+Yaoauthor=Z.+Liuauthor=L.+Dengauthor=J.+L.+Anglinauthor=H.+Jiangauthor=B.+V.+Prasadauthor=Y.+Song&title=Crystallographic+Investigation+and+Selective+Inhibition+of+Mutant+Isocitrate+Dehydrogenase&doi=10.1021%2Fml400036z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span></div><div class="casAuthors">Zheng, Baisong; Yao, Yuan; Liu, Zhen; Deng, Lisheng; Anglin, Justin L.; Jiang, Hong; Prasad, B. V. Venkataram; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-546</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ∼75% glioma and ∼20% acute myeloid leukemia.  Different from the wild-type enzyme, mutant IDH1 catalyzes the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid.  Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer.  We found two 1-hydroxypyridin-2-one compds. that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM.  These compds. exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the prodn. of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chem. probes for cancer biol. studies.  We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic, and hydrophobic interactions with the mutant enzyme.  Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0vzVLGCPZLVg90H21EOLACvtfcHk0lhAEV2ZHf5IhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D&md5=c34c67949fe816bdf151525a578535f3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml400036z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400036z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DAnglin%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCrystallographic%2520Investigation%2520and%2520Selective%2520Inhibition%2520of%2520Mutant%2520Isocitrate%2520Dehydrogenase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D542%26epage%3D546%26doi%3D10.1021%2Fml400036z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogiso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, SAR and Selective Antitumor Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8307</span><span class="NLM_x">–</span> <span class="NLM_lpage">8318</span><span class="refDoi"> DOI: 10.1021/jm500660f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500660f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8307-8318&author=Z.+Liuauthor=Y.+Yaoauthor=M.+Kogisoauthor=B.+Zhengauthor=L.+Dengauthor=J.+J.+Qiuauthor=S.+Dongauthor=H.+Lvauthor=J.+M.+Galloauthor=X.-N.+Liauthor=Y.+Song&title=Inhibition+of+Cancer-Associated+Mutant+Isocitrate+Dehydrogenases%3A+Synthesis%2C+SAR+and+Selective+Antitumor+Activity&doi=10.1021%2Fjm500660f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm500660f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500660f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKogiso%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DJ.%2BJ.%26aulast%3DDong%26aufirst%3DS.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DX.-N.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520Cancer-Associated%2520Mutant%2520Isocitrate%2520Dehydrogenases%253A%2520Synthesis%252C%2520SAR%2520and%2520Selective%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8307%26epage%3D8318%26doi%3D10.1021%2Fjm500660f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McManus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le-Strat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquette, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassort, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englaro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederschain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, S.</span><span> </span><span class="NLM_article-title">Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">762</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1074/jbc.M114.608497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1074%2Fjbc.M114.608497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=25391653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2rtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=762-774&author=G.+Dengauthor=J.+Shenauthor=M.+Yinauthor=J.+McManusauthor=M.+Mathieuauthor=P.+Geeauthor=T.+Heauthor=C.+Shiauthor=O.+Bedelauthor=L.+R.+McLeanauthor=F.+Le-Stratauthor=Y.+Zhangauthor=J.+P.+Marquetteauthor=Q.+Gaoauthor=B.+Zhangauthor=A.+Rakauthor=D.+Hoffmannauthor=E.+Rooneyauthor=A.+Vassortauthor=W.+Englaroauthor=Y.+Liauthor=V.+Patelauthor=F.+Adrianauthor=S.+Grossauthor=D.+Wiederschainauthor=H.+Chengauthor=S.+Licht&title=Selective+inhibition+of+mutant+isocitrate+dehydrogenase+1+%28IDH1%29+via+disruption+of+a+metal+binding+network+by+an+allosteric+small+molecule&doi=10.1074%2Fjbc.M114.608497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (IDH1) via Disruption of a Metal Binding Network by an Allosteric Small Molecule</span></div><div class="casAuthors">Deng, Gejing; Shen, Junqing; Yin, Ming; McManus, Jessica; Mathieu, Magali; Gee, Patricia; He, Timothy; Shi, Chaomei; Bedel, Olivier; McLean, Larry R.; Le-Strat, Frank; Zhang, Ying; Marquette, Jean-Pierre; Gao, Qiang; Zhang, Bailin; Rak, Alexey; Hoffmann, Dietmar; Rooney, Eamonn; Vassort, Aurelie; Englaro, Walter; Li, Yi; Patel, Vinod; Adrian, Francisco; Gross, Stefan; Wiederschain, Dmitri; Cheng, Hong; Licht, Stuart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">762-774</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cancer-assocd. point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) confer a neomorphic enzymic activity: the redn. of α-ketoglutarate to D-2-hydroxyglutaric acid (2HG), which is proposed to act as an oncogenic metabolite by inducing hypermethylation of histones and DNA.  Although selective inhibitors of mutant IDH1 and IDH2 have been identified and are currently under investigation as potential cancer therapeutics, the mechanistic basis for their selectivity is not yet well understood.  A high throughput screen for selective inhibitors of IDH1 bearing the oncogenic mutation R132H identified compd. 1, a bis-imidazole phenol that inhibits D-2-hydroxyglutaric acid prodn. in cells.  We investigated the mode of inhibition of compd. 1 and a previously published IDH1 mutant inhibitor with a different chem. scaffold.  Steady-state kinetics and biophys. studies show that both of these compds. selectively inhibit mutant IDH1 by binding to an allosteric site and that inhibition is competitive with respect to Mg2+.  A crystal structure of compd. 1 complexed with R132H IDH1 indicates that the inhibitor binds at the dimer interface and makes direct contact with a residue involved in binding of the catalytically essential divalent cation.  These results show that targeting a divalent cation binding residue can enable selective inhibition of mutant IDH1 and suggest that differences in magnesium binding between wild-type and mutant enzymes may contribute to the inhibitors' selectivity for the mutant enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd8VKauy1y9rVg90H21EOLACvtfcHk0lgiFnUm7guwKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2rtw%253D%253D&md5=6513af66926eb2b087ba472504a93fc5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.608497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.608497%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DM.%26aulast%3DMcManus%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DGee%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DBedel%26aufirst%3DO.%26aulast%3DMcLean%26aufirst%3DL.%2BR.%26aulast%3DLe-Strat%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMarquette%26aufirst%3DJ.%2BP.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DD.%26aulast%3DRooney%26aufirst%3DE.%26aulast%3DVassort%26aufirst%3DA.%26aulast%3DEnglaro%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DS.%26atitle%3DSelective%2520inhibition%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%2520%2528IDH1%2529%2520via%2520disruption%2520of%2520a%2520metal%2520binding%2520network%2520by%2520an%2520allosteric%2520small%2520molecule%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D762%26epage%3D774%26doi%3D10.1074%2Fjbc.M114.608497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of ″off-on switch″ of activities of human IDH1 by tumor-associated mutation R132H</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1200</span><span class="refDoi"> DOI: 10.1038/cr.2010.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fcr.2010.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20975740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1188-1200&author=B.+Yangauthor=C.+Zhongauthor=Y.+Pengauthor=Z.+Laiauthor=J.+Ding&title=Molecular+mechanisms+of+%E2%80%B3off-on+switch%E2%80%B3+of+activities+of+human+IDH1+by+tumor-associated+mutation+R132H&doi=10.1038%2Fcr.2010.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H</span></div><div class="casAuthors">Yang, Bei; Zhong, Chen; Peng, Yingjie; Lai, Zheng; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1188-1200</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human cytosolic NADP-IDH (IDH1) has recently been found to be involved in tumorigenesis.  Notably, the tumor-derived IDH1 mutations identified so far mainly occur at Arg132, and mutation R132H is the most prevalent one.  This mutation impairs the oxidative IDH activity of the enzyme, but renders a new redn. function of converting α-ketoglutarate (αKG) to 2-hydroxyglutarate.  Here, we report the structures of the R132H mutant IDH1 with and without isocitrate (ICT) bound.  The structural data together with mutagenesis and biochem. data reveal a previously undefined initial ICT-binding state and demonstrate that IDH activity requires a conformational change to a closed pre-transition state.  Arg132 plays multiple functional roles in the catalytic reaction; in particular, the R132H mutation hinders the conformational changes from the initial ICT-binding state to the pre-transition state, leading to the impairment of the IDH activity.  Our results describe for the first time that there is an intermediate conformation that corresponds to an initial ICT-binding state and that the R132H mutation can trap the enzyme in this conformation, therefore shedding light on the mol. mechanism of the "off switch" of the potentially tumor-suppressive IDH activity.  Furthermore, we proved the necessity of Tyr139 for the gained αKG redn. activity and propose that Tyr139 may play a vital role by compensating the increased neg. charge on the C2 atom of αKG during the transfer of a hydride anion from NADPH to αKG, which provides new insights into the mechanism of the "on switch" of the hypothetically oncogenic redn. activity of IDH1 by this mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpory1c32RonLVg90H21EOLACvtfcHk0lgiFnUm7guwKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI&md5=04d83e2a90480837c09eb8c0140ecc88</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.145%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanisms%2520of%2520%25E2%2580%25B3off-on%2520switch%25E2%2580%25B3%2520of%2520activities%2520of%2520human%2520IDH1%2520by%2520tumor-associated%2520mutation%2520R132H%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1188%26epage%3D1200%26doi%3D10.1038%2Fcr.2010.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lapidot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vormoor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caceres-Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. E.</span><span> </span><span class="NLM_article-title">A cell initiating human acute myeloid leukaemia after transplantation into SCID mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span><span class="refDoi"> DOI: 10.1038/367645a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2F367645a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=7509044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A280%3ADyaK2c7ltVKrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1994&pages=645-648&author=T.+Lapidotauthor=C.+Sirardauthor=J.+Vormoorauthor=B.+Murdochauthor=T.+Hoangauthor=J.+Caceres-Cortesauthor=M.+Mindenauthor=B.+Patersonauthor=M.+A.+Caligiuriauthor=J.+E.+Dick&title=A+cell+initiating+human+acute+myeloid+leukaemia+after+transplantation+into+SCID+mice&doi=10.1038%2F367645a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A cell initiating human acute myeloid leukaemia after transplantation into SCID mice</span></div><div class="casAuthors">Lapidot T; Sirard C; Vormoor J; Murdoch B; Hoang T; Caceres-Cortes J; Minden M; Paterson B; Caligiuri M A; Dick J E</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6464</span>),
    <span class="NLM_cas:pages">645-8</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Most human acute myeloid leukaemia (AML) cells have limited proliferative capacity, suggesting that the leukaemic clone may be maintained by a rare population of stem cells.  This putative leukaemic stem cell has not been characterized because the available in vitro assays can only detect progenitors with limited proliferative and replating potential.  We have now identified an AML-initiating cell by transplantation into severe combined immune-deficient (SCID) mice.  These cells homed to the bone marrow and proliferated extensively in response to in vivo cytokine treatment, resulting in a pattern of dissemination and leukaemic cell morphology similar to that seen in the original patients.  Limiting dilution analysis showed that the frequency of these leukaemia-initiating cells in the peripheral blood of AML patients was one engraftment unit in 250,000 cells.  We fractionated AML cells on the basis of cell-surface-marker expression and found that the leukaemia-initiating cells that could engraft SCID mice to produce large numbers of colony-forming progenitors were CD34+ CD38-; however, the CD34+ CD38+ and CD34- fractions contained no cells with these properties.  This in vivo model replicates many aspects of human AML and defines a new leukaemia-initiating cell which is less mature than colony-forming cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvfHJZ5BZZYP3jf77P2BG3fW6udTcc2ea5FJ5HTXfipLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7ltVKrsg%253D%253D&md5=692809a03a33f917ae2815cedadb7973</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2F367645a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F367645a0%26sid%3Dliteratum%253Aachs%26aulast%3DLapidot%26aufirst%3DT.%26aulast%3DSirard%26aufirst%3DC.%26aulast%3DVormoor%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DB.%26aulast%3DHoang%26aufirst%3DT.%26aulast%3DCaceres-Cortes%26aufirst%3DJ.%26aulast%3DMinden%26aufirst%3DM.%26aulast%3DPaterson%26aufirst%3DB.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DDick%26aufirst%3DJ.%2BE.%26atitle%3DA%2520cell%2520initiating%2520human%2520acute%2520myeloid%2520leukaemia%2520after%2520transplantation%2520into%2520SCID%2520mice%26jtitle%3DNature%26date%3D1994%26volume%3D367%26spage%3D645%26epage%3D648%26doi%3D10.1038%2F367645a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Luchman, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stechishin, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesnelong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weljie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairncross, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S.</span><span> </span><span class="NLM_article-title">An in vivo patient-derived model of endogenous IDH1-mutant glioma</span> <span class="citation_source-journal">Neuro. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1093/neuonc/nor207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1093%2Fneuonc%2Fnor207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=22166263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2hs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=184-191&author=H.+A.+Luchmanauthor=O.+D.+Stechishinauthor=N.+H.+Dangauthor=M.+D.+Bloughauthor=C.+Chesnelongauthor=J.+J.+Kellyauthor=S.+A.+Nguyenauthor=J.+A.+Chanauthor=A.+M.+Weljieauthor=J.+G.+Cairncrossauthor=S.+Weiss&title=An+in+vivo+patient-derived+model+of+endogenous+IDH1-mutant+glioma&doi=10.1093%2Fneuonc%2Fnor207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An in vivo patient-derived model of endogenous IDH1-mutant glioma</span></div><div class="casAuthors">Luchman, H. Artee; Stechishin, Owen D.; Dang, N. Ha; Blough, Michael D.; Chesnelong, Charles; Kelly, John J.; Nguyen, Stephanie A.; Chan, Jennifer A.; Weljie, Aalim M.; Cairncross, J. Gregory; Weiss, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-191</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Somatic mutations in the catalytic domain of isocitrate dehydrogenase (IDH) 1/2 and accumulation of the oncometabolite 2-hydroxyglutarate (2-HG) appear to be among the earliest events in gliomagenesis and may contribute to malignant transformation.  The lack of cell lines with endogenous mutations has been one of the major challenges in studying IDH1/2-mutant glioma and developing novel therapeutics for these tumors.  Here, we describe the isolation of a glioma brain tumor stem cell line (BT142) with an endogenous R132H mutation in IDH1, aggressive tumor-initiating capacity, and 2-HG prodn.  The neurosphere culture method was used to establish a brain tumor stem cell line from an IDH1-mutant anaplastic oligoastrocytoma sample, and an orthotopic xenograft system was developed to allow its rapid expansion.  Prodn. of 2-HG by glioma cells with endogenous IDH1 mutations was confirmed by mass spectrometry.  BT142 retained an endogenous R132H IDH1 mutation in culture and possessed aggressive tumor-initiating capacity, allowing it to be readily propagated in orthotopic xenografts of nonobese diabetic/severe combined immune deficiency (NOD SCID) mice.  Endogenous 2-HG prodn. by BT142 was detectable in both cell culture medium and xenograft animal serum.  BT142 is the first brain tumor cell line with an endogenous IDH1 mutation and detectable 2-HG prodn. both in vitro and in vivo, which thus provides a unique model for studying the biol. of IDH1-mutant glioma and in vivo validation of compds. targeting IDH1-mutant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQxQYkboS8-bVg90H21EOLACvtfcHk0lj6hfSKOU698Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2hs7vI&md5=599a3e62b9baac34abe637fa0a64a5e7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnor207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnor207%26sid%3Dliteratum%253Aachs%26aulast%3DLuchman%26aufirst%3DH.%2BA.%26aulast%3DStechishin%26aufirst%3DO.%2BD.%26aulast%3DDang%26aufirst%3DN.%2BH.%26aulast%3DBlough%26aufirst%3DM.%2BD.%26aulast%3DChesnelong%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%2BJ.%26aulast%3DNguyen%26aufirst%3DS.%2BA.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DWeljie%26aufirst%3DA.%2BM.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DWeiss%26aufirst%3DS.%26atitle%3DAn%2520in%2520vivo%2520patient-derived%2520model%2520of%2520endogenous%2520IDH1-mutant%2520glioma%26jtitle%3DNeuro.%2520Oncol.%26date%3D2012%26volume%3D14%26spage%3D184%26epage%3D191%26doi%3D10.1093%2Fneuonc%2Fnor207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, T.</span><span> </span><span class="NLM_article-title">The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span><span class="refDoi"> DOI: 10.1111/j.1750-3639.2010.00379.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1111%2Fj.1750-3639.2010.00379.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20331619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKht7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=877-889&author=F.+Wanauthor=S.+Zhangauthor=R.+Xieauthor=B.+Gaoauthor=B.+Camposauthor=C.+Herold-Mendeauthor=T.+Lei&title=The+utility+and+limitations+of+neurosphere+assay%2C+CD133+immunophenotyping+and+side+population+assay+in+glioma+stem+cell+research&doi=10.1111%2Fj.1750-3639.2010.00379.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research</span></div><div class="casAuthors">Wan, Feng; Zhang, Suojun; Xie, Ruifan; Gao, Baocheng; Campos, Benito; Herold-Mende, Christel; Lei, Ting</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">877-889</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The newly proposed glioma stem cell (GSC) hypothesis may re-model the way we diagnose and treat the tumor, which highlights the need for a complete knowledge on the genetic and epigenetic "blueprints" of GSCs.  To identify the true "stemness" signatures, pure GSC populations are primarily needed.  Reliable in vitro methods enriching for GSCs and thereby identifying the key stem-like characteristics constitute the preliminary step forward.  We discuss in this review the current widely used methods for enriching and isolating GSCs, namely neurosphere assay, CD133 Immunophenotyping and side population assay, and detail their limitations and potential pitfalls that could complicate interpretation of corresponding results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrleaZxkJUBc7Vg90H21EOLACvtfcHk0lj6hfSKOU698Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKht7bN&md5=09f9ae3b110b21a2bb65baa0d831c09c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.2010.00379.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.2010.00379.x%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DLei%26aufirst%3DT.%26atitle%3DThe%2520utility%2520and%2520limitations%2520of%2520neurosphere%2520assay%252C%2520CD133%2520immunophenotyping%2520and%2520side%2520population%2520assay%2520in%2520glioma%2520stem%2520cell%2520research%26jtitle%3DBrain%2520Pathol.%26date%3D2010%26volume%3D20%26spage%3D877%26epage%3D889%26doi%3D10.1111%2Fj.1750-3639.2010.00379.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Laks, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masterman-Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visnyei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angenieux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazareff, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblum, H. I.</span><span> </span><span class="NLM_article-title">Neurosphere formation is an independent predictor of clinical outcome in malignant glioma</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span><span class="refDoi"> DOI: 10.1002/stem.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1002%2Fstem.15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=980-987&author=D.+R.+Laksauthor=M.+Masterman-Smithauthor=K.+Visnyeiauthor=B.+Angenieuxauthor=N.+M.+Orozcoauthor=I.+Foranauthor=W.+H.+Yongauthor=H.+V.+Vintersauthor=L.+M.+Liauauthor=J.+A.+Lazareffauthor=P.+S.+Mischelauthor=T.+F.+Cloughesyauthor=S.+Horvathauthor=H.+I.+Kornblum&title=Neurosphere+formation+is+an+independent+predictor+of+clinical+outcome+in+malignant+glioma&doi=10.1002%2Fstem.15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fstem.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fstem.15%26sid%3Dliteratum%253Aachs%26aulast%3DLaks%26aufirst%3DD.%2BR.%26aulast%3DMasterman-Smith%26aufirst%3DM.%26aulast%3DVisnyei%26aufirst%3DK.%26aulast%3DAngenieux%26aufirst%3DB.%26aulast%3DOrozco%26aufirst%3DN.%2BM.%26aulast%3DForan%26aufirst%3DI.%26aulast%3DYong%26aufirst%3DW.%2BH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DLazareff%26aufirst%3DJ.%2BA.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DHorvath%26aufirst%3DS.%26aulast%3DKornblum%26aufirst%3DH.%2BI.%26atitle%3DNeurosphere%2520formation%2520is%2520an%2520independent%2520predictor%2520of%2520clinical%2520outcome%2520in%2520malignant%2520glioma%26jtitle%3DStem%2520Cells%26date%3D2009%26volume%3D27%26spage%3D980%26epage%3D987%26doi%3D10.1002%2Fstem.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chaichana, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora-Berridi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara-Quintana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinones-Hinojosa, A.</span><span> </span><span class="NLM_article-title">Neurosphere assays: growth factors and hormone differences in tumor and nontumor studies</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2851</span><span class="NLM_x">–</span> <span class="NLM_lpage">2857</span><span class="refDoi"> DOI: 10.1634/stemcells.2006-0399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1634%2Fstemcells.2006-0399" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2851-2857&author=K.+Chaichanaauthor=G.+Zamora-Berridiauthor=J.+Camara-Quintanaauthor=A.+Quinones-Hinojosa&title=Neurosphere+assays%3A+growth+factors+and+hormone+differences+in+tumor+and+nontumor+studies&doi=10.1634%2Fstemcells.2006-0399"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1634%2Fstemcells.2006-0399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Fstemcells.2006-0399%26sid%3Dliteratum%253Aachs%26aulast%3DChaichana%26aufirst%3DK.%26aulast%3DZamora-Berridi%26aufirst%3DG.%26aulast%3DCamara-Quintana%26aufirst%3DJ.%26aulast%3DQuinones-Hinojosa%26aufirst%3DA.%26atitle%3DNeurosphere%2520assays%253A%2520growth%2520factors%2520and%2520hormone%2520differences%2520in%2520tumor%2520and%2520nontumor%2520studies%26jtitle%3DStem%2520Cells%26date%3D2006%26volume%3D24%26spage%3D2851%26epage%3D2857%26doi%3D10.1634%2Fstemcells.2006-0399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adesina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlaky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idamakanti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Police, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallenbeck, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintagumpala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span> </span><span class="NLM_article-title">Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma</span> <span class="citation_source-journal">Neuro. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1185</span><span class="refDoi"> DOI: 10.1093/neuonc/not065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1093%2Fneuonc%2Fnot065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=23658322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGnu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1173-1185&author=Z.+Liuauthor=X.+Zhaoauthor=H.+Maoauthor=P.+A.+Baxterauthor=Y.+Huangauthor=L.+Yuauthor=L.+Wadhwaauthor=J.+M.+Suauthor=A.+Adesinaauthor=L.+Perlakyauthor=M.+Hurwitzauthor=N.+Idamakantiauthor=S.+R.+Policeauthor=P.+L.+Hallenbeckauthor=R.+L.+Hurwitzauthor=C.+C.+Lauauthor=M.+Chintagumpalaauthor=S.+M.+Blaneyauthor=X.+N.+Li&title=Intravenous+injection+of+oncolytic+picornavirus+SVV-001+prolongs+animal+survival+in+a+panel+of+primary+tumor-based+orthotopic+xenograft+mouse+models+of+pediatric+glioma&doi=10.1093%2Fneuonc%2Fnot065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma</span></div><div class="casAuthors">Liu, Zhigang; Zhao, Xiumei; Mao, Hua; Baxter, Patricia A.; Huang, Yulun; Yu, Litian; Wadhwa, Lalita; Su, Jack M.; Adesina, Adekunle; Perlaky, Lazlo; Hurwitz, Mary; Idamakanti, Neeraja; Police, Seshidhar Reddy; Hallenbeck, Paul L.; Hurwitz, Richard L.; Lau, Ching C.; Chintagumpala, Murali; Blaney, Susan M.; Li, Xiao-Nan</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1173-1185</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Seneca Valley virus (SVV-001) is a nonpathogenic oncolytic virus that can be systemically administered and can pass through the blood-brain barrier.  We examd. its therapeutic efficacy and the mechanism of tumor cell infection in pediatric malignant gliomas.  Methods: In vitro antitumor activities were examd. in primary cultures, preformed neurospheres, and self-renewing glioma cells derived from 6 patient tumor orthotopic xenograft mouse models (1 anaplastic astrocytoma and 5 GBM).  In vivo therapeutic efficacy was examd. by systemic treatment of preformed xenografts in 3 permissive and 2 resistant models.  The functional role of sialic acid in mediating SVV-001 infection was investigated using neuraminidase and lectins that cleave or competitively bind to linkage-specific sialic acids.  Results: SVV-001 at a multiplicity of infection of 0.5 to 25 replicated in and effectively killed primary cultures, preformed neurospheres, and self-renewing stemlike single glioma cells derived from 4 of the 6 glioma models in vitro.  A single i.v. injection of SVV-001 (5 × 1012 viral particles/kg) led to the infection of orthotopic xenografts without harming normal mouse brain cells, resulting in significantly prolonged survival in all 3 permissive and 1 resistant mouse models (P < .05).  Treatment with neuraminidase and competitive binding using lectins specific for α2,3-linked and/or α2,6-linked sialic acid significantly suppressed SVV-001 infectivity (P < .01).  Conclusion: SVV-001 possesses strong antitumor activity against pediatric malignant gliomas and utilizes α2,3-linked and α2,6-linked sialic acids as mediators of tumor cell infection.  Our findings support the consideration of SVV-001 for clin. trials in children with malignant glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX3fv8LCBY07Vg90H21EOLACvtfcHk0lg8ExO_Y3HjMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGnu7%252FL&md5=6858de67b09b9f9ae585cfe721b3afd1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnot065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnot065%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DBaxter%26aufirst%3DP.%2BA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWadhwa%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DJ.%2BM.%26aulast%3DAdesina%26aufirst%3DA.%26aulast%3DPerlaky%26aufirst%3DL.%26aulast%3DHurwitz%26aufirst%3DM.%26aulast%3DIdamakanti%26aufirst%3DN.%26aulast%3DPolice%26aufirst%3DS.%2BR.%26aulast%3DHallenbeck%26aufirst%3DP.%2BL.%26aulast%3DHurwitz%26aufirst%3DR.%2BL.%26aulast%3DLau%26aufirst%3DC.%2BC.%26aulast%3DChintagumpala%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DLi%26aufirst%3DX.%2BN.%26atitle%3DIntravenous%2520injection%2520of%2520oncolytic%2520picornavirus%2520SVV-001%2520prolongs%2520animal%2520survival%2520in%2520a%2520panel%2520of%2520primary%2520tumor-based%2520orthotopic%2520xenograft%2520mouse%2520models%2520of%2520pediatric%2520glioma%26jtitle%3DNeuro.%2520Oncol.%26date%3D2013%26volume%3D15%26spage%3D1173%26epage%3D1185%26doi%3D10.1093%2Fneuonc%2Fnot065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span> In  <span class="citation_source-book">Macromolecular Crystallography, Part A, Method Enzymology</span>; <span class="NLM_contrib-group">Carter, C. W.,  Jr.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">276</span>, pp  <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Macromolecular+Crystallography%2C+Part+A%2C+Method+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26btitle%3DMacromolecular%2520Crystallography%252C%2520Part%2520A%252C%2520Method%2520Enzymology%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lg8ExO_Y3HjMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lg8ExO_Y3HjMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0ljYI6C49kDdJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Tomašić, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mašič, L. P.</span><span> </span><span class="NLM_article-title">Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span><span class="refDoi"> DOI: 10.1517/17460441.2012.688743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1517%2F17460441.2012.688743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=22607309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=549-560&author=T.+Toma%C5%A1i%C4%87author=L.+P.+Ma%C5%A1i%C4%8D&title=Rhodanine+as+a+scaffold+in+drug+discovery%3A+a+critical+review+of+its+biological+activities+and+mechanisms+of+target+modulation&doi=10.1517%2F17460441.2012.688743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation</span></div><div class="casAuthors">Tomasic, Tihomir; Peterlin Masic, Lucija</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Rhodanine-based compds. have been assocd. with numerous biol. activities.  After many years of research in drug discovery, they have gained a reputation as being pan assay interference compds. (PAINS) and frequent hitters in screening campaigns.  Rhodanine-based compds. are also aggregators that can non-specifically interact with target proteins as well as Michael acceptors and interfere photometrically in biol. assays due to their color.Areas covered: The authors review the recently reported biol. activities of rhodanine-based compds.  Furthermore, the article provides details of their synthesis and occurrence in compd. libraries through high-throughput screening (HTS) and virtual high-throughput screening (VHTS).  Addnl., the authors provide the reader with possible mechanisms of non-specific target modulation, anal. of the crystal structures of enzyme-rhodanine complexes and a comparison of rhodanine and thiazolidine-2,4-dione moieties.Expert opinion: The biol. activity of compds. possessing a rhodanine moiety should be considered very critically despite the convincing data obtained in biol. assays.  In addn. to the lack of selectivity, unusual structure-activity relationship profiles and safety and specificity problems mean that rhodanines are generally not optimizable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorolVH32PdC7Vg90H21EOLACvtfcHk0ljYI6C49kDdJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWmtLw%253D&md5=a02e78c0c7788aaeb044f3753c901117</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688743%26sid%3Dliteratum%253Aachs%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3DMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%2BP.%26atitle%3DRhodanine%2520as%2520a%2520scaffold%2520in%2520drug%2520discovery%253A%2520a%2520critical%2520review%2520of%2520its%2520biological%2520activities%2520and%2520mechanisms%2520of%2520target%2520modulation%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D549%26epage%3D560%26doi%3D10.1517%2F17460441.2012.688743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Naohiro Uemura, Momoka Hosaka, Aoi Washio, Yasushi Yoshida, Takashi Mino, <span class="NLM_string-name hlFld-ContribAuthor">Masami Sakamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Chiral Symmetry Breaking of Thiohydantoins by Attrition-Enhanced Deracemization. </span><span class="cited-content_cbyCitation_journal-name">Crystal Growth & Design</span><span> <strong>2020,</strong> <em>20 </em>
                                    (8)
                                     , 4898-4903. <a href="https://doi.org/10.1021/acs.cgd.0c00829" title="DOI URL">https://doi.org/10.1021/acs.cgd.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.cgd.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.cgd.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystal%2520Growth%2520%2526%2520Design%26atitle%3DChiral%252BSymmetry%252BBreaking%252Bof%252BThiohydantoins%252Bby%252BAttrition-Enhanced%252BDeracemization%26aulast%3DUemura%26aufirst%3DNaohiro%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17062020%26date%3D21072020%26date%3D27072020%26date%3D21072020%26volume%3D20%26issue%3D8%26spage%3D4898%26epage%3D4903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xu Dai, Ji-Na Hao, Jinlou Gu, <span class="NLM_string-name hlFld-ContribAuthor">Yongsheng Li</span>. </span><span class="cited-content_cbyCitation_article-title">Multivalued Logic Assay of the Disease Marker of α-Ketoglutaric Acid by a Luminescent MOF-Based Biosensor. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2020,</strong> <em>3 </em>
                                    (6)
                                     , 3792-3799. <a href="https://doi.org/10.1021/acsabm.0c00378" title="DOI URL">https://doi.org/10.1021/acsabm.0c00378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.0c00378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.0c00378%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DMultivalued%252BLogic%252BAssay%252Bof%252Bthe%252BDisease%252BMarker%252Bof%252B%2525CE%2525B1-Ketoglutaric%252BAcid%252Bby%252Ba%252BLuminescent%252BMOF-Based%252BBiosensor%26aulast%3DDai%26aufirst%3DXu%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D08042020%26date%3D17052020%26date%3D29052020%26date%3D18052020%26volume%3D3%26issue%3D6%26spage%3D3792%26epage%3D3799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fangrui Wu, Yuanda Hua, Salma Kaochar, Shenyou Nie, Yi-Lun Lin, Yuan Yao, Jingyu Wu, Xiaowei Wu, Xiaoyong Fu, Rachel Schiff, Christel M. Davis, Matthew Robertson, Erik A. Ehli, Cristian Coarfa, Nicholas Mitsiades, <span class="NLM_string-name hlFld-ContribAuthor">Yongcheng Song</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery, Structure–Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (9)
                                     , 4716-4731. <a href="https://doi.org/10.1021/acs.jmedchem.9b02164" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02164</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02164%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationship%25252C%252Band%252BBiological%252BActivity%252Bof%252BHistone-Competitive%252BInhibitors%252Bof%252BHistone%252BAcetyltransferases%252BP300%25252FCBP%26aulast%3DWu%26aufirst%3DFangrui%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26122019%26date%3D21042020%26volume%3D63%26issue%3D9%26spage%3D4716%26epage%3D4731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jian Lin, Wei Lu, Justin A. Caravella, Ann Marie Campbell, R. Bruce Diebold, Anna Ericsson, Edward Fritzen, Gary R. Gustafson, David R. Lancia, Jr., Tatiana Shelekhin, Zhongguo Wang, Jennifer Castro, Andrea Clarke, Deepali Gotur, Helen R. Josephine, Marie Katz, Hien Diep, Mark Kershaw, Lili Yao, Goss Kauffman, Stephen E. Hubbs, George P. Luke, Angela V. Toms, Liann Wang, Kenneth W. Bair, Kenneth J. Barr, Christopher Dinsmore, Duncan Walker, <span class="NLM_string-name hlFld-ContribAuthor">Susan Ashwell</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6575-6596. <a href="https://doi.org/10.1021/acs.jmedchem.9b00362" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00362</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00362%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BQuinolinone%252BDerivatives%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BMutant%252BIsocitrate%252BDehydrogenase%252B1%252B%252528mIDH1%252529%252BInhibitors%26aulast%3DLin%26aufirst%3DJian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07032019%26date%3D08072019%26date%3D14062019%26volume%3D62%26issue%3D14%26spage%3D6575%26epage%3D6596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tianfang Ma, Fangxia Zou, Stefan Pusch, Yungen Xu, Andreas von Deimling, <span class="NLM_string-name hlFld-ContribAuthor">Xiaoming Zha</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 8981-9003. <a href="https://doi.org/10.1021/acs.jmedchem.8b00159" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00159%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252BMutant%252BIsocitrate%252BDehydrogenases%252B1%252Band%252B2%252B%252528mIDH1%25252F2%252529%25253A%252BAn%252BUpdate%252Band%252BPerspective%26aulast%3DMa%26aufirst%3DTianfang%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30012018%26date%3D18062018%26date%3D31052018%26volume%3D61%26issue%3D20%26spage%3D8981%26epage%3D9003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher T.  Walsh</span>, <span class="hlFld-ContribAuthor ">Benjamin P.  Tu</span>, and <span class="hlFld-ContribAuthor ">Yi  Tang</span>  . </span><span class="cited-content_cbyCitation_article-title">Eight Kinetically Stable but Thermodynamically Activated Molecules that Power Cell Metabolism. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (4)
                                     , 1460-1494. <a href="https://doi.org/10.1021/acs.chemrev.7b00510" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00510%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DEight%252BKinetically%252BStable%252Bbut%252BThermodynamically%252BActivated%252BMolecules%252Bthat%252BPower%252BCell%252BMetabolism%26aulast%3DWalsh%26aufirst%3DChristopher%2BT.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D29082017%26date%3D22122017%26date%3D28022018%26volume%3D118%26issue%3D4%26spage%3D1460%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stuart  Jones</span>, <span class="hlFld-ContribAuthor ">Jonathan  Ahmet</span>, <span class="hlFld-ContribAuthor ">Kelly  Ayton</span>, <span class="hlFld-ContribAuthor ">Matthew  Ball</span>, <span class="hlFld-ContribAuthor ">Mark  Cockerill</span>, <span class="hlFld-ContribAuthor ">Emma  Fairweather</span>, <span class="hlFld-ContribAuthor ">Nicola  Hamilton</span>, <span class="hlFld-ContribAuthor ">Paul  Harper</span>, <span class="hlFld-ContribAuthor ">James  Hitchin</span>, <span class="hlFld-ContribAuthor ">Allan  Jordan</span>, <span class="hlFld-ContribAuthor ">Colin  Levy</span>, <span class="hlFld-ContribAuthor ">Ruth  Lopez</span>, <span class="hlFld-ContribAuthor ">Eddie  McKenzie</span>, <span class="hlFld-ContribAuthor ">Martin  Packer</span>, <span class="hlFld-ContribAuthor ">Darren  Plant</span>, <span class="hlFld-ContribAuthor ">Iain  Simpson</span>, <span class="hlFld-ContribAuthor ">Peter  Simpson</span>, <span class="hlFld-ContribAuthor ">Ian  Sinclair</span>, <span class="hlFld-ContribAuthor ">Tim C. P.  Somervaille</span>, <span class="hlFld-ContribAuthor ">Helen  Small</span>, <span class="hlFld-ContribAuthor ">Gary J.  Spencer</span>, <span class="hlFld-ContribAuthor ">Graeme  Thomson</span>, <span class="hlFld-ContribAuthor ">Michael  Tonge</span>, <span class="hlFld-ContribAuthor ">Ian  Waddell</span>, <span class="hlFld-ContribAuthor ">Jarrod  Walsh</span>, <span class="hlFld-ContribAuthor ">Bohdan  Waszkowycz</span>, <span class="hlFld-ContribAuthor ">Mark  Wigglesworth</span>, <span class="hlFld-ContribAuthor ">Daniel H.  Wiseman</span>, and <span class="hlFld-ContribAuthor ">Donald  Ogilvie</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 11120-11137. <a href="https://doi.org/10.1021/acs.jmedchem.6b01320" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01320</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01320%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BAllosteric%252BInhibitors%252Bof%252BMutant%252BIsocitrate%252BDehydrogenase%252B1%252B%252528R132H%252BIDH1%252529%252BDisplaying%252BActivity%252Bin%252BHuman%252BAcute%252BMyeloid%252BLeukemia%252BCells%26aulast%3DJones%26aufirst%3DStuart%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D27092016%26date%3D05122016%26date%3D22122016%26date%3D15112016%26volume%3D59%26issue%3D24%26spage%3D11120%26epage%3D11137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jason M.  Law</span>, <span class="hlFld-ContribAuthor ">Sebastian C.  Stark</span>, <span class="hlFld-ContribAuthor ">Ke  Liu</span>, <span class="hlFld-ContribAuthor ">Norah E.  Liang</span>, <span class="hlFld-ContribAuthor ">Mahmud M.  Hussain</span>, <span class="hlFld-ContribAuthor ">Matthias  Leiendecker</span>, <span class="hlFld-ContribAuthor ">Daisuke  Ito</span>, <span class="hlFld-ContribAuthor ">Oscar  Verho</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Stern</span>, <span class="hlFld-ContribAuthor ">Stephen E.  Johnston</span>, <span class="hlFld-ContribAuthor ">Yan-Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Gavin P.  Dunn</span>, <span class="hlFld-ContribAuthor ">Alykhan F.  Shamji</span>, and <span class="hlFld-ContribAuthor ">Stuart L.  Schreiber</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 8-Membered Ring Sulfonamides as Inhibitors of Oncogenic Mutant Isocitrate Dehydrogenase 1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (10)
                                     , 944-949. <a href="https://doi.org/10.1021/acsmedchemlett.6b00264" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00264%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B8-Membered%252BRing%252BSulfonamides%252Bas%252BInhibitors%252Bof%252BOncogenic%252BMutant%252BIsocitrate%252BDehydrogenase%252B1%26aulast%3DLaw%26aufirst%3DJason%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D05072016%26date%3D18082016%26date%3D31082016%26date%3D13102016%26date%3D18082016%26volume%3D7%26issue%3D10%26spage%3D944%26epage%3D949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aniruddha  Das</span>, <span class="hlFld-ContribAuthor ">Masud  Alam</span>, <span class="hlFld-ContribAuthor ">Chiranjib  Gogoi</span>, <span class="hlFld-ContribAuthor ">Rana  Dalapati</span>, <span class="hlFld-ContribAuthor ">Shyam  Biswas</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of a functionalized aluminum metal–organic framework as a turn-off fluorescence sensor for α-ketoglutaric acid. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2020,</strong> <em>49 </em>
                                    (46)
                                     , 16928-16934. <a href="https://doi.org/10.1039/D0DT02323J" title="DOI URL">https://doi.org/10.1039/D0DT02323J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0DT02323J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0DT02323J%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DRational%252Bdesign%252Bof%252Ba%252Bfunctionalized%252Baluminum%252Bmetal%2525E2%252580%252593organic%252Bframework%252Bas%252Ba%252Bturn-off%252Bfluorescence%252Bsensor%252Bfor%252B%2525CE%2525B1-ketoglutaric%252Bacid%26aulast%3DDas%26aufirst%3DAniruddha%26date%3D2020%26date%3D2020%26volume%3D49%26issue%3D46%26spage%3D16928%26epage%3D16934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priscila Goes  Camargo</span>, <span class="hlFld-ContribAuthor ">Bruna Taciane da Silva  Bortoleti</span>, <span class="hlFld-ContribAuthor ">Marcieli  Fabris</span>, <span class="hlFld-ContribAuthor ">Manoela Daiele  Gonçalves</span>, <span class="hlFld-ContribAuthor ">Fernanda  Tomiotto-Pellissier</span>, <span class="hlFld-ContribAuthor ">Idessania Nazareth  Costa</span>, <span class="hlFld-ContribAuthor ">Ivete  Conchon-Costa</span>, <span class="hlFld-ContribAuthor ">Camilo Henrique da Silva  Lima</span>, <span class="hlFld-ContribAuthor ">Wander Rogério  Pavanelli</span>, <span class="hlFld-ContribAuthor ">Marcelle de Lima Ferreira  Bispo</span>, <span class="hlFld-ContribAuthor ">Fernando  Macedo Jr</span>. </span><span class="cited-content_cbyCitation_article-title">Thiohydantoins as anti-leishmanial agents:
              n vitro
              biological evaluation and multi-target investigation by molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>4 </em>, 1-10. <a href="https://doi.org/10.1080/07391102.2020.1845979" title="DOI URL">https://doi.org/10.1080/07391102.2020.1845979</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1845979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1845979%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DThiohydantoins%252Bas%252Banti-leishmanial%252Bagents%25253A%252Bn%252Bvitro%252Bbiological%252Bevaluation%252Band%252Bmulti-target%252Binvestigation%252Bby%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DCamargo%26aufirst%3DPriscila%2BGoes%26date%3D2020%26date%3D2020%26volume%3D4%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenyu  Li</span>, <span class="hlFld-ContribAuthor ">Xingkang  Wu</span>, <span class="hlFld-ContribAuthor ">Lejiao  Jia</span>, <span class="hlFld-ContribAuthor ">Jun  Li</span>, <span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Tang</span>, <span class="hlFld-ContribAuthor ">Zhiying  Li</span>, <span class="hlFld-ContribAuthor ">Huagang  Bu</span>, <span class="hlFld-ContribAuthor ">Chengwu  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel 2-arylbenzimidazoles as selective mutant isocitrate dehydrogenase 2 R140Q inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (9)
                                     , 127070. <a href="https://doi.org/10.1016/j.bmcl.2020.127070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252B2-arylbenzimidazoles%252Bas%252Bselective%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B2%252BR140Q%252Binhibitors%26aulast%3DLi%26aufirst%3DZhenyu%26date%3D2020%26volume%3D30%26issue%3D9%26spage%3D127070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walid  Guerrab</span>, <span class="hlFld-ContribAuthor ">Hassane  Lgaz</span>, <span class="hlFld-ContribAuthor ">Sevgi  Kansiz</span>, <span class="hlFld-ContribAuthor ">Joel T.  Mague</span>, <span class="hlFld-ContribAuthor ">Necmi  Dege</span>, <span class="hlFld-ContribAuthor ">M.  Ansar</span>, <span class="hlFld-ContribAuthor ">Riadh  Marzouki</span>, <span class="hlFld-ContribAuthor ">Jamal  Taoufik</span>, <span class="hlFld-ContribAuthor ">Ismat H.  Ali</span>, <span class="hlFld-ContribAuthor ">Ill-Min  Chung</span>, <span class="hlFld-ContribAuthor ">Youssef  Ramli</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a novel phenytoin derivative: Crystal structure, Hirshfeld surface analysis and DFT calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1205 </em>, 127630. <a href="https://doi.org/10.1016/j.molstruc.2019.127630" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.127630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.127630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.127630%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%252Bof%252Ba%252Bnovel%252Bphenytoin%252Bderivative%25253A%252BCrystal%252Bstructure%25252C%252BHirshfeld%252Bsurface%252Banalysis%252Band%252BDFT%252Bcalculations%26aulast%3DGuerrab%26aufirst%3DWalid%26date%3D2020%26volume%3D1205%26spage%3D127630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priscila Goes Camargo  de Carvalho</span>, <span class="hlFld-ContribAuthor ">Jhonatan Macedo  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Renata Perugini Biasi  Garbin</span>, <span class="hlFld-ContribAuthor ">Gerson  Nakazato</span>, <span class="hlFld-ContribAuthor ">Sueli Fumie  Yamada Ogatta</span>, <span class="hlFld-ContribAuthor ">Ângelo  de Fátima</span>, <span class="hlFld-ContribAuthor ">Marcelle  de Lima Ferreira Bispo</span>, <span class="hlFld-ContribAuthor ">Fernando  Macedo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antimicrobial Activity of Thiohydantoins Obtained from L-Amino Acids. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2019,</strong> <em>17 </em>
                                    (1)
                                     , 94-102. <a href="https://doi.org/10.2174/1570180816666181212153011" title="DOI URL">https://doi.org/10.2174/1570180816666181212153011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180816666181212153011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180816666181212153011%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DSynthesis%252Band%252BAntimicrobial%252BActivity%252Bof%252BThiohydantoins%252BObtained%252Bfrom%252BL-Amino%252BAcids%26aulast%3Dde%2BCarvalho%26aufirst%3DPriscila%2BGoes%2BCamargo%26date%3D2019%26volume%3D17%26issue%3D1%26spage%3D94%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosaria  Ottanà</span>, <span class="hlFld-ContribAuthor ">Paolo  Paoli</span>, <span class="hlFld-ContribAuthor ">Giulia  Lori</span>, <span class="hlFld-ContribAuthor ">Ilenia  Adornato</span>, <span class="hlFld-ContribAuthor ">Santo  Previti</span>, <span class="hlFld-ContribAuthor ">Alexandra  Naß</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>, <span class="hlFld-ContribAuthor ">Rosanna  Maccari</span>. </span><span class="cited-content_cbyCitation_article-title">Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103211. <a href="https://doi.org/10.1016/j.bioorg.2019.103211" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103211%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%252Band%252Bevaluation%252Bof%252Bnon-carboxylate%252B5-arylidene-2-thioxo-4-imidazolidinones%252Bas%252Bnovel%252Bnon-competitive%252Binhibitors%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252B1B%26aulast%3DOttan%25C3%25A0%26aufirst%3DRosaria%26date%3D2019%26volume%3D92%26spage%3D103211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khaled R.A.  Abdellatif</span>, <span class="hlFld-ContribAuthor ">Wael A.A.  Fadaly</span>, <span class="hlFld-ContribAuthor ">Yaser A.  Mostafa</span>, <span class="hlFld-ContribAuthor ">Dana M.  Zaher</span>, <span class="hlFld-ContribAuthor ">Hany A.  Omar</span>. </span><span class="cited-content_cbyCitation_article-title">Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>91 </em>, 103132. <a href="https://doi.org/10.1016/j.bioorg.2019.103132" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103132%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThiohydantoin%252Bderivatives%252Bincorporating%252Ba%252Bpyrazole%252Bcore%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bas%252Bdual%252Binhibitors%252Bof%252Btopoisomerase-I%252Band%252Bcycloxygenase-2%252Bwith%252Banti-cancer%252Band%252Banti-inflammatory%252Bactivities%26aulast%3DAbdellatif%26aufirst%3DKhaled%2BR.A.%26date%3D2019%26volume%3D91%26spage%3D103132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amira A  El-Sayed</span>, <span class="hlFld-ContribAuthor ">Saad R  Atta-Allah</span>, <span class="hlFld-ContribAuthor ">Magdy M  Hemdan</span>. </span><span class="cited-content_cbyCitation_article-title">Utility of 3-(thiophen-2-yl)prop-2-enoyl isothiocyanate in heterocyclic synthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Research</span><span> <strong>2019,</strong> <em>43 </em>
                                    (9-10)
                                     , 307-312. <a href="https://doi.org/10.1177/1747519819862176" title="DOI URL">https://doi.org/10.1177/1747519819862176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1747519819862176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1747519819862176%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Research%26atitle%3DUtility%252Bof%252B3-%252528thiophen-2-yl%252529prop-2-enoyl%252Bisothiocyanate%252Bin%252Bheterocyclic%252Bsynthesis%26aulast%3DEl-Sayed%26aufirst%3DAmira%2BA%26date%3D2019%26date%3D2019%26volume%3D43%26issue%3D9-10%26spage%3D307%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Verdura</span>, <span class="hlFld-ContribAuthor ">Elisabet  Cuyàs</span>, <span class="hlFld-ContribAuthor ">Jesús  Lozano-Sánchez</span>, <span class="hlFld-ContribAuthor ">Cristian  Bastidas-Velez</span>, <span class="hlFld-ContribAuthor ">Laura  Llorach-Parés</span>, <span class="hlFld-ContribAuthor ">Salvador  Fernández-Arroyo</span>, <span class="hlFld-ContribAuthor ">Anna  Hernández-Aguilera</span>, <span class="hlFld-ContribAuthor ">Jorge  Joven</span>, <span class="hlFld-ContribAuthor ">Alfons  Nonell-Canals</span>, <span class="hlFld-ContribAuthor ">Joaquim  Bosch-Barrera</span>, <span class="hlFld-ContribAuthor ">Begoña  Martin-Castillo</span>, <span class="hlFld-ContribAuthor ">Luciano  Vellon</span>, <span class="hlFld-ContribAuthor ">Melchor  Sanchez-Martinez</span>, <span class="hlFld-ContribAuthor ">Antonio  Segura-Carretero</span>, <span class="hlFld-ContribAuthor ">Javier A  Menendez</span>. </span><span class="cited-content_cbyCitation_article-title">An olive oil phenolic is a new chemotype of mutant isocitrate dehydrogenase 1 (IDH1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Carcinogenesis</span><span> <strong>2019,</strong> <em>40 </em>
                                    (1)
                                     , 27-40. <a href="https://doi.org/10.1093/carcin/bgy159" title="DOI URL">https://doi.org/10.1093/carcin/bgy159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/carcin/bgy159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fcarcin%2Fbgy159%26sid%3Dliteratum%253Aachs%26jtitle%3DCarcinogenesis%26atitle%3DAn%252Bolive%252Boil%252Bphenolic%252Bis%252Ba%252Bnew%252Bchemotype%252Bof%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B1%252B%252528IDH1%252529%252Binhibitors%26aulast%3DVerdura%26aufirst%3DSara%26date%3D2019%26date%3D2018%26volume%3D40%26issue%3D1%26spage%3D27%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqi  Liu</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Hu</span>, <span class="hlFld-ContribAuthor ">Anhui  Gao</span>, <span class="hlFld-ContribAuthor ">Meng  Xu</span>, <span class="hlFld-ContribAuthor ">Lixin  Gao</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianrong  Gao</span>, <span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3-aryl-4-indolyl-maleimides as potent mutant isocitrate dehydrogenase-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (4)
                                     , 589-603. <a href="https://doi.org/10.1016/j.bmc.2018.12.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.12.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.12.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.12.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3-aryl-4-indolyl-maleimides%252Bas%252Bpotent%252Bmutant%252Bisocitrate%252Bdehydrogenase-1%252Binhibitors%26aulast%3DLiu%26aufirst%3DXiaoqi%26date%3D2019%26volume%3D27%26issue%3D4%26spage%3D589%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">SeoHyun  Cho</span>, <span class="hlFld-ContribAuthor ">Seok-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Dongyun  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Recent applications of hydantoin and thiohydantoin in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 517-545. <a href="https://doi.org/10.1016/j.ejmech.2018.12.066" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.066%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bapplications%252Bof%252Bhydantoin%252Band%252Bthiohydantoin%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DCho%26aufirst%3DSeoHyun%26date%3D2019%26volume%3D164%26spage%3D517%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Hu</span>, <span class="hlFld-ContribAuthor ">Anhui  Gao</span>, <span class="hlFld-ContribAuthor ">Honghui  Liao</span>, <span class="hlFld-ContribAuthor ">Mengmeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Gaoya  Xu</span>, <span class="hlFld-ContribAuthor ">Lixin  Gao</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianrong  Gao</span>, <span class="hlFld-ContribAuthor ">Qing  Ye</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>. </span><span class="cited-content_cbyCitation_article-title">3-(7-Azaindolyl)-4-indolylmaleimides as a novel class of mutant isocitrate dehydrogenase-1 inhibitors: Design, synthesis, and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (10)
                                     , 1800039. <a href="https://doi.org/10.1002/ardp.201800039" title="DOI URL">https://doi.org/10.1002/ardp.201800039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201800039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201800039%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3D3-%2525287-Azaindolyl%252529-4-indolylmaleimides%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bmutant%252Bisocitrate%252Bdehydrogenase-1%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%26aulast%3DHu%26aufirst%3DYuanyuan%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D10%26spage%3D1800039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. A.  Gazieva</span>, <span class="hlFld-ContribAuthor ">T. V.  Nechaeva</span>, <span class="hlFld-ContribAuthor ">N. N.  Kostikova</span>, <span class="hlFld-ContribAuthor ">N. V.  Sigay</span>, <span class="hlFld-ContribAuthor ">S. A.  Serkov</span>, <span class="hlFld-ContribAuthor ">S. V.  Popkov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, S-alkylation, and fungicidal activity of 4-(benzylideneamino)thioglycolurils. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2018,</strong> <em>67 </em>
                                    (6)
                                     , 1059-1064. <a href="https://doi.org/10.1007/s11172-018-2180-x" title="DOI URL">https://doi.org/10.1007/s11172-018-2180-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-018-2180-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-018-2180-x%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DSynthesis%25252C%252BS-alkylation%25252C%252Band%252Bfungicidal%252Bactivity%252Bof%252B4-%252528benzylideneamino%252529thioglycolurils%26aulast%3DGazieva%26aufirst%3DG.%2BA.%26date%3D2018%26date%3D2018%26volume%3D67%26issue%3D6%26spage%3D1059%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangying  Wang</span>, <span class="hlFld-ContribAuthor ">Zhuoling  Li</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Guoyi  Yan</span>, <span class="hlFld-ContribAuthor ">Mingxing  Hu</span>, <span class="hlFld-ContribAuthor ">Lifeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Yinglan  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuanwei  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel class of pyridine derivatives that selectively inhibits mutant isocitrate dehydrogenase 2. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2018,</strong> <em>91 </em>
                                    (6)
                                     , 1087-1093. <a href="https://doi.org/10.1111/cbdd.13139" title="DOI URL">https://doi.org/10.1111/cbdd.13139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13139%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bpyridine%252Bderivatives%252Bthat%252Bselectively%252Binhibits%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B2%26aulast%3DWang%26aufirst%3DFangying%26date%3D2018%26date%3D2018%26volume%3D91%26issue%3D6%26spage%3D1087%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazar  Trotsko</span>, <span class="hlFld-ContribAuthor ">Urszula  Kosikowska</span>, <span class="hlFld-ContribAuthor ">Agata  Paneth</span>, <span class="hlFld-ContribAuthor ">Monika  Wujec</span>, <span class="hlFld-ContribAuthor ">Anna  Malm</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties. </span><span class="cited-content_cbyCitation_journal-name">Saudi Pharmaceutical Journal</span><span> <strong>2018,</strong> <em>26 </em>
                                    (4)
                                     , 568-577. <a href="https://doi.org/10.1016/j.jsps.2018.01.016" title="DOI URL">https://doi.org/10.1016/j.jsps.2018.01.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsps.2018.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsps.2018.01.016%26sid%3Dliteratum%253Aachs%26jtitle%3DSaudi%2520Pharmaceutical%2520Journal%26atitle%3DSynthesis%252Band%252Bantibacterial%252Bactivity%252Bof%252Bnew%252B%2525282%25252C4-dioxothiazolidin-5-yl%25252Fylidene%252529acetic%252Bacid%252Bderivatives%252Bwith%252Bthiazolidine-2%25252C4-dione%25252C%252Brhodanine%252Band%252B2-thiohydantoin%252Bmoieties%26aulast%3DTrotsko%26aufirst%3DNazar%26date%3D2018%26volume%3D26%26issue%3D4%26spage%3D568%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masaki  Hirano</span>, <span class="hlFld-ContribAuthor ">Fumiharu  Ohka</span>, <span class="hlFld-ContribAuthor ">Sachi  Maeda</span>, <span class="hlFld-ContribAuthor ">Lushun  Chalise</span>, <span class="hlFld-ContribAuthor ">Akane  Yamamichi</span>, <span class="hlFld-ContribAuthor ">Kosuke  Aoki</span>, <span class="hlFld-ContribAuthor ">Akira  Kato</span>, <span class="hlFld-ContribAuthor ">Kuniaki  Tanahashi</span>, <span class="hlFld-ContribAuthor ">Kazuya  Motomura</span>, <span class="hlFld-ContribAuthor ">Yusuke  Nishimura</span>, <span class="hlFld-ContribAuthor ">Masahito  Hara</span>, <span class="hlFld-ContribAuthor ">Keiko  Shinjo</span>, <span class="hlFld-ContribAuthor ">Yutaka  Kondo</span>, <span class="hlFld-ContribAuthor ">Toshihiko  Wakabayashi</span>, <span class="hlFld-ContribAuthor ">Atsushi  Natsume</span>. </span><span class="cited-content_cbyCitation_article-title">A novel high-sensitivity assay to detect a small fraction of mutant IDH1 using droplet digital PCR. </span><span class="cited-content_cbyCitation_journal-name">Brain Tumor Pathology</span><span> <strong>2018,</strong> <em>35 </em>
                                    (2)
                                     , 97-105. <a href="https://doi.org/10.1007/s10014-018-0310-7" title="DOI URL">https://doi.org/10.1007/s10014-018-0310-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10014-018-0310-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10014-018-0310-7%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Tumor%2520Pathology%26atitle%3DA%252Bnovel%252Bhigh-sensitivity%252Bassay%252Bto%252Bdetect%252Ba%252Bsmall%252Bfraction%252Bof%252Bmutant%252BIDH1%252Busing%252Bdroplet%252Bdigital%252BPCR%26aulast%3DHirano%26aufirst%3DMasaki%26date%3D2018%26date%3D2018%26volume%3D35%26issue%3D2%26spage%3D97%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julia  Delahousse</span>, <span class="hlFld-ContribAuthor ">Loic  Verlingue</span>, <span class="hlFld-ContribAuthor ">Sophie  Broutin</span>, <span class="hlFld-ContribAuthor ">Clémence  Legoupil</span>, <span class="hlFld-ContribAuthor ">Mehdi  Touat</span>, <span class="hlFld-ContribAuthor ">Ludovic  Doucet</span>, <span class="hlFld-ContribAuthor ">Samy  Ammari</span>, <span class="hlFld-ContribAuthor ">Ludovic  Lacroix</span>, <span class="hlFld-ContribAuthor ">Michel  Ducreux</span>, <span class="hlFld-ContribAuthor ">Jean-Yves  Scoazec</span>, <span class="hlFld-ContribAuthor ">David  Malka</span>, <span class="hlFld-ContribAuthor ">Angelo  Paci</span>, <span class="hlFld-ContribAuthor ">Antoine  Hollebecque</span>. </span><span class="cited-content_cbyCitation_article-title">Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Cancer</span><span> <strong>2018,</strong> <em>90 </em>, 83-91. <a href="https://doi.org/10.1016/j.ejca.2017.11.024" title="DOI URL">https://doi.org/10.1016/j.ejca.2017.11.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejca.2017.11.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejca.2017.11.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Cancer%26atitle%3DCirculating%252Boncometabolite%252BD-2-hydroxyglutarate%252Benantiomer%252Bis%252Ba%252Bsurrogate%252Bmarker%252Bof%252Bisocitrate%252Bdehydrogenase%2525E2%252580%252593mutated%252Bintrahepatic%252Bcholangiocarcinomas%26aulast%3DDelahousse%26aufirst%3DJulia%26date%3D2018%26volume%3D90%26spage%3D83%26epage%3D91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanumantha  Madala</span>, <span class="hlFld-ContribAuthor ">Surendra  Punganuru</span>, <span class="hlFld-ContribAuthor ">Viswanath  Arutla</span>, <span class="hlFld-ContribAuthor ">Subhasis  Misra</span>, <span class="hlFld-ContribAuthor ">T.  Thomas</span>, <span class="hlFld-ContribAuthor ">Kalkunte  Srivenugopal</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (2)
                                     , 49. <a href="https://doi.org/10.3390/cancers10020049" title="DOI URL">https://doi.org/10.3390/cancers10020049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10020049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10020049%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DBeyond%252BBrooding%252Bon%252BOncometabolic%252BHavoc%252Bin%252BIDH-Mutant%252BGliomas%252Band%252BAML%25253A%252BCurrent%252Band%252BFuture%252BTherapeutic%252BStrategies%26aulast%3DMadala%26aufirst%3DHanumantha%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D2%26spage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Bin  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Hou</span>, <span class="hlFld-ContribAuthor ">Hui  Lin</span>, <span class="hlFld-ContribAuthor ">Ping-Hua  Sun</span>, <span class="hlFld-ContribAuthor ">Jing  Lin</span>, <span class="hlFld-ContribAuthor ">Wei-Min  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 5-hydroxy-2-methyl-4
              H
              -pyran-4-one derivatives as antiglioma agents. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2018,</strong> <em>9 </em>
                                    (3)
                                     , 471-476. <a href="https://doi.org/10.1039/C7MD00551B" title="DOI URL">https://doi.org/10.1039/C7MD00551B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00551B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00551B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B5-hydroxy-2-methyl-4%252BH%252B-pyran-4-one%252Bderivatives%252Bas%252Bantiglioma%252Bagents%26aulast%3DLi%26aufirst%3DYi-Bin%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3D471%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Yang</span>, <span class="hlFld-ContribAuthor ">Xianqiang  Sun</span>, <span class="hlFld-ContribAuthor ">Zhongming  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaolan  Cheng</span>, <span class="hlFld-ContribAuthor ">Wuguang  Lu</span>, <span class="hlFld-ContribAuthor ">Xueting  Cai</span>, <span class="hlFld-ContribAuthor ">Chunping  Hu</span>, <span class="hlFld-ContribAuthor ">Xu  Shen</span>, <span class="hlFld-ContribAuthor ">Peng  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric inhibitor remotely modulates the conformation of the orthestric pockets in mutant IDH2/R140Q. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-16427-w" title="DOI URL">https://doi.org/10.1038/s41598-017-16427-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-16427-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-16427-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAllosteric%252Binhibitor%252Bremotely%252Bmodulates%252Bthe%252Bconformation%252Bof%252Bthe%252Borthestric%252Bpockets%252Bin%252Bmutant%252BIDH2%25252FR140Q%26aulast%3DChen%26aufirst%3DJiao%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kseniya  Tishchenko</span>, <span class="hlFld-ContribAuthor ">Marina  Muratova</span>, <span class="hlFld-ContribAuthor ">Dmitry  Volkov</span>, <span class="hlFld-ContribAuthor ">Vera  Filichkina</span>, <span class="hlFld-ContribAuthor ">Dmitry  Nedosekin</span>, <span class="hlFld-ContribAuthor ">Vladimir  Zharov</span>, <span class="hlFld-ContribAuthor ">Mikhail  Proskurnin</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-wavelength thermal-lens spectrometry for high-accuracy measurements of absorptivities and quantum yields of photodegradation of a hemoprotein–lipid complex. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2017,</strong> <em>10 </em>
                                    (6)
                                     , 781-791. <a href="https://doi.org/10.1016/j.arabjc.2016.01.009" title="DOI URL">https://doi.org/10.1016/j.arabjc.2016.01.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2016.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2016.01.009%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DMulti-wavelength%252Bthermal-lens%252Bspectrometry%252Bfor%252Bhigh-accuracy%252Bmeasurements%252Bof%252Babsorptivities%252Band%252Bquantum%252Byields%252Bof%252Bphotodegradation%252Bof%252Ba%252Bhemoprotein%2525E2%252580%252593lipid%252Bcomplex%26aulast%3DTishchenko%26aufirst%3DKseniya%26date%3D2017%26volume%3D10%26issue%3D6%26spage%3D781%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan  Pusch</span>, <span class="hlFld-ContribAuthor ">Sonja  Krausert</span>, <span class="hlFld-ContribAuthor ">Viktoria  Fischer</span>, <span class="hlFld-ContribAuthor ">Jörg  Balss</span>, <span class="hlFld-ContribAuthor ">Martina  Ott</span>, <span class="hlFld-ContribAuthor ">Daniel  Schrimpf</span>, <span class="hlFld-ContribAuthor ">David  Capper</span>, <span class="hlFld-ContribAuthor ">Felix  Sahm</span>, <span class="hlFld-ContribAuthor ">Jessica  Eisel</span>, <span class="hlFld-ContribAuthor ">Ann-Christin  Beck</span>, <span class="hlFld-ContribAuthor ">Manfred  Jugold</span>, <span class="hlFld-ContribAuthor ">Viktoria  Eichwald</span>, <span class="hlFld-ContribAuthor ">Stefan  Kaulfuss</span>, <span class="hlFld-ContribAuthor ">Olaf  Panknin</span>, <span class="hlFld-ContribAuthor ">Hartmut  Rehwinkel</span>, <span class="hlFld-ContribAuthor ">Katja  Zimmermann</span>, <span class="hlFld-ContribAuthor ">Roman C.  Hillig</span>, <span class="hlFld-ContribAuthor ">Judith  Guenther</span>, <span class="hlFld-ContribAuthor ">Luisella  Toschi</span>, <span class="hlFld-ContribAuthor ">Roland  Neuhaus</span>, <span class="hlFld-ContribAuthor ">Andrea  Haegebart</span>, <span class="hlFld-ContribAuthor ">Holger  Hess-Stumpp</span>, <span class="hlFld-ContribAuthor ">Markus  Bauser</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Wick</span>, <span class="hlFld-ContribAuthor ">Andreas  Unterberg</span>, <span class="hlFld-ContribAuthor ">Christel  Herold-Mende</span>, <span class="hlFld-ContribAuthor ">Michael  Platten</span>, <span class="hlFld-ContribAuthor ">Andreas  von Deimling</span>. </span><span class="cited-content_cbyCitation_article-title">Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica</span><span> <strong>2017,</strong> <em>133 </em>
                                    (4)
                                     , 629-644. <a href="https://doi.org/10.1007/s00401-017-1677-y" title="DOI URL">https://doi.org/10.1007/s00401-017-1677-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00401-017-1677-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00401-017-1677-y%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%26atitle%3DPan-mutant%252BIDH1%252Binhibitor%252BBAY%252B1436032%252Bfor%252Beffective%252Btreatment%252Bof%252BIDH1%252Bmutant%252Bastrocytoma%252Bin%252Bvivo%26aulast%3DPusch%26aufirst%3DStefan%26date%3D2017%26date%3D2017%26volume%3D133%26issue%3D4%26spage%3D629%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mu-Yuan  Yu</span>, <span class="hlFld-ContribAuthor ">Xu-Jie  Qin</span>, <span class="hlFld-ContribAuthor ">Li-Dong  Shao</span>, <span class="hlFld-ContribAuthor ">Xing-Rong  Peng</span>, <span class="hlFld-ContribAuthor ">Lei  Li</span>, <span class="hlFld-ContribAuthor ">Han  Yang</span>, <span class="hlFld-ContribAuthor ">Ming-Hua  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Macahydantoins A and B, two new thiohydantoin derivatives from Maca ( Lepidium meyenii ): Structural elucidation and concise synthesis of macahydantoin A. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (17)
                                     , 1684-1686. <a href="https://doi.org/10.1016/j.tetlet.2017.03.038" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.03.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.03.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.03.038%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMacahydantoins%252BA%252Band%252BB%25252C%252Btwo%252Bnew%252Bthiohydantoin%252Bderivatives%252Bfrom%252BMaca%252B%252528%252BLepidium%252Bmeyenii%252B%252529%25253A%252BStructural%252Belucidation%252Band%252Bconcise%252Bsynthesis%252Bof%252Bmacahydantoin%252BA%26aulast%3DYu%26aufirst%3DMu-Yuan%26date%3D2017%26volume%3D58%26issue%3D17%26spage%3D1684%26epage%3D1686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Fu</span>, <span class="hlFld-ContribAuthor ">Zhi  Chen</span>, <span class="hlFld-ContribAuthor ">Xueying  Ma</span>, <span class="hlFld-ContribAuthor ">Guang  Chen</span>, <span class="hlFld-ContribAuthor ">Yuxia  Liu</span>, <span class="hlFld-ContribAuthor ">Ziping  Cao</span>, <span class="hlFld-ContribAuthor ">Fei  Qu</span>, <span class="hlFld-ContribAuthor ">Daoshan  Yang</span>, <span class="hlFld-ContribAuthor ">Xianen  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Sun</span>, <span class="hlFld-ContribAuthor ">Guoliang  Li</span>, <span class="hlFld-ContribAuthor ">Shijuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Fengli  Qu</span>, <span class="hlFld-ContribAuthor ">Rongmei  Kong</span>, <span class="hlFld-ContribAuthor ">Hua  Wang</span>, <span class="hlFld-ContribAuthor ">Jinmao  You</span>. </span><span class="cited-content_cbyCitation_article-title">Simultaneous absorbance-ratiometric, fluorimetric, and colorimetric analysis and biological imaging of α-ketoglutaric acid based on a special sensing mechanism. </span><span class="cited-content_cbyCitation_journal-name">Sensors and Actuators B: Chemical</span><span> <strong>2017,</strong> <em>241 </em>, 1035-1042. <a href="https://doi.org/10.1016/j.snb.2016.10.044" title="DOI URL">https://doi.org/10.1016/j.snb.2016.10.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.snb.2016.10.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.snb.2016.10.044%26sid%3Dliteratum%253Aachs%26jtitle%3DSensors%2520and%2520Actuators%2520B%253A%2520Chemical%26atitle%3DSimultaneous%252Babsorbance-ratiometric%25252C%252Bfluorimetric%25252C%252Band%252Bcolorimetric%252Banalysis%252Band%252Bbiological%252Bimaging%252Bof%252B%2525CE%2525B1-ketoglutaric%252Bacid%252Bbased%252Bon%252Ba%252Bspecial%252Bsensing%252Bmechanism%26aulast%3DFu%26aufirst%3DQiang%26date%3D2017%26volume%3D241%26spage%3D1035%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  He</span>, <span class="hlFld-ContribAuthor ">Mengzhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Qin  Li</span>, <span class="hlFld-ContribAuthor ">Zhengxi  Hu</span>, <span class="hlFld-ContribAuthor ">Hucheng  Zhu</span>, <span class="hlFld-ContribAuthor ">Junjun  Liu</span>, <span class="hlFld-ContribAuthor ">Jianping  Wang</span>, <span class="hlFld-ContribAuthor ">Yongbo  Xue</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Yonghui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Asperspiropene A, a novel fungal metabolite as an inhibitor of cancer-associated mutant isocitrate dehydrogenase 1. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2017,</strong> <em>4 </em>
                                    (6)
                                     , 1137-1144. <a href="https://doi.org/10.1039/C6QO00847J" title="DOI URL">https://doi.org/10.1039/C6QO00847J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6QO00847J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6QO00847J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DAsperspiropene%252BA%25252C%252Ba%252Bnovel%252Bfungal%252Bmetabolite%252Bas%252Ban%252Binhibitor%252Bof%252Bcancer-associated%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B1%26aulast%3DHe%26aufirst%3DYan%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D6%26spage%3D1137%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongcheng  Song</span>, <span class="hlFld-ContribAuthor ">Fangrui  Wu</span>, <span class="hlFld-ContribAuthor ">Jingyu  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2016,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-016-0279-9" title="DOI URL">https://doi.org/10.1186/s13045-016-0279-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-016-0279-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-016-0279-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DTargeting%252Bhistone%252Bmethylation%252Bfor%252Bcancer%252Btherapy%25253A%252Benzymes%25252C%252Binhibitors%25252C%252Bbiological%252Bactivity%252Band%252Bperspectives%26aulast%3DSong%26aufirst%3DYongcheng%26date%3D2016%26date%3D2016%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronique G.  LeBlanc</span>, <span class="hlFld-ContribAuthor ">Marco A.  Marra</span>. </span><span class="cited-content_cbyCitation_article-title">DNA methylation in adult diffuse gliomas. </span><span class="cited-content_cbyCitation_journal-name">Briefings in Functional Genomics</span><span> <strong>2016,</strong> <em>16(Suppl 4) </em>, elw019. <a href="https://doi.org/10.1093/bfgp/elw019" title="DOI URL">https://doi.org/10.1093/bfgp/elw019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bfgp/elw019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbfgp%2Felw019%26sid%3Dliteratum%253Aachs%26jtitle%3DBriefings%2520in%2520Functional%2520Genomics%26atitle%3DDNA%252Bmethylation%252Bin%252Badult%252Bdiffuse%252Bgliomas%26aulast%3DLeBlanc%26aufirst%3DVeronique%2BG.%26date%3D2016%26date%3D2016%26volume%3D16%2528Suppl%25204%2529%26spage%3Delw019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan  Merk</span>, <span class="hlFld-ContribAuthor ">Alberto  Bartesaghi</span>, <span class="hlFld-ContribAuthor ">Soojay  Banerjee</span>, <span class="hlFld-ContribAuthor ">Veronica  Falconieri</span>, <span class="hlFld-ContribAuthor ">Prashant  Rao</span>, <span class="hlFld-ContribAuthor ">Mindy I.  Davis</span>, <span class="hlFld-ContribAuthor ">Rajan  Pragani</span>, <span class="hlFld-ContribAuthor ">Matthew B.  Boxer</span>, <span class="hlFld-ContribAuthor ">Lesley A.  Earl</span>, <span class="hlFld-ContribAuthor ">Jacqueline L.S.  Milne</span>, <span class="hlFld-ContribAuthor ">Sriram  Subramaniam</span>. </span><span class="cited-content_cbyCitation_article-title">Breaking Cryo-EM Resolution Barriers to Facilitate Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2016,</strong> <em>165 </em>
                                    (7)
                                     , 1698-1707. <a href="https://doi.org/10.1016/j.cell.2016.05.040" title="DOI URL">https://doi.org/10.1016/j.cell.2016.05.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2016.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2016.05.040%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DBreaking%252BCryo-EM%252BResolution%252BBarriers%252Bto%252BFacilitate%252BDrug%252BDiscovery%26aulast%3DMerk%26aufirst%3DAlan%26date%3D2016%26volume%3D165%26issue%3D7%26spage%3D1698%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Clark</span>, <span class="hlFld-ContribAuthor ">Wilson X.  Mai</span>, <span class="hlFld-ContribAuthor ">Timothy F.  Cloughesy</span>, <span class="hlFld-ContribAuthor ">David A.  Nathanson</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma. </span><span class="cited-content_cbyCitation_journal-name">Current Neurology and Neuroscience Reports</span><span> <strong>2016,</strong> <em>16 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s11910-015-0613-6" title="DOI URL">https://doi.org/10.1007/s11910-015-0613-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11910-015-0613-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11910-015-0613-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Neurology%2520and%2520Neuroscience%2520Reports%26atitle%3DEmerging%252BApproaches%252Bfor%252BTargeting%252BMetabolic%252BVulnerabilities%252Bin%252BMalignant%252BGlioma%26aulast%3DClark%26aufirst%3DPeter%2BM.%26date%3D2016%26date%3D2016%26volume%3D16%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangxia  Zou</span>, <span class="hlFld-ContribAuthor ">Stefan  Pusch</span>, <span class="hlFld-ContribAuthor ">Jessica  Eisel</span>, <span class="hlFld-ContribAuthor ">Tianfang  Ma</span>, <span class="hlFld-ContribAuthor ">Qihua  Zhu</span>, <span class="hlFld-ContribAuthor ">Dawei  Deng</span>, <span class="hlFld-ContribAuthor ">Yueqing  Gu</span>, <span class="hlFld-ContribAuthor ">Yungen  Xu</span>, <span class="hlFld-ContribAuthor ">Andreas  von Deimling</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Zha</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a novel selective inhibitor of mutant isocitrate dehydrogenase 1 at allosteric site by docking-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (99)
                                     , 96735-96742. <a href="https://doi.org/10.1039/C6RA21617J" title="DOI URL">https://doi.org/10.1039/C6RA21617J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA21617J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA21617J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIdentification%252Bof%252Ba%252Bnovel%252Bselective%252Binhibitor%252Bof%252Bmutant%252Bisocitrate%252Bdehydrogenase%252B1%252Bat%252Ballosteric%252Bsite%252Bby%252Bdocking-based%252Bvirtual%252Bscreening%26aulast%3DZou%26aufirst%3DFangxia%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D99%26spage%3D96735%26epage%3D96742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Reactions catalyzed by (A) wild-type IDH1, (B) mutant IDH1, and (C) α-KG-dependent histone demethylases. D2HG, the product of mutant IDH1, inhibits α-KG-dependent histone demethylases, resulting in histones with more methylated lysine residues. (D) The structures of three known inhibitors of mutant IDH1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures and Activities of Compounds <b>35</b>–<b>41</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Method<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) R<sup>1</sup>NCS, KOH, H<sub>2</sub>O-EtOH; (ii) H<sub>2</sub>SO<sub>4</sub>, acetone; (iii) an aldehyde, e.g., 6-methoxynicotinaldehyde, NaOAc, HOAc, reflux; (iv) HCl, reflux.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray structures of IDH1(R132H):inhibitor complexes. (A) The overall structure of IDH1(R132H) in complex with compound <b>16</b> (ball and stick model) and NADPH (tube model). (B) The 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map of IDH1(R132H):<b>16</b> at the inhibitor-binding site, contoured at 1σ. (C) The <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> omit map of IDH1(R132H):<b>16</b>, contoured at 3σ. (D) The superimposed structures of IDH1(R132H) (electrostatic surface model) in complex with <b>16</b> (with C atoms in green) and <b>22</b> (in pink). (E) The close-up views of compound <b>16</b> and (F) compound <b>22</b> in IDH1(R132H). The protein backbones are shown as blue lines and H-bonds as purple dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Superimposed structures of IDH1(R132H):<b>16</b> (protein as blue lines) and IDH1(R132H):α-KG (protein as brown lines), showing the two ligand binding sites. Also aligned are the crystal structures of IDH1(R132H):ICT (with C atoms in gray) and :<b>22</b> (in purple), showing that both ligands are also located in the binding site I. (<b>B</b>) Superposition of the structures of IDH1(R132H):<b>16</b> (protein as blue ribbons) and IDH1(R132H):α-KG (as yellow ribbons), showing a large protein conformational difference. Compound <b>16</b> (C atoms in green) and α-KG (in brown) are shown as ball and stick models. In addition, the conformation as well as the binding site of NADPH of the two structures (tube models in green and brown, respectively) are also significantly different.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Best fitting models for enzyme kinetic studies of compound <b>18</b>. (A) Competitive inhibition model with variable concentrations of α-KG using a Lineweaver–Burk plot and (B) a noncompetitive inhibition model with variable concentrations of NADPH using a Michaelis–Menten plot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative ITC results and fitting curves for (A) compound <b>18</b> binding to IDH1(R132H) (100 μM); (B) <b>18</b> binding to IDH1(R132H) (100 μM) in the presence of NADPH (300 μM); and (C) <b>18</b> binding to IDH1(R132H) (100 μM) in the presence of NADPH (300 μM) and α-KG (300 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/medium/jm-2015-00684g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cellular activity of mutant IDH1 inhibitors. (A) Treatment of compounds <b>16</b> and <b>18</b> caused significantly reduced amount of D2HG in HT1080 cells. (B) Treatment of <b>18</b> significantly reduced methylation levels on histone lysine residues in HT1080 cells, while inactive compound <b>20</b> did not significantly affect histone methylation levels. (<b>C</b>) Treatment of compounds <b>18</b>, <b>16</b>, and <b>1</b> inhibited neurosphere formation of BT142 glioma cells with IDH1 R132H mutation but (D) did not affect neurosphere formation of BXD-3752 glioma cells without an IDH1 mutation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-17/acs.jmedchem.5b00684/20150904/images/large/jm-2015-00684g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00684&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i27">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span> </span><span class="NLM_article-title">Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">33946</span><span class="NLM_x">–</span> <span class="NLM_lpage">33957</span><span class="refDoi"> DOI: 10.1074/jbc.M404298200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1074%2Fjbc.M404298200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=15173171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=33946-33957&author=X.+Xuauthor=J.+Zhaoauthor=Z.+Xuauthor=B.+Pengauthor=Q.+Huangauthor=E.+Arnoldauthor=J.+Ding&title=Structures+of+human+cytosolic+NADP-dependent+isocitrate+dehydrogenase+reveal+a+novel+self-regulatory+mechanism+of+activity&doi=10.1074%2Fjbc.M404298200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Cytosolic NADP-dependent Isocitrate Dehydrogenase Reveal a Novel Self-regulatory Mechanism of Activity</span></div><div class="casAuthors">Xu, Xiang; Zhao, Jingyue; Xu, Zhen; Peng, Baozhen; Huang, Qiuhua; Arnold, Eddy; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">33946-33957</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Isocitrate dehydrogenases (IDHs) catalyze the oxidative decarboxylation of isocitrate to α-ketoglutarate, and regulation of the enzymic activity of IDHs is crucial for their biol. functions.  Bacterial IDHs are reversibly regulated by phosphorylation of a strictly conserved serine residue at the active site.  Eukaryotic NADP-dependent IDHs (NADP-IDHs) have been shown to have diverse important biol. functions; however, their regulatory mechanism remains unclear.  Structural studies of human cytosolic NADP-IDH (HcIDH) in complex with NADP and in complex with NADP, isocitrate, and Ca2+ reveal three biol. relevant conformational states of the enzyme that differ substantially in the structure of the active site and in the overall structure.  A structural segment at the active site that forms a conserved α-helix in all known NADP-IDH structures assumes a loop conformation in the open, inactive form of HcIDH; a partially unraveled α-helix in the semi-open, intermediate form; and an α-helix in the closed, active form.  The side chain of Asp279 of this segment occupies the isocitrate-binding site and forms hydrogen bonds with Ser94 (the equiv. of the phosphorylation site in bacterial IDHs) in the inactive form and chelates the metal ion in the active form.  The structural data led us to propose a novel self-regulatory mechanism for HcIDH that mimics the phosphorylation mechanism used by the bacterial homologs, consistent with biochem. and biol. data.  This mechanism might be applicable to other eukaryotic NADP-IDHs.  The results also provide insights into the recognition and specificity of substrate and cofactor by eukaryotic NADP-IDHs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomJaUxoQoMZ7Vg90H21EOLACvtfcHk0lhxeTanN1pJmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOhs70%253D&md5=79474e467a8cca43c26551c86745b3e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M404298200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M404298200%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DArnold%26aufirst%3DE.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520human%2520cytosolic%2520NADP-dependent%2520isocitrate%2520dehydrogenase%2520reveal%2520a%2520novel%2520self-regulatory%2520mechanism%2520of%2520activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D33946%26epage%3D33957%26doi%3D10.1074%2Fjbc.M404298200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leary, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angenendt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mankoo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallia, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolsky, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busam, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tekleab, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, L. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartigan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strausberg, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marie, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinjo, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karchin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmigiani, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span> </span><span class="NLM_article-title">An integrated genomic analysis of human glioblastoma multiforme</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">321</span><span class="NLM_x">, </span> <span class="NLM_fpage">1807</span><span class="NLM_x">–</span> <span class="NLM_lpage">1812</span><span class="refDoi"> DOI: 10.1126/science.1164382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1126%2Fscience.1164382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=18772396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2008&pages=1807-1812&author=D.+W.+Parsonsauthor=S.+Jonesauthor=X.+Zhangauthor=J.+C.+Linauthor=R.+J.+Learyauthor=P.+Angenendtauthor=P.+Mankooauthor=H.+Carterauthor=I.+M.+Siuauthor=G.+L.+Galliaauthor=A.+Oliviauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=S.+Keirauthor=T.+Nikolskayaauthor=Y.+Nikolskyauthor=D.+A.+Busamauthor=H.+Tekleabauthor=L.+A.+Diazauthor=J.+Hartiganauthor=D.+R.+Smithauthor=R.+L.+Strausbergauthor=S.+K.+Marieauthor=S.+M.+Shinjoauthor=H.+Yanauthor=G.+J.+Rigginsauthor=D.+D.+Bignerauthor=R.+Karchinauthor=N.+Papadopoulosauthor=G.+Parmigianiauthor=B.+Vogelsteinauthor=V.+E.+Velculescuauthor=K.+W.+Kinzler&title=An+integrated+genomic+analysis+of+human+glioblastoma+multiforme&doi=10.1126%2Fscience.1164382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">An Integrated genomic analysis of human glioblastoma multiforme</span></div><div class="casAuthors">Parsons, D. Williams; Jones, Sian; Zhang, Xiaosong; Lin, Jimmy Cheng-Ho; Leary, Rebecca J.; Angenendt, Philipp; Mankoo, Parminder; Carter, Hannah; Siu, I.-Mei; Gallia, Gary L.; Olivi, Alessandro; McLendon, Roger; Rasheed, B. Ahmed; Keir, Stephen; Nikolskaya, Tatiana; Nikolsky, Yuri; Busam, Dana A.; Tekleab, Hanna; Diaz, Luis A., Jr.; Hartigan, James; Smith, Doug R.; Strausberg, Robert L.; Marie, Suely Kazue Nagahashi; Shinjo, Sueli Mieko Oba; Yan, Hai; Riggins, Gregory J.; Bigner, Darell D.; Karchin, Rachel; Papadopoulos, Nick; Parmigiani, Giovanni; Vogelstein, Bert; Velculescu, Victor E.; Kinzler, Kenneth W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">5897</span>),
    <span class="NLM_cas:pages">1807-1812</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review based on author's research.  Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer.  To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, detd. the presence of amplifications and deletions using high-d. oligonucleotide arrays, and performed gene expression analyses using next-generation sequencing technologies in 22 human tumor samples.  This comprehensive anal. led to the discovery of a variety of genes that were not known to be altered in GBMs.  Most notably, we found recurrent mutations in the active site of isocitrate dehydrogenase 1 (IDH1) in 12% of GBM patients.  Mutations in IDH1 occurred in a large fraction of young patients and in most patients with secondary GBMs and were assocd. with an increase in overall survival.  These studies demonstrate the value of unbiased genomic analyses in the characterization of human brain cancer and identify a potentially useful genetic alteration for the classification and targeted therapy of GBMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFSe-eB8psp7Vg90H21EOLACvtfcHk0lhxeTanN1pJmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCrtLrE&md5=88c9e87c4b9dc8ebedcaa2b5d9f3ce13</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164382%26sid%3Dliteratum%253Aachs%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DJ.%2BC.%26aulast%3DLeary%26aufirst%3DR.%2BJ.%26aulast%3DAngenendt%26aufirst%3DP.%26aulast%3DMankoo%26aufirst%3DP.%26aulast%3DCarter%26aufirst%3DH.%26aulast%3DSiu%26aufirst%3DI.%2BM.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26aulast%3DOlivi%26aufirst%3DA.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DKeir%26aufirst%3DS.%26aulast%3DNikolskaya%26aufirst%3DT.%26aulast%3DNikolsky%26aufirst%3DY.%26aulast%3DBusam%26aufirst%3DD.%2BA.%26aulast%3DTekleab%26aufirst%3DH.%26aulast%3DDiaz%26aufirst%3DL.%2BA.%26aulast%3DHartigan%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BR.%26aulast%3DStrausberg%26aufirst%3DR.%2BL.%26aulast%3DMarie%26aufirst%3DS.%2BK.%26aulast%3DShinjo%26aufirst%3DS.%2BM.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DKarchin%26aufirst%3DR.%26aulast%3DPapadopoulos%26aufirst%3DN.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26atitle%3DAn%2520integrated%2520genomic%2520analysis%2520of%2520human%2520glioblastoma%2520multiforme%26jtitle%3DScience%26date%3D2008%26volume%3D321%26spage%3D1807%26epage%3D1812%26doi%3D10.1126%2Fscience.1164382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, W. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Q. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span> </span><span class="NLM_article-title">Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/j.ccr.2010.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1016%2Fj.ccr.2010.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=21251613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvValsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=17-30&author=W.+Xuauthor=H.+Yangauthor=Y.+Liuauthor=Y.+Yangauthor=P.+Wangauthor=S.+H.+Kimauthor=S.+Itoauthor=C.+Yangauthor=M.+T.+Xiaoauthor=L.+X.+Liuauthor=W.+Q.+Jiangauthor=J.+Liuauthor=J.+Y.+Zhangauthor=B.+Wangauthor=S.+Fryeauthor=Y.+Zhangauthor=Y.+H.+Xuauthor=Q.+Y.+Leiauthor=K.+L.+Guanauthor=S.+M.+Zhaoauthor=Y.+Xiong&title=Oncometabolite+2-hydroxyglutarate+is+a+competitive+inhibitor+of+alpha-ketoglutarate-dependent+dioxygenases&doi=10.1016%2Fj.ccr.2010.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases</span></div><div class="casAuthors">Xu, Wei; Yang, Hui; Liu, Ying; Yang, Ying; Wang, Ping; Kim, Se-Hee; Ito, Shinsuke; Yang, Chen; Wang, Pu; Xiao, Meng-Tao; Liu, Li-xia; Jiang, Wen-qing; Liu, Jing; Zhang, Jin-ye; Wang, Bin; Frye, Stephen; Zhang, Yi; Xu, Yan-hui; Lei, Qun-ying; Guan, Kun-Liang; Zhao, Shi-min; Xiong, Yue</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-30</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: IDH1 and IDH2 mutations occur frequently in gliomas and acute myeloid leukemia, leading to simultaneous loss and gain of activities in the prodn. of α-ketoglutarate (α-KG) and 2-hydroxyglutarate (2-HG), resp.  Here we demonstrate that 2-HG is a competitive inhibitor of multiple α-KG-dependent dioxygenases, including histone demethylases and the TET family of 5-methylcytosine (5mC) hydroxylases. 2-HG occupies the same space as α-KG does in the active site of histone demethylases.  Ectopic expression of tumor-derived IDH1 and IDH2 mutants inhibits histone demethylation and 5mC hydroxylation.  In glioma, IDH1 mutations are assocd. with increased histone methylation and decreased 5-hydroxylmethylcytosine (5hmC).  Hence, tumor-derived IDH1 and IDH2 mutations reduce α-KG and accumulate an α-KG antagonist, 2-HG, leading to genome-wide histone and DNA methylation alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpry-WZlrav7Vg90H21EOLACvtfcHk0liQLMlL6BYKlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvValsQ%253D%253D&md5=27f1e2d50b9dc1dd30bcc576d6318662</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DM.%2BT.%26aulast%3DLiu%26aufirst%3DL.%2BX.%26aulast%3DJiang%26aufirst%3DW.%2BQ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DFrye%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%2BH.%26aulast%3DLei%26aufirst%3DQ.%2BY.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26aulast%3DZhao%26aufirst%3DS.%2BM.%26aulast%3DXiong%26aufirst%3DY.%26atitle%3DOncometabolite%25202-hydroxyglutarate%2520is%2520a%2520competitive%2520inhibitor%2520of%2520alpha-ketoglutarate-dependent%2520dioxygenases%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D17%26epage%3D30%26doi%3D10.1016%2Fj.ccr.2010.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairns, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittinger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenkein, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">207</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span><span class="refDoi"> DOI: 10.1084/jem.20092506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1084%2Fjem.20092506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20142433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFGqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2010&pages=339-344&author=S.+Grossauthor=R.+A.+Cairnsauthor=M.+D.+Mindenauthor=E.+M.+Driggersauthor=M.+A.+Bittingerauthor=H.+G.+Jangauthor=M.+Sasakiauthor=S.+Jinauthor=D.+P.+Schenkeinauthor=S.+M.+Suauthor=L.+Dangauthor=V.+R.+Fantinauthor=T.+W.+Mak&title=Cancer-associated+metabolite+2-hydroxyglutarate+accumulates+in+acute+myelogenous+leukemia+with+isocitrate+dehydrogenase+1+and+2+mutations&doi=10.1084%2Fjem.20092506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations</span></div><div class="casAuthors">Gross, Stefan; Cairns, Rob A.; Minden, Mark D.; Driggers, Edward M.; Bittinger, Mark A.; Jang, Hyun Gyung; Sasaki, Masato; Jin, Shengfang; Schenkein, David P.; Su, Shinsan M.; Dang, Lenny; Fantin, Valeria R.; Mak, Tak W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">339-344</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2), are present in most gliomas and secondary glioblastomas, but are rare in other neoplasms.  IDH1/2 mutations are heterozygous, and affect a single Arg residue.  Recently, IDH1 mutations were identified in 8% of acute myelogenous leukemia (AML) patients.  A glioma study revealed that IDH1 mutations cause a gain-of-function, resulting in the prodn. and accumulation of 2-hydroxyglutarate (2-HG).  Genotyping of 145 AML biopsies identified 11 IDH1 R132 mutant samples.  Liq. chromatog.-mass spectrometry metabolite screening revealed increased 2-HG levels in IDH1 R132 mutant cells and sera, and uncovered 2 IDH2 R172K mutations.  IDH1/2 mutations were assocd. with normal karyotypes.  Recombinant IDH1 R132C and IDH2 R172K proteins catalyze the novel NADP (NADPH)-dependent redn. of α-ketoglutarate (α-KG) to 2-HG.  The IDH1 R132C mutation commonly found in AML reduces the affinity for isocitrate, and increases the affinity for NADPH and α-KG.  This prevents the oxidative decarboxylation of isocitrate to α-KG, and facilitates the conversion of α-KG to 2-HG.  IDH1/2 mutations confer an enzymic gain of function that dramatically increases 2-HG in AML.  This provides an explanation for the heterozygous acquisition of these mutations during tumorigenesis.  2-HG is a tractable metabolic biomarker of mutant IDH1/2 enzyme activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8uyv8xo4qzLVg90H21EOLACvtfcHk0liQLMlL6BYKlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFGqur0%253D&md5=7e900e78bc4b5a715c504272d6248551</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1084%2Fjem.20092506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20092506%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DS.%26aulast%3DCairns%26aufirst%3DR.%2BA.%26aulast%3DMinden%26aufirst%3DM.%2BD.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DSchenkein%26aufirst%3DD.%2BP.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DCancer-associated%2520metabolite%25202-hydroxyglutarate%2520accumulates%2520in%2520acute%2520myelogenous%2520leukemia%2520with%2520isocitrate%2520dehydrogenase%25201%2520and%25202%2520mutations%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2010%26volume%3D207%26spage%3D339%26epage%3D344%26doi%3D10.1084%2Fjem.20092506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasheed, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batinic-Haberle, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riggins, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinzler, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velculescu, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations in gliomas</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x">, </span> <span class="NLM_fpage">765</span><span class="NLM_x">–</span> <span class="NLM_lpage">773</span><span class="refDoi"> DOI: 10.1056/NEJMoa0808710</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1056%2FNEJMoa0808710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=19228619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2009&pages=765-773&author=H.+Yanauthor=D.+W.+Parsonsauthor=G.+Jinauthor=R.+McLendonauthor=B.+A.+Rasheedauthor=W.+Yuanauthor=I.+Kosauthor=I.+Batinic-Haberleauthor=S.+Jonesauthor=G.+J.+Rigginsauthor=H.+Friedmanauthor=A.+Friedmanauthor=D.+Reardonauthor=J.+Herndonauthor=K.+W.+Kinzlerauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=D.+D.+Bigner&title=IDH1+and+IDH2+mutations+in+gliomas&doi=10.1056%2FNEJMoa0808710"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations in gliomas</span></div><div class="casAuthors">Yan, Hai; Parsons, D. Williams; Jin, Genglin; McLendon, Roger; Ahmed Rasheed, B.; Yuan, Weishi; Kos, Ivan; Batinic-Haberle, Ines; Jones, Sian; Riggins, Gregory J.; Friedman, Henry; Friedman, Allan; Reardon, David; Herndon, James; Kinzler, Kenneth W.; Velculescu, Victor E.; Vogelstein, Bert; Bigner, Darell D.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">360</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">765-773</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: A recent genomewide mutational anal. of glioblastomas (World Health Organization [WHO] grade IV glioma) revealed somatic mutations of the isocitrate dehydrogenase 1 gene (IDH1) in a fraction of such tumors, most frequently in tumors that were known to have evolved from lower-grade gliomas (secondary glioblastomas).  METHODS: We detd. the sequence of the IDH1 gene and the related IDH2 gene in 445 central nervous system (CNS) tumors and 494 non-CNS tumors.  The enzymic activity of the proteins that were produced from normal and mutant IDH1 and IDH2 genes was detd. in cultured glioma cells that were transfected with these genes.  RESULTS: We identified mutations that affected amino acid 132 of IDH1 in more than 70% of WHO grade II and III astrocytomas and oligodendrogliomas and in glioblastomas that developed from these lower-grade lesions.  Tumors without mutations in IDH1 often had mutations affecting the analogous amino acid (R172) of the IDH2 gene.  Tumors with IDH1 or IDH2 mutations had distinctive genetic and clin. characteristics, and patients with such tumors had a better outcome than those with wild-type IDH genes.  Each of four tested IDH1 and IDH2 mutations reduced the enzymic activity of the encoded protein.  CONCLUSIONS: Mutations of NADP+-dependent isocitrate dehydrogenases encoded by IDH1 and IDH2 occur in a majority of several types of malignant gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMldYfHJnRn7Vg90H21EOLACvtfcHk0lhqJAPHBG9Jcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitFWru7o%253D&md5=2b3b5db5e16f3714f3ed6cab86939031</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0808710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0808710%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DD.%2BW.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DMcLendon%26aufirst%3DR.%26aulast%3DRasheed%26aufirst%3DB.%2BA.%26aulast%3DYuan%26aufirst%3DW.%26aulast%3DKos%26aufirst%3DI.%26aulast%3DBatinic-Haberle%26aufirst%3DI.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DRiggins%26aufirst%3DG.%2BJ.%26aulast%3DFriedman%26aufirst%3DH.%26aulast%3DFriedman%26aufirst%3DA.%26aulast%3DReardon%26aufirst%3DD.%26aulast%3DHerndon%26aufirst%3DJ.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520in%2520gliomas%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D360%26spage%3D765%26epage%3D773%26doi%3D10.1056%2FNEJMoa0808710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hartmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capper, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christians, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felsberg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawrin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wick, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unterberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeuken, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesseling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reifenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Deimling, A.</span><span> </span><span class="NLM_article-title">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">474</span><span class="refDoi"> DOI: 10.1007/s00401-009-0561-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1007%2Fs00401-009-0561-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=19554337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A280%3ADC%252BD1MrpvVOqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2009&pages=469-474&author=C.+Hartmannauthor=J.+Meyerauthor=J.+Balssauthor=D.+Capperauthor=W.+Muellerauthor=A.+Christiansauthor=J.+Felsbergauthor=M.+Wolterauthor=C.+Mawrinauthor=W.+Wickauthor=M.+Wellerauthor=C.+Herold-Mendeauthor=A.+Unterbergauthor=J.+W.+Jeukenauthor=P.+Wesselingauthor=G.+Reifenbergerauthor=A.+von+Deimling&title=Type+and+frequency+of+IDH1+and+IDH2+mutations+are+related+to+astrocytic+and+oligodendroglial+differentiation+and+age%3A+a+study+of+1%2C010+diffuse+gliomas&doi=10.1007%2Fs00401-009-0561-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas</span></div><div class="casAuthors">Hartmann Christian; Meyer Jochen; Balss Jorg; Capper David; Mueller Wolf; Christians Arne; Felsberg Jorg; Wolter Marietta; Mawrin Christian; Wick Wolfgang; Weller Michael; Herold-Mende Christel; Unterberg Andreas; Jeuken Judith W M; Wesseling Peter; Reifenberger Guido; von Deimling Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Somatic mutations in the IDH1 gene encoding cytosolic NADP+-dependent isocitrate dehydrogenase have been shown in the majority of astrocytomas, oligodendrogliomas and oligoastrocytomas of WHO grades II and III.  IDH2 encoding mitochondrial NADP+-dependent isocitrate dehydrogenase is also mutated in these tumors, albeit at much lower frequencies.  Preliminary data suggest an importance of IDH1 mutation for prognosis showing that patients with anaplastic astrocytomas, oligodendrogliomas and oligoastrocytomas harboring IDH1 mutations seem to fare much better than patients without this mutation in their tumors.  To determine mutation types and their frequencies, we examined 1,010 diffuse gliomas.  We detected 716 IDH1 mutations and 31 IDH2 mutations.  We found 165 IDH1 (72.7%) and 2 IDH2 mutations (0.9%) in 227 diffuse astrocytomas WHO grade II, 146 IDH1 (64.0%) and 2 IDH2 mutations (0.9%) in 228 anaplastic astrocytomas WHO grade III, 105 IDH1 (82.0%) and 6 IDH2 mutations (4.7%) in 128 oligodendrogliomas WHO grade II, 121 IDH1 (69.5%) and 9 IDH2 mutations (5.2%) in 174 anaplastic oligodendrogliomas WHO grade III, 62 IDH1 (81.6%) and 1 IDH2 mutations (1.3%) in 76 oligoastrocytomas WHO grade II and 117 IDH1 (66.1%) and 11 IDH2 mutations (6.2%) in 177 anaplastic oligoastrocytomas WHO grade III.  We report on an inverse association of IDH1 and IDH2 mutations in these gliomas and a non-random distribution of the mutation types within the tumor entities.  IDH1 mutations of the R132C type are strongly associated with astrocytoma, while IDH2 mutations predominantly occur in oligodendroglial tumors.  In addition, patients with anaplastic glioma harboring IDH1 mutations were on average 6 years younger than those without these alterations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSWtaE6XzJLN_6xYuD7tu2XfW6udTcc2eZ64fFXat8gHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrpvVOqsA%253D%253D&md5=cf2e0709bbe2f6d49d466b7083f2e486</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00401-009-0561-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-009-0561-9%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DC.%26aulast%3DMeyer%26aufirst%3DJ.%26aulast%3DBalss%26aufirst%3DJ.%26aulast%3DCapper%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DW.%26aulast%3DChristians%26aufirst%3DA.%26aulast%3DFelsberg%26aufirst%3DJ.%26aulast%3DWolter%26aufirst%3DM.%26aulast%3DMawrin%26aufirst%3DC.%26aulast%3DWick%26aufirst%3DW.%26aulast%3DWeller%26aufirst%3DM.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DUnterberg%26aufirst%3DA.%26aulast%3DJeuken%26aufirst%3DJ.%2BW.%26aulast%3DWesseling%26aufirst%3DP.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3Dvon%2BDeimling%26aufirst%3DA.%26atitle%3DType%2520and%2520frequency%2520of%2520IDH1%2520and%2520IDH2%2520mutations%2520are%2520related%2520to%2520astrocytic%2520and%2520oligodendroglial%2520differentiation%2520and%2520age%253A%2520a%2520study%2520of%25201%252C010%2520diffuse%2520gliomas%26jtitle%3DActa%2520Neuropathol.%26date%3D2009%26volume%3D118%26spage%3D469%26epage%3D474%26doi%3D10.1007%2Fs00401-009-0561-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Amary, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacsi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maggiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berisha, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollock, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grigoriadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eskandarpour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presneau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogendoorn, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Futreal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tirabosco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, A. M.</span><span> </span><span class="NLM_article-title">IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours</span> <span class="citation_source-journal">J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">224</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span><span class="refDoi"> DOI: 10.1002/path.2913</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1002%2Fpath.2913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=21598255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntVGms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2011&pages=334-343&author=M.+F.+Amaryauthor=K.+Bacsiauthor=F.+Maggianiauthor=S.+Damatoauthor=D.+Halaiauthor=F.+Berishaauthor=R.+Pollockauthor=P.+O%E2%80%99Donnellauthor=A.+Grigoriadisauthor=T.+Dissauthor=M.+Eskandarpourauthor=N.+Presneauauthor=P.+C.+Hogendoornauthor=A.+Futrealauthor=R.+Tiraboscoauthor=A.+M.+Flanagan&title=IDH1+and+IDH2+mutations+are+frequent+events+in+central+chondrosarcoma+and+central+and+periosteal+chondromas+but+not+in+other+mesenchymal+tumours&doi=10.1002%2Fpath.2913"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumors</span></div><div class="casAuthors">Amary, M. Fernanda; Bacsi, Krisztian; Maggiani, Francesca; Damato, Stephen; Halai, Dina; Berisha, Fitim; Pollock, Robin; O'Donnell, Paul; Grigoriadis, Anita; Diss, Tim; Eskandarpour, Malihe; Presneau, Nadege; Hogendoorn, Pancras C.; Futreal, Andrew; Tirabosco, Roberto; Flanagan, Adrienne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">334-343</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Somatic mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 occur in gliomas and acute myeloid leukemia (AML).  Since patients with multiple enchondromas have occasionally been reported to have these conditions, we hypothesized that the same mutations would occur in cartilaginous neoplasms.  Approx. 1200 mesenchymal tumors, including 220 cartilaginous tumors, 222 osteosarcomas and another ∼750 bone and soft tissue tumors, were screened for IDH1 R132 mutations, using Sequenom mass spectrometry.  Cartilaginous tumors and chondroblastic osteosarcomas, wild-type for IDH1 R132, were analyzed for IDH2 (R172, R140) mutations.  Validation was performed by capillary sequencing and restriction enzyme digestion.  Heterozygous somatic IDH1/IDH2 mutations, which result in the prodn. of a potential oncometabolite, 2-hydroxyglutarate, were only detected in central and periosteal cartilaginous tumors, and were found in at least 56% of these, ∼40% of which were represented by R132C.  IDH1 R132H mutations were confirmed by immunoreactivity for this mutant allele.  The ratio of IDH1:IDH2 mutation was 10.6 : 1.  No IDH2 R140 mutations were detected.  Mutations were detected in enchondromas through to conventional central and dedifferentiated chondrosarcomas, in patients with both solitary and multiple neoplasms.  No germline mutations were detected.  No mutations were detected in peripheral chondrosarcomas and osteochondromas.  In conclusion, IDH1 and IDH2 mutations represent the first common genetic abnormalities to be identified in conventional central and periosteal cartilaginous tumors.  As in gliomas and AML, the mutations appear to occur early in tumorigenesis.  We speculate that a mosaic pattern of IDH-mutation-bearing cells explains the reports of diverse tumors (gliomas, AML, multiple cartilaginous neoplasms, haemangiomas) occurring in the same patient.  Copyright © 2011 Pathol. Society of Great Britain and Ireland.  Published by John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotnKlczQQ1mLVg90H21EOLACvtfcHk0lhqJAPHBG9Jcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntVGms7c%253D&md5=59128645aa54d08a4251d8f763ccb28e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fpath.2913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.2913%26sid%3Dliteratum%253Aachs%26aulast%3DAmary%26aufirst%3DM.%2BF.%26aulast%3DBacsi%26aufirst%3DK.%26aulast%3DMaggiani%26aufirst%3DF.%26aulast%3DDamato%26aufirst%3DS.%26aulast%3DHalai%26aufirst%3DD.%26aulast%3DBerisha%26aufirst%3DF.%26aulast%3DPollock%26aufirst%3DR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DP.%26aulast%3DGrigoriadis%26aufirst%3DA.%26aulast%3DDiss%26aufirst%3DT.%26aulast%3DEskandarpour%26aufirst%3DM.%26aulast%3DPresneau%26aufirst%3DN.%26aulast%3DHogendoorn%26aufirst%3DP.%2BC.%26aulast%3DFutreal%26aufirst%3DA.%26aulast%3DTirabosco%26aufirst%3DR.%26aulast%3DFlanagan%26aufirst%3DA.%2BM.%26atitle%3DIDH1%2520and%2520IDH2%2520mutations%2520are%2520frequent%2520events%2520in%2520central%2520chondrosarcoma%2520and%2520central%2520and%2520periosteal%2520chondromas%2520but%2520not%2520in%2520other%2520mesenchymal%2520tumours%26jtitle%3DJ.%2520Pathol.%26date%3D2011%26volume%3D224%26spage%3D334%26epage%3D343%26doi%3D10.1002%2Fpath.2913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittinger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prins, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heiden, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">462</span><span class="NLM_x">, </span> <span class="NLM_fpage">739</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span><span class="refDoi"> DOI: 10.1038/nature08617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fnature08617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=19935646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=462&publication_year=2009&pages=739-744&author=L.+Dangauthor=D.+W.+Whiteauthor=S.+Grossauthor=B.+D.+Bennettauthor=M.+A.+Bittingerauthor=E.+M.+Driggersauthor=V.+R.+Fantinauthor=H.+G.+Jangauthor=S.+Jinauthor=M.+C.+Keenanauthor=K.+M.+Marksauthor=R.+M.+Prinsauthor=P.+S.+Wardauthor=K.+E.+Yenauthor=L.+M.+Liauauthor=J.+D.+Rabinowitzauthor=L.+C.+Cantleyauthor=C.+B.+Thompsonauthor=M.+G.+van+der+Heidenauthor=S.+M.+Su&title=Cancer-associated+IDH1+mutations+produce+2-hydroxyglutarate&doi=10.1038%2Fnature08617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer-associated IDH1 mutations produce 2-hydroxyglutarate</span></div><div class="casAuthors">Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun-Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">462</span>
        (<span class="NLM_cas:issue">7274</span>),
    <span class="NLM_cas:pages">739-744</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the enzyme cytosolic isocitrate dehydrogenase 1 (IDH1) are a common feature of a major subset of primary human brain cancers.  These mutations occur at a single amino acid residue of the IDH1 active site, resulting in loss of the enzyme's ability to catalyze conversion of isocitrate to α-ketoglutarate.  However, only a single copy of the gene is mutated in tumors, raising the possibility that the mutations do not result in a simple loss of function.  Here we show that cancer-assocd. IDH1 mutations result in a new ability of the enzyme to catalyze the NADPH-dependent redn. of α-ketoglutarate to R(-)-2-hydroxyglutarate (2HG).  Structural studies demonstrate that when arginine 132 is mutated to histidine, residues in the active site are shifted to produce structural changes consistent with reduced oxidative decarboxylation of isocitrate and acquisition of the ability to convert α-ketoglutarate to 2HG.  Excess accumulation of 2HG has been shown to lead to an elevated risk of malignant brain tumors in patients with inborn errors of 2HG metab.  Similarly, in human malignant gliomas harbouring IDH1 mutations, we find markedly elevated levels of 2HG.  These data demonstrate that the IDH1 mutations result in prodn. of the onco-metabolite 2HG, and indicate that the excess 2HG which accumulates in vivo contributes to the formation and malignant progression of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkIgPaD-aavrVg90H21EOLACvtfcHk0ljtaLdA67gbSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGlurzE&md5=b8661605276da5cbd92641e45c5b8c87</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature08617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08617%26sid%3Dliteratum%253Aachs%26aulast%3DDang%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DD.%2BW.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBittinger%26aufirst%3DM.%2BA.%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKeenan%26aufirst%3DM.%2BC.%26aulast%3DMarks%26aufirst%3DK.%2BM.%26aulast%3DPrins%26aufirst%3DR.%2BM.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3Dvan%2Bder%2BHeiden%26aufirst%3DM.%2BG.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DCancer-associated%2520IDH1%2520mutations%2520produce%25202-hydroxyglutarate%26jtitle%3DNature%26date%3D2009%26volume%3D462%26spage%3D739%26epage%3D744%26doi%3D10.1038%2Fnature08617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coller, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedvat, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perl, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinowitz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1016/j.ccr.2010.01.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1016%2Fj.ccr.2010.01.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20171147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsVWqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=225-234&author=P.+S.+Wardauthor=J.+Patelauthor=D.+R.+Wiseauthor=O.+Abdel-Wahabauthor=B.+D.+Bennettauthor=H.+A.+Collerauthor=J.+R.+Crossauthor=V.+R.+Fantinauthor=C.+V.+Hedvatauthor=A.+E.+Perlauthor=J.+D.+Rabinowitzauthor=M.+Carrollauthor=S.+M.+Suauthor=K.+A.+Sharpauthor=R.+L.+Levineauthor=C.+B.+Thompson&title=The+common+feature+of+leukemia-associated+IDH1+and+IDH2+mutations+is+a+neomorphic+enzyme+activity+converting+alpha-ketoglutarate+to+2-hydroxyglutarate&doi=10.1016%2Fj.ccr.2010.01.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate</span></div><div class="casAuthors">Ward, Patrick S.; Patel, Jay; Wise, David R.; Abdel-Wahab, Omar; Bennett, Bryson D.; Coller, Hilary A.; Cross, Justin R.; Fantin, Valeria R.; Hedvat, Cyrus V.; Perl, Alexander E.; Rabinowitz, Joshua D.; Carroll, Martin; Su, Shinsan M.; Sharp, Kim A.; Levine, Ross L.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-234</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The somatic mutations in cytosolic isocitrate dehydrogenase 1 (IDH1) obsd. in gliomas can lead to the prodn. of 2-hydroxyglutarate (2HG).  Here, the authors report that tumor 2HG is elevated in a high percentage of patients with cytogenetically normal acute myeloid leukemia (AML).  Surprisingly, less than half of cases with elevated 2HG possessed IDH1 mutations.  The remaining cases with elevated 2HG had mutations in IDH2, the mitochondrial homolog of IDH1.  These data demonstrate that a shared feature of all cancer-assocd. IDH mutations is prodn. of the oncometabolite 2HG.  Furthermore, AML patients with IDH mutations display a significantly reduced no. of other well characterized AML-assocd. mutations and/or assocd. chromosomal abnormalities, potentially implicating IDH mutation in a distinct mechanism of AML pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppKH_IGRymibVg90H21EOLACvtfcHk0ljtaLdA67gbSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsVWqtLg%253D&md5=cf235f63ccd050ff3b121b94d3c49b9e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2010.01.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2010.01.020%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DWise%26aufirst%3DD.%2BR.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DColler%26aufirst%3DH.%2BA.%26aulast%3DCross%26aufirst%3DJ.%2BR.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DHedvat%26aufirst%3DC.%2BV.%26aulast%3DPerl%26aufirst%3DA.%2BE.%26aulast%3DRabinowitz%26aufirst%3DJ.%2BD.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520common%2520feature%2520of%2520leukemia-associated%2520IDH1%2520and%2520IDH2%2520mutations%2520is%2520a%2520neomorphic%2520enzyme%2520activity%2520converting%2520alpha-ketoglutarate%2520to%25202-hydroxyglutarate%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D225%26epage%3D234%26doi%3D10.1016%2Fj.ccr.2010.01.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abdel-Wahab, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melnick, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Rourke, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">IDH mutation impairs histone demethylation and results in a block to cell differentiation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">478</span><span class="refDoi"> DOI: 10.1038/nature10860</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fnature10860" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=22343901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=474-478&author=C.+Luauthor=P.+S.+Wardauthor=G.+S.+Kapoorauthor=D.+Rohleauthor=S.+Turcanauthor=O.+Abdel-Wahabauthor=C.+R.+Edwardsauthor=R.+Khaninauthor=M.+E.+Figueroaauthor=A.+Melnickauthor=K.+E.+Wellenauthor=D.+M.+O%E2%80%99Rourkeauthor=S.+L.+Bergerauthor=T.+A.+Chanauthor=R.+L.+Levineauthor=I.+K.+Mellinghoffauthor=C.+B.+Thompson&title=IDH+mutation+impairs+histone+demethylation+and+results+in+a+block+to+cell+differentiation&doi=10.1038%2Fnature10860"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">IDH mutation impairs histone demethylation and results in a block to cell differentiation</span></div><div class="casAuthors">Lu, Chao; Ward, Patrick S.; Kapoor, Gurpreet S.; Rohle, Dan; Turcan, Sevin; Abdel-Wahab, Omar; Edwards, Christopher R.; Khanin, Raya; Figueroa, Maria E.; Melnick, Ari; Wellen, Kathryn E.; O'Rourke, Donald M.; Berger, Shelley L.; Chan, Timothy A.; Levine, Ross L.; Mellinghoff, Ingo K.; Thompson, Craig B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7390</span>),
    <span class="NLM_cas:pages">474-478</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recurrent mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 have been identified in gliomas, acute myeloid leukemias (AML) and chondrosarcomas, and share a novel enzymic property of producing 2-hydroxyglutarate (2HG) from α-ketoglutarate.  Here we report that 2HG-producing IDH mutants can prevent the histone demethylation that is required for lineage-specific progenitor cells to differentiate into terminally differentiated cells.  In tumor samples from glioma patients, IDH mutations were assocd. with a distinct gene expression profile enriched for genes expressed in neural progenitor cells, and this was assocd. with increased histone methylation.  To test whether the ability of IDH mutants to promote histone methylation contributes to a block in cell differentiation in non-transformed cells, we tested the effect of neomorphic IDH mutants on adipocyte differentiation in vitro.  Introduction of either mutant IDH or cell-permeable 2HG was assocd. with repression of the inducible expression of lineage-specific differentiation genes and a block to differentiation.  This correlated with a significant increase in repressive histone methylation marks without observable changes in promoter DNA methylation.  Gliomas were found to have elevated levels of similar histone repressive marks.  Stable transfection of a 2HG-producing mutant IDH into immortalized astrocytes resulted in progressive accumulation of histone methylation.  Of the marks examd., increased H3K9 methylation reproducibly preceded a rise in DNA methylation as cells were passaged in culture.  Furthermore, we found that the 2HG-inhibitable H3K9 demethylase KDM4C was induced during adipocyte differentiation, and that RNA-interference suppression of KDM4C was sufficient to block differentiation.  Together these data demonstrate that 2HG can inhibit histone demethylation and that inhibition of histone demethylation can be sufficient to block the differentiation of non-transformed cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxj9sZYgiJH7Vg90H21EOLACvtfcHk0lhg5AvhIHHqBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKks74%253D&md5=d5bb18c8ef2bbd1d28540cf7dabc9b57</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature10860&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10860%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DKapoor%26aufirst%3DG.%2BS.%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DAbdel-Wahab%26aufirst%3DO.%26aulast%3DEdwards%26aufirst%3DC.%2BR.%26aulast%3DKhanin%26aufirst%3DR.%26aulast%3DFigueroa%26aufirst%3DM.%2BE.%26aulast%3DMelnick%26aufirst%3DA.%26aulast%3DWellen%26aufirst%3DK.%2BE.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DD.%2BM.%26aulast%3DBerger%26aufirst%3DS.%2BL.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DIDH%2520mutation%2520impairs%2520histone%2520demethylation%2520and%2520results%2520in%2520a%2520block%2520to%2520cell%2520differentiation%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D474%26epage%3D478%26doi%3D10.1038%2Fnature10860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goenka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yilmaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabius, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guryanova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heguy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huse, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span> </span><span class="NLM_article-title">IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">483</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">483</span><span class="refDoi"> DOI: 10.1038/nature10866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fnature10866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=22343889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38XisVKktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=483&publication_year=2012&pages=479-483&author=S.+Turcanauthor=D.+Rohleauthor=A.+Goenkaauthor=L.+A.+Walshauthor=F.+Fangauthor=E.+Yilmazauthor=C.+Camposauthor=A.+W.+Fabiusauthor=C.+Luauthor=P.+S.+Wardauthor=C.+B.+Thompsonauthor=A.+Kaufmanauthor=O.+Guryanovaauthor=R.+Levineauthor=A.+Heguyauthor=A.+Vialeauthor=L.+G.+Morrisauthor=J.+T.+Huseauthor=I.+K.+Mellinghoffauthor=T.+A.+Chan&title=IDH1+mutation+is+sufficient+to+establish+the+glioma+hypermethylator+phenotype&doi=10.1038%2Fnature10866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype</span></div><div class="casAuthors">Turcan, Sevin; Rohle, Daniel; Goenka, Anuj; Walsh, Logan A.; Fang, Fang; Yilmaz, Emrullah; Campos, Carl; Fabius, Armida W. M.; Lu, Chao; Ward, Patrick S.; Thompson, Craig B.; Kaufman, Andrew; Guryanova, Olga; Levine, Ross; Heguy, Adriana; Viale, Agnes; Morris, Luc G. T.; Huse, Jason T.; Mellinghoff, Ingo K.; Chan, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">483</span>
        (<span class="NLM_cas:issue">7390</span>),
    <span class="NLM_cas:pages">479-483</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Both genome-wide genetic and epigenetic alterations are fundamentally important for the development of cancers, but the interdependence of these aberrations is poorly understood.  Glioblastomas and other cancers with the CpG island methylator phenotype (CIMP) constitute a subset of tumors with extensive epigenomic aberrations and a distinct biol.  Glioma CIMP (G-CIMP) is a powerful determinant of tumor pathogenicity, but the mol. basis of G-CIMP remains unresolved.  Here we show that mutation of a single gene, isocitrate dehydrogenase 1 (IDH1), establishes G-CIMP by remodelling the methylome.  This remodelling results in reorganization of the methylome and transcriptome.  Examn. of the epigenome of a large set of intermediate-grade gliomas demonstrates a distinct G-CIMP phenotype that is highly dependent on the presence of IDH mutation.  Introduction of mutant IDH1 into primary human astrocytes alters specific histone marks, induces extensive DNA hypermethylation, and reshapes the methylome in a fashion that mirrors the changes obsd. in G-CIMP-pos. lower-grade gliomas.  Furthermore, the epigenomic alterations resulting from mutant IDH1 activate key gene expression programs, characterize G-CIMP-pos. proneural glioblastomas but not other glioblastomas, and are predictive of improved survival.  Our findings demonstrate that IDH mutation is the mol. basis of CIMP in gliomas, provide a framework for understanding oncogenesis in these gliomas, and highlight the interplay between genomic and epigenomic changes in human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGkrX6t11CcLVg90H21EOLACvtfcHk0lhg5AvhIHHqBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisVKktLc%253D&md5=4afa997b44a163435033c76b6d90b0b1</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnature10866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10866%26sid%3Dliteratum%253Aachs%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DGoenka%26aufirst%3DA.%26aulast%3DWalsh%26aufirst%3DL.%2BA.%26aulast%3DFang%26aufirst%3DF.%26aulast%3DYilmaz%26aufirst%3DE.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DFabius%26aufirst%3DA.%2BW.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DKaufman%26aufirst%3DA.%26aulast%3DGuryanova%26aufirst%3DO.%26aulast%3DLevine%26aufirst%3DR.%26aulast%3DHeguy%26aufirst%3DA.%26aulast%3DViale%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DL.%2BG.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26aulast%3DChan%26aufirst%3DT.%2BA.%26atitle%3DIDH1%2520mutation%2520is%2520sufficient%2520to%2520establish%2520the%2520glioma%2520hypermethylator%2520phenotype%26jtitle%3DNature%26date%3D2012%26volume%3D483%26spage%3D479%26epage%3D483%26doi%3D10.1038%2Fnature10866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Prensner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnaiyan, A. M.</span><span> </span><span class="NLM_article-title">Metabolism unhinged: IDH mutations in cancer</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1038/nm0311-291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fnm0311-291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=21383741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVGgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=291-293&author=J.+R.+Prensnerauthor=A.+M.+Chinnaiyan&title=Metabolism+unhinged%3A+IDH+mutations+in+cancer&doi=10.1038%2Fnm0311-291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolism unhinged: IDH mutations in cancer</span></div><div class="casAuthors">Prensner, John R.; Chinnaiyan, Arul M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-293</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recently characterized IDH1 and IDH2 mutations in leukemia and glioblastoma have introduced a fascinating cancer-specific role for metabolic genes essential to cellular respiration.  Studies also link aberrant IDH1 and IDH2 activity to an altered metabolite profile, an observation that may have broad implications for both cancer epigenetics and clin. management of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpopuegY-UsALVg90H21EOLACvtfcHk0lhg5AvhIHHqBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVGgtLw%253D&md5=6df1b41aab0341769974251276ba6dec</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnm0311-291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0311-291%26sid%3Dliteratum%253Aachs%26aulast%3DPrensner%26aufirst%3DJ.%2BR.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26atitle%3DMetabolism%2520unhinged%253A%2520IDH%2520mutations%2520in%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D291%26epage%3D293%26doi%3D10.1038%2Fnm0311-291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Garber, K.</span><span> </span><span class="NLM_article-title">Oncometabolite? IDH1 discoveries raise possibility of new metabolism targets in brain cancers and leukemia</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">926</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span><span class="refDoi"> DOI: 10.1093/jnci/djq262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1093%2Fjnci%2Fdjq262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20576929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlegsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=926-928&author=K.+Garber&title=Oncometabolite%3F+IDH1+discoveries+raise+possibility+of+new+metabolism+targets+in+brain+cancers+and+leukemia&doi=10.1093%2Fjnci%2Fdjq262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Oncometabolite? IDH1 Discoveries Raise Possibility of New Metabolism Targets in Brain Cancers and Leukemia</span></div><div class="casAuthors">Garber, Ken</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">926-928</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  Compared with normal cells, which primarily generate energy aerobically in mitochondria, most tumor cells rely more heavily on glycolysis (the anaerobic conversion of glucose to lactate) to generate energy.  Tumors also display other unique metabolic features.  But the discovery of a mutated metabolic enzyme was strong evidence that metabolic abnormalities play an important role in oncogenesis, and it set off a frantic effort to understand what the mutation was doing in such common and lethal cancers.  Answers have proven just as surprising as the initial discovery.  And the revelations, although incomplete and still controversial, are paving the way for drugs targeting mutant isocitrate dehydrogenase (IDH) and for diagnostic tests to identify patients likely to benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUWv5GxNnQqrVg90H21EOLACvtfcHk0lhg5AvhIHHqBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlegsL0%253D&md5=66fe53c6c537f459144c907a59e47d90</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjq262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjq262%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DK.%26atitle%3DOncometabolite%253F%2520IDH1%2520discoveries%2520raise%2520possibility%2520of%2520new%2520metabolism%2520targets%2520in%2520brain%2520cancers%2520and%2520leukemia%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2010%26volume%3D102%26spage%3D926%26epage%3D928%26doi%3D10.1093%2Fjnci%2Fdjq262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straley, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantin, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span> </span><span class="NLM_article-title">Discovery of the first potent inhibitors of mutant IDH1 that lower tumor 2-HG in vivo</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1021/ml300225h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300225h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=850-855&author=J.+Popovici-Mullerauthor=J.+O.+Saundersauthor=F.+G.+Salituroauthor=J.+M.+Travinsauthor=S.+Yanauthor=F.+Zhaoauthor=S.+Grossauthor=L.+Dangauthor=K.+E.+Yenauthor=H.+Yangauthor=K.+S.+Straleyauthor=S.+Jinauthor=K.+Kuniiauthor=V.+R.+Fantinauthor=S.+Zhangauthor=Q.+Panauthor=D.+Shiauthor=S.+A.+Billerauthor=S.+M.+Su&title=Discovery+of+the+first+potent+inhibitors+of+mutant+IDH1+that+lower+tumor+2-HG+in+vivo&doi=10.1021%2Fml300225h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo</span></div><div class="casAuthors">Popovici-Muller, Janeta; Saunders, Jeffrey O.; Salituro, Francesco G.; Travins, Jeremy M.; Yan, Shunqi; Zhao, Fang; Gross, Stefan; Dang, Lenny; Yen, Katharine E.; Yang, Hua; Straley, Kimberly S.; Jin, Shengfang; Kunii, Kaiko; Fantin, Valeria R.; Zhang, Shunan; Pan, Qiongqun; Shi, Derek; Biller, Scott A.; Su, Shinsan M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">850-855</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a series of R132H IDH1 inhibitors from a high throughput screen led to the first potent mols. that show robust tumor 2-HG inhibition in a xenograft model.  Compd. 35 shows good potency in the U87 R132H cell based assay and ∼90% tumor 2-HG inhibition in the corresponding mouse xenograft model following BID dosing.  The magnitude and duration of tumor 2-HG inhibition correlates with free plasma concn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprvfJ98f1ns7Vg90H21EOLACvtfcHk0lh_vqdGkzQfyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGkurnE&md5=eabdaa3351155971ed3feceace0d17c4</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml300225h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300225h%26sid%3Dliteratum%253Aachs%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DSaunders%26aufirst%3DJ.%2BO.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DTravins%26aufirst%3DJ.%2BM.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DDang%26aufirst%3DL.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DStraley%26aufirst%3DK.%2BS.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DShi%26aufirst%3DD.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26atitle%3DDiscovery%2520of%2520the%2520first%2520potent%2520inhibitors%2520of%2520mutant%2520IDH1%2520that%2520lower%2520tumor%25202-HG%2520in%2520vivo%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D850%26epage%3D855%26doi%3D10.1021%2Fml300225h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Rohle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popovici-Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palaskas, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turcan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grommes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsoi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldrini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komisopoulou, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunii, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedraza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schalm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kernytsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblum, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graeber, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellinghoff, I. K.</span><span> </span><span class="NLM_article-title">An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span><span class="refDoi"> DOI: 10.1126/science.1236062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1126%2Fscience.1236062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=23558169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=626-630&author=D.+Rohleauthor=J.+Popovici-Mullerauthor=N.+Palaskasauthor=S.+Turcanauthor=C.+Grommesauthor=C.+Camposauthor=J.+Tsoiauthor=O.+Clarkauthor=B.+Oldriniauthor=E.+Komisopoulouauthor=K.+Kuniiauthor=A.+Pedrazaauthor=S.+Schalmauthor=L.+Silvermanauthor=A.+Millerauthor=F.+Wangauthor=H.+Yangauthor=Y.+Chenauthor=A.+Kernytskyauthor=M.+K.+Rosenblumauthor=W.+Liuauthor=S.+A.+Billerauthor=S.+M.+Suauthor=C.+W.+Brennanauthor=T.+A.+Chanauthor=T.+G.+Graeberauthor=K.+E.+Yenauthor=I.+K.+Mellinghoff&title=An+inhibitor+of+mutant+IDH1+delays+growth+and+promotes+differentiation+of+glioma+cells&doi=10.1126%2Fscience.1236062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells</span></div><div class="casAuthors">Rohle, Dan; Popovici-Muller, Janeta; Palaskas, Nicolaos; Turcan, Sevin; Grommes, Christian; Campos, Carl; Tsoi, Jennifer; Clark, Owen; Oldrini, Barbara; Komisopoulou, Evangelia; Kunii, Kaiko; Pedraza, Alicia; Schalm, Stefanie; Silverman, Lee; Miller, Alexandra; Wang, Fang; Yang, Hua; Chen, Yue; Kernytsky, Andrew; Rosenblum, Marc K.; Liu, Wei; Biller, Scott A.; Su, Shinsan M.; Brennan, Cameron W.; Chan, Timothy A.; Graeber, Thomas G.; Yen, Katharine E.; Mellinghoff, Ingo K.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">626-630</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metab. of cancer cells for cancer therapy.  One potential drug target is isocitrate dehydrogenase 1 (IDH1), which is mutated in multiple human cancers.  Here, we examine the role of mutant IDH1 in fully transformed cells with endogenous IDH1 mutations.  A selective R132H-IDH1 inhibitor (AGI-5198) identified through a high-throughput screen blocked, in a dose-dependent manner, the ability of the mutant enzyme (mIDH1) to produce R-2-hydroxyglutarate (R-2HG).  Under conditions of near-complete R-2HG inhibition, the mIDH1 inhibitor induced demethylation of histone H3K9me3 and expression of genes assocd. with gliogenic differentiation.  Blockade of mIDH1 impaired the growth of IDH1-mutant-but not IDH1-wild-type-glioma cells without appreciable changes in genome-wide DNA methylation.  These data suggest that mIDH1 may promote glioma growth through mechanisms beyond its well-characterized epigenetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz81Au_Pr-4rVg90H21EOLACvtfcHk0lh_vqdGkzQfyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbg%253D&md5=c4499103628349dcf9866c44924acf3c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.1236062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1236062%26sid%3Dliteratum%253Aachs%26aulast%3DRohle%26aufirst%3DD.%26aulast%3DPopovici-Muller%26aufirst%3DJ.%26aulast%3DPalaskas%26aufirst%3DN.%26aulast%3DTurcan%26aufirst%3DS.%26aulast%3DGrommes%26aufirst%3DC.%26aulast%3DCampos%26aufirst%3DC.%26aulast%3DTsoi%26aufirst%3DJ.%26aulast%3DClark%26aufirst%3DO.%26aulast%3DOldrini%26aufirst%3DB.%26aulast%3DKomisopoulou%26aufirst%3DE.%26aulast%3DKunii%26aufirst%3DK.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DSchalm%26aufirst%3DS.%26aulast%3DSilverman%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DKernytsky%26aufirst%3DA.%26aulast%3DRosenblum%26aufirst%3DM.%2BK.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DSu%26aufirst%3DS.%2BM.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DChan%26aufirst%3DT.%2BA.%26aulast%3DGraeber%26aufirst%3DT.%2BG.%26aulast%3DYen%26aufirst%3DK.%2BE.%26aulast%3DMellinghoff%26aufirst%3DI.%2BK.%26atitle%3DAn%2520inhibitor%2520of%2520mutant%2520IDH1%2520delays%2520growth%2520and%2520promotes%2520differentiation%2520of%2520glioma%2520cells%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D626%26epage%3D630%26doi%3D10.1126%2Fscience.1236062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anglin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">546</span><span class="refDoi"> DOI: 10.1021/ml400036z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400036z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=542-546&author=B.+Zhengauthor=Y.+Yaoauthor=Z.+Liuauthor=L.+Dengauthor=J.+L.+Anglinauthor=H.+Jiangauthor=B.+V.+Prasadauthor=Y.+Song&title=Crystallographic+Investigation+and+Selective+Inhibition+of+Mutant+Isocitrate+Dehydrogenase&doi=10.1021%2Fml400036z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase</span></div><div class="casAuthors">Zheng, Baisong; Yao, Yuan; Liu, Zhen; Deng, Lisheng; Anglin, Justin L.; Jiang, Hong; Prasad, B. V. Venkataram; Song, Yongcheng</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">542-546</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutations in isocitrate dehydrogenase (IDH), a key enzyme in the tricarboxylic acid cycle, have recently been found in ∼75% glioma and ∼20% acute myeloid leukemia.  Different from the wild-type enzyme, mutant IDH1 catalyzes the redn. of α-ketoglutaric acid to D-2-hydroxyglutaric acid.  Strong evidence has shown mutant IDH1 represents a novel target for this type of cancer.  We found two 1-hydroxypyridin-2-one compds. that are potent inhibitors of R132H and R132C IDH1 mutants with Ki values as low as 120 nM.  These compds. exhibit >60-fold selectivity against wild-type IDH1 and can inhibit the prodn. of D-2-hydroxyglutaric acid in IDH1 mutated cells, representing novel chem. probes for cancer biol. studies.  We also report the first inhibitor-bound crystal structures of IDH1(R132H), showing these inhibitors have H-bond, electrostatic, and hydrophobic interactions with the mutant enzyme.  Comparison with the substrate-bound IDH1 structures revealed the structural basis for the high enzyme selectivity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH0vzVLGCPZLVg90H21EOLACvtfcHk0ljbqObVGqy_fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWrtLg%253D&md5=c34c67949fe816bdf151525a578535f3</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml400036z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400036z%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DAnglin%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPrasad%26aufirst%3DB.%2BV.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCrystallographic%2520Investigation%2520and%2520Selective%2520Inhibition%2520of%2520Mutant%2520Isocitrate%2520Dehydrogenase%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D542%26epage%3D546%26doi%3D10.1021%2Fml400036z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogiso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lv, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases: Synthesis, SAR and Selective Antitumor Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">8307</span><span class="NLM_x">–</span> <span class="NLM_lpage">8318</span><span class="refDoi"> DOI: 10.1021/jm500660f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500660f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8307-8318&author=Z.+Liuauthor=Y.+Yaoauthor=M.+Kogisoauthor=B.+Zhengauthor=L.+Dengauthor=J.+J.+Qiuauthor=S.+Dongauthor=H.+Lvauthor=J.+M.+Galloauthor=X.-N.+Liauthor=Y.+Song&title=Inhibition+of+Cancer-Associated+Mutant+Isocitrate+Dehydrogenases%3A+Synthesis%2C+SAR+and+Selective+Antitumor+Activity&doi=10.1021%2Fjm500660f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm500660f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500660f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DKogiso%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DDeng%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DJ.%2BJ.%26aulast%3DDong%26aufirst%3DS.%26aulast%3DLv%26aufirst%3DH.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DLi%26aufirst%3DX.-N.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DInhibition%2520of%2520Cancer-Associated%2520Mutant%2520Isocitrate%2520Dehydrogenases%253A%2520Synthesis%252C%2520SAR%2520and%2520Selective%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8307%26epage%3D8318%26doi%3D10.1021%2Fjm500660f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Deng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McManus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le-Strat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquette, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rooney, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassort, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englaro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiederschain, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, S.</span><span> </span><span class="NLM_article-title">Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small molecule</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">762</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span><span class="refDoi"> DOI: 10.1074/jbc.M114.608497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1074%2Fjbc.M114.608497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=25391653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2rtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=762-774&author=G.+Dengauthor=J.+Shenauthor=M.+Yinauthor=J.+McManusauthor=M.+Mathieuauthor=P.+Geeauthor=T.+Heauthor=C.+Shiauthor=O.+Bedelauthor=L.+R.+McLeanauthor=F.+Le-Stratauthor=Y.+Zhangauthor=J.+P.+Marquetteauthor=Q.+Gaoauthor=B.+Zhangauthor=A.+Rakauthor=D.+Hoffmannauthor=E.+Rooneyauthor=A.+Vassortauthor=W.+Englaroauthor=Y.+Liauthor=V.+Patelauthor=F.+Adrianauthor=S.+Grossauthor=D.+Wiederschainauthor=H.+Chengauthor=S.+Licht&title=Selective+inhibition+of+mutant+isocitrate+dehydrogenase+1+%28IDH1%29+via+disruption+of+a+metal+binding+network+by+an+allosteric+small+molecule&doi=10.1074%2Fjbc.M114.608497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (IDH1) via Disruption of a Metal Binding Network by an Allosteric Small Molecule</span></div><div class="casAuthors">Deng, Gejing; Shen, Junqing; Yin, Ming; McManus, Jessica; Mathieu, Magali; Gee, Patricia; He, Timothy; Shi, Chaomei; Bedel, Olivier; McLean, Larry R.; Le-Strat, Frank; Zhang, Ying; Marquette, Jean-Pierre; Gao, Qiang; Zhang, Bailin; Rak, Alexey; Hoffmann, Dietmar; Rooney, Eamonn; Vassort, Aurelie; Englaro, Walter; Li, Yi; Patel, Vinod; Adrian, Francisco; Gross, Stefan; Wiederschain, Dmitri; Cheng, Hong; Licht, Stuart</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">762-774</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Cancer-assocd. point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) confer a neomorphic enzymic activity: the redn. of α-ketoglutarate to D-2-hydroxyglutaric acid (2HG), which is proposed to act as an oncogenic metabolite by inducing hypermethylation of histones and DNA.  Although selective inhibitors of mutant IDH1 and IDH2 have been identified and are currently under investigation as potential cancer therapeutics, the mechanistic basis for their selectivity is not yet well understood.  A high throughput screen for selective inhibitors of IDH1 bearing the oncogenic mutation R132H identified compd. 1, a bis-imidazole phenol that inhibits D-2-hydroxyglutaric acid prodn. in cells.  We investigated the mode of inhibition of compd. 1 and a previously published IDH1 mutant inhibitor with a different chem. scaffold.  Steady-state kinetics and biophys. studies show that both of these compds. selectively inhibit mutant IDH1 by binding to an allosteric site and that inhibition is competitive with respect to Mg2+.  A crystal structure of compd. 1 complexed with R132H IDH1 indicates that the inhibitor binds at the dimer interface and makes direct contact with a residue involved in binding of the catalytically essential divalent cation.  These results show that targeting a divalent cation binding residue can enable selective inhibition of mutant IDH1 and suggest that differences in magnesium binding between wild-type and mutant enzymes may contribute to the inhibitors' selectivity for the mutant enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd8VKauy1y9rVg90H21EOLACvtfcHk0ljbqObVGqy_fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2rtw%253D%253D&md5=6513af66926eb2b087ba472504a93fc5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.608497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.608497%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DG.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DM.%26aulast%3DMcManus%26aufirst%3DJ.%26aulast%3DMathieu%26aufirst%3DM.%26aulast%3DGee%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DBedel%26aufirst%3DO.%26aulast%3DMcLean%26aufirst%3DL.%2BR.%26aulast%3DLe-Strat%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMarquette%26aufirst%3DJ.%2BP.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DHoffmann%26aufirst%3DD.%26aulast%3DRooney%26aufirst%3DE.%26aulast%3DVassort%26aufirst%3DA.%26aulast%3DEnglaro%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DGross%26aufirst%3DS.%26aulast%3DWiederschain%26aufirst%3DD.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DS.%26atitle%3DSelective%2520inhibition%2520of%2520mutant%2520isocitrate%2520dehydrogenase%25201%2520%2528IDH1%2529%2520via%2520disruption%2520of%2520a%2520metal%2520binding%2520network%2520by%2520an%2520allosteric%2520small%2520molecule%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D762%26epage%3D774%26doi%3D10.1074%2Fjbc.M114.608497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Yang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, J.</span><span> </span><span class="NLM_article-title">Molecular mechanisms of ″off-on switch″ of activities of human IDH1 by tumor-associated mutation R132H</span> <span class="citation_source-journal">Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1200</span><span class="refDoi"> DOI: 10.1038/cr.2010.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2Fcr.2010.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20975740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1188-1200&author=B.+Yangauthor=C.+Zhongauthor=Y.+Pengauthor=Z.+Laiauthor=J.+Ding&title=Molecular+mechanisms+of+%E2%80%B3off-on+switch%E2%80%B3+of+activities+of+human+IDH1+by+tumor-associated+mutation+R132H&doi=10.1038%2Fcr.2010.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanisms of "off-on switch" of activities of human IDH1 by tumor-associated mutation R132H</span></div><div class="casAuthors">Yang, Bei; Zhong, Chen; Peng, Yingjie; Lai, Zheng; Ding, Jianping</div><div class="citationInfo"><span class="NLM_cas:title">Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1188-1200</span>CODEN:
                <span class="NLM_cas:coden">CREEB6</span>;
        ISSN:<span class="NLM_cas:issn">1001-0602</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human cytosolic NADP-IDH (IDH1) has recently been found to be involved in tumorigenesis.  Notably, the tumor-derived IDH1 mutations identified so far mainly occur at Arg132, and mutation R132H is the most prevalent one.  This mutation impairs the oxidative IDH activity of the enzyme, but renders a new redn. function of converting α-ketoglutarate (αKG) to 2-hydroxyglutarate.  Here, we report the structures of the R132H mutant IDH1 with and without isocitrate (ICT) bound.  The structural data together with mutagenesis and biochem. data reveal a previously undefined initial ICT-binding state and demonstrate that IDH activity requires a conformational change to a closed pre-transition state.  Arg132 plays multiple functional roles in the catalytic reaction; in particular, the R132H mutation hinders the conformational changes from the initial ICT-binding state to the pre-transition state, leading to the impairment of the IDH activity.  Our results describe for the first time that there is an intermediate conformation that corresponds to an initial ICT-binding state and that the R132H mutation can trap the enzyme in this conformation, therefore shedding light on the mol. mechanism of the "off switch" of the potentially tumor-suppressive IDH activity.  Furthermore, we proved the necessity of Tyr139 for the gained αKG redn. activity and propose that Tyr139 may play a vital role by compensating the increased neg. charge on the C2 atom of αKG during the transfer of a hydride anion from NADPH to αKG, which provides new insights into the mechanism of the "on switch" of the hypothetically oncogenic redn. activity of IDH1 by this mutation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpory1c32RonLVg90H21EOLACvtfcHk0lhst-u4b4LEEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKjtbfI&md5=04d83e2a90480837c09eb8c0140ecc88</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fcr.2010.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcr.2010.145%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DC.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DJ.%26atitle%3DMolecular%2520mechanisms%2520of%2520%25E2%2580%25B3off-on%2520switch%25E2%2580%25B3%2520of%2520activities%2520of%2520human%2520IDH1%2520by%2520tumor-associated%2520mutation%2520R132H%26jtitle%3DCell%2520Res.%26date%3D2010%26volume%3D20%26spage%3D1188%26epage%3D1200%26doi%3D10.1038%2Fcr.2010.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lapidot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vormoor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murdoch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caceres-Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, J. E.</span><span> </span><span class="NLM_article-title">A cell initiating human acute myeloid leukaemia after transplantation into SCID mice</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">645</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span><span class="refDoi"> DOI: 10.1038/367645a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1038%2F367645a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=7509044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A280%3ADyaK2c7ltVKrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1994&pages=645-648&author=T.+Lapidotauthor=C.+Sirardauthor=J.+Vormoorauthor=B.+Murdochauthor=T.+Hoangauthor=J.+Caceres-Cortesauthor=M.+Mindenauthor=B.+Patersonauthor=M.+A.+Caligiuriauthor=J.+E.+Dick&title=A+cell+initiating+human+acute+myeloid+leukaemia+after+transplantation+into+SCID+mice&doi=10.1038%2F367645a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">A cell initiating human acute myeloid leukaemia after transplantation into SCID mice</span></div><div class="casAuthors">Lapidot T; Sirard C; Vormoor J; Murdoch B; Hoang T; Caceres-Cortes J; Minden M; Paterson B; Caligiuri M A; Dick J E</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">367</span>
        (<span class="NLM_cas:issue">6464</span>),
    <span class="NLM_cas:pages">645-8</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Most human acute myeloid leukaemia (AML) cells have limited proliferative capacity, suggesting that the leukaemic clone may be maintained by a rare population of stem cells.  This putative leukaemic stem cell has not been characterized because the available in vitro assays can only detect progenitors with limited proliferative and replating potential.  We have now identified an AML-initiating cell by transplantation into severe combined immune-deficient (SCID) mice.  These cells homed to the bone marrow and proliferated extensively in response to in vivo cytokine treatment, resulting in a pattern of dissemination and leukaemic cell morphology similar to that seen in the original patients.  Limiting dilution analysis showed that the frequency of these leukaemia-initiating cells in the peripheral blood of AML patients was one engraftment unit in 250,000 cells.  We fractionated AML cells on the basis of cell-surface-marker expression and found that the leukaemia-initiating cells that could engraft SCID mice to produce large numbers of colony-forming progenitors were CD34+ CD38-; however, the CD34+ CD38+ and CD34- fractions contained no cells with these properties.  This in vivo model replicates many aspects of human AML and defines a new leukaemia-initiating cell which is less mature than colony-forming cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvfHJZ5BZZYP3jf77P2BG3fW6udTcc2eY9mC9raAL6Brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7ltVKrsg%253D%253D&md5=692809a03a33f917ae2815cedadb7973</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2F367645a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F367645a0%26sid%3Dliteratum%253Aachs%26aulast%3DLapidot%26aufirst%3DT.%26aulast%3DSirard%26aufirst%3DC.%26aulast%3DVormoor%26aufirst%3DJ.%26aulast%3DMurdoch%26aufirst%3DB.%26aulast%3DHoang%26aufirst%3DT.%26aulast%3DCaceres-Cortes%26aufirst%3DJ.%26aulast%3DMinden%26aufirst%3DM.%26aulast%3DPaterson%26aufirst%3DB.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DDick%26aufirst%3DJ.%2BE.%26atitle%3DA%2520cell%2520initiating%2520human%2520acute%2520myeloid%2520leukaemia%2520after%2520transplantation%2520into%2520SCID%2520mice%26jtitle%3DNature%26date%3D1994%26volume%3D367%26spage%3D645%26epage%3D648%26doi%3D10.1038%2F367645a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Luchman, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stechishin, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blough, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chesnelong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weljie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cairncross, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S.</span><span> </span><span class="NLM_article-title">An in vivo patient-derived model of endogenous IDH1-mutant glioma</span> <span class="citation_source-journal">Neuro. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1093/neuonc/nor207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1093%2Fneuonc%2Fnor207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=22166263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2hs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=184-191&author=H.+A.+Luchmanauthor=O.+D.+Stechishinauthor=N.+H.+Dangauthor=M.+D.+Bloughauthor=C.+Chesnelongauthor=J.+J.+Kellyauthor=S.+A.+Nguyenauthor=J.+A.+Chanauthor=A.+M.+Weljieauthor=J.+G.+Cairncrossauthor=S.+Weiss&title=An+in+vivo+patient-derived+model+of+endogenous+IDH1-mutant+glioma&doi=10.1093%2Fneuonc%2Fnor207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">An in vivo patient-derived model of endogenous IDH1-mutant glioma</span></div><div class="casAuthors">Luchman, H. Artee; Stechishin, Owen D.; Dang, N. Ha; Blough, Michael D.; Chesnelong, Charles; Kelly, John J.; Nguyen, Stephanie A.; Chan, Jennifer A.; Weljie, Aalim M.; Cairncross, J. Gregory; Weiss, Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-191</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Somatic mutations in the catalytic domain of isocitrate dehydrogenase (IDH) 1/2 and accumulation of the oncometabolite 2-hydroxyglutarate (2-HG) appear to be among the earliest events in gliomagenesis and may contribute to malignant transformation.  The lack of cell lines with endogenous mutations has been one of the major challenges in studying IDH1/2-mutant glioma and developing novel therapeutics for these tumors.  Here, we describe the isolation of a glioma brain tumor stem cell line (BT142) with an endogenous R132H mutation in IDH1, aggressive tumor-initiating capacity, and 2-HG prodn.  The neurosphere culture method was used to establish a brain tumor stem cell line from an IDH1-mutant anaplastic oligoastrocytoma sample, and an orthotopic xenograft system was developed to allow its rapid expansion.  Prodn. of 2-HG by glioma cells with endogenous IDH1 mutations was confirmed by mass spectrometry.  BT142 retained an endogenous R132H IDH1 mutation in culture and possessed aggressive tumor-initiating capacity, allowing it to be readily propagated in orthotopic xenografts of nonobese diabetic/severe combined immune deficiency (NOD SCID) mice.  Endogenous 2-HG prodn. by BT142 was detectable in both cell culture medium and xenograft animal serum.  BT142 is the first brain tumor cell line with an endogenous IDH1 mutation and detectable 2-HG prodn. both in vitro and in vivo, which thus provides a unique model for studying the biol. of IDH1-mutant glioma and in vivo validation of compds. targeting IDH1-mutant cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQxQYkboS8-bVg90H21EOLACvtfcHk0lhst-u4b4LEEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2hs7vI&md5=599a3e62b9baac34abe637fa0a64a5e7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnor207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnor207%26sid%3Dliteratum%253Aachs%26aulast%3DLuchman%26aufirst%3DH.%2BA.%26aulast%3DStechishin%26aufirst%3DO.%2BD.%26aulast%3DDang%26aufirst%3DN.%2BH.%26aulast%3DBlough%26aufirst%3DM.%2BD.%26aulast%3DChesnelong%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DJ.%2BJ.%26aulast%3DNguyen%26aufirst%3DS.%2BA.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DWeljie%26aufirst%3DA.%2BM.%26aulast%3DCairncross%26aufirst%3DJ.%2BG.%26aulast%3DWeiss%26aufirst%3DS.%26atitle%3DAn%2520in%2520vivo%2520patient-derived%2520model%2520of%2520endogenous%2520IDH1-mutant%2520glioma%26jtitle%3DNeuro.%2520Oncol.%26date%3D2012%26volume%3D14%26spage%3D184%26epage%3D191%26doi%3D10.1093%2Fneuonc%2Fnor207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold-Mende, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, T.</span><span> </span><span class="NLM_article-title">The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research</span> <span class="citation_source-journal">Brain Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">889</span><span class="refDoi"> DOI: 10.1111/j.1750-3639.2010.00379.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1111%2Fj.1750-3639.2010.00379.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20331619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFKht7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=877-889&author=F.+Wanauthor=S.+Zhangauthor=R.+Xieauthor=B.+Gaoauthor=B.+Camposauthor=C.+Herold-Mendeauthor=T.+Lei&title=The+utility+and+limitations+of+neurosphere+assay%2C+CD133+immunophenotyping+and+side+population+assay+in+glioma+stem+cell+research&doi=10.1111%2Fj.1750-3639.2010.00379.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research</span></div><div class="casAuthors">Wan, Feng; Zhang, Suojun; Xie, Ruifan; Gao, Baocheng; Campos, Benito; Herold-Mende, Christel; Lei, Ting</div><div class="citationInfo"><span class="NLM_cas:title">Brain Pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">877-889</span>CODEN:
                <span class="NLM_cas:coden">BRPAE7</span>;
        ISSN:<span class="NLM_cas:issn">1015-6305</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The newly proposed glioma stem cell (GSC) hypothesis may re-model the way we diagnose and treat the tumor, which highlights the need for a complete knowledge on the genetic and epigenetic "blueprints" of GSCs.  To identify the true "stemness" signatures, pure GSC populations are primarily needed.  Reliable in vitro methods enriching for GSCs and thereby identifying the key stem-like characteristics constitute the preliminary step forward.  We discuss in this review the current widely used methods for enriching and isolating GSCs, namely neurosphere assay, CD133 Immunophenotyping and side population assay, and detail their limitations and potential pitfalls that could complicate interpretation of corresponding results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrleaZxkJUBc7Vg90H21EOLACvtfcHk0liL3G98IAR-QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFKht7bN&md5=09f9ae3b110b21a2bb65baa0d831c09c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1111%2Fj.1750-3639.2010.00379.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1750-3639.2010.00379.x%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DCampos%26aufirst%3DB.%26aulast%3DHerold-Mende%26aufirst%3DC.%26aulast%3DLei%26aufirst%3DT.%26atitle%3DThe%2520utility%2520and%2520limitations%2520of%2520neurosphere%2520assay%252C%2520CD133%2520immunophenotyping%2520and%2520side%2520population%2520assay%2520in%2520glioma%2520stem%2520cell%2520research%26jtitle%3DBrain%2520Pathol.%26date%3D2010%26volume%3D20%26spage%3D877%26epage%3D889%26doi%3D10.1111%2Fj.1750-3639.2010.00379.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Laks, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masterman-Smith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visnyei, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angenieux, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orozco, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liau, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazareff, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblum, H. I.</span><span> </span><span class="NLM_article-title">Neurosphere formation is an independent predictor of clinical outcome in malignant glioma</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">980</span><span class="NLM_x">–</span> <span class="NLM_lpage">987</span><span class="refDoi"> DOI: 10.1002/stem.15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1002%2Fstem.15" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=980-987&author=D.+R.+Laksauthor=M.+Masterman-Smithauthor=K.+Visnyeiauthor=B.+Angenieuxauthor=N.+M.+Orozcoauthor=I.+Foranauthor=W.+H.+Yongauthor=H.+V.+Vintersauthor=L.+M.+Liauauthor=J.+A.+Lazareffauthor=P.+S.+Mischelauthor=T.+F.+Cloughesyauthor=S.+Horvathauthor=H.+I.+Kornblum&title=Neurosphere+formation+is+an+independent+predictor+of+clinical+outcome+in+malignant+glioma&doi=10.1002%2Fstem.15"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fstem.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fstem.15%26sid%3Dliteratum%253Aachs%26aulast%3DLaks%26aufirst%3DD.%2BR.%26aulast%3DMasterman-Smith%26aufirst%3DM.%26aulast%3DVisnyei%26aufirst%3DK.%26aulast%3DAngenieux%26aufirst%3DB.%26aulast%3DOrozco%26aufirst%3DN.%2BM.%26aulast%3DForan%26aufirst%3DI.%26aulast%3DYong%26aufirst%3DW.%2BH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DLiau%26aufirst%3DL.%2BM.%26aulast%3DLazareff%26aufirst%3DJ.%2BA.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DHorvath%26aufirst%3DS.%26aulast%3DKornblum%26aufirst%3DH.%2BI.%26atitle%3DNeurosphere%2520formation%2520is%2520an%2520independent%2520predictor%2520of%2520clinical%2520outcome%2520in%2520malignant%2520glioma%26jtitle%3DStem%2520Cells%26date%3D2009%26volume%3D27%26spage%3D980%26epage%3D987%26doi%3D10.1002%2Fstem.15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chaichana, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamora-Berridi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camara-Quintana, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinones-Hinojosa, A.</span><span> </span><span class="NLM_article-title">Neurosphere assays: growth factors and hormone differences in tumor and nontumor studies</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2851</span><span class="NLM_x">–</span> <span class="NLM_lpage">2857</span><span class="refDoi"> DOI: 10.1634/stemcells.2006-0399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1634%2Fstemcells.2006-0399" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2006&pages=2851-2857&author=K.+Chaichanaauthor=G.+Zamora-Berridiauthor=J.+Camara-Quintanaauthor=A.+Quinones-Hinojosa&title=Neurosphere+assays%3A+growth+factors+and+hormone+differences+in+tumor+and+nontumor+studies&doi=10.1634%2Fstemcells.2006-0399"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1634%2Fstemcells.2006-0399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Fstemcells.2006-0399%26sid%3Dliteratum%253Aachs%26aulast%3DChaichana%26aufirst%3DK.%26aulast%3DZamora-Berridi%26aufirst%3DG.%26aulast%3DCamara-Quintana%26aufirst%3DJ.%26aulast%3DQuinones-Hinojosa%26aufirst%3DA.%26atitle%3DNeurosphere%2520assays%253A%2520growth%2520factors%2520and%2520hormone%2520differences%2520in%2520tumor%2520and%2520nontumor%2520studies%26jtitle%3DStem%2520Cells%26date%3D2006%26volume%3D24%26spage%3D2851%26epage%3D2857%26doi%3D10.1634%2Fstemcells.2006-0399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadhwa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adesina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlaky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idamakanti, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Police, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallenbeck, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurwitz, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chintagumpala, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. N.</span><span> </span><span class="NLM_article-title">Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma</span> <span class="citation_source-journal">Neuro. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1185</span><span class="refDoi"> DOI: 10.1093/neuonc/not065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1093%2Fneuonc%2Fnot065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=23658322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlGnu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1173-1185&author=Z.+Liuauthor=X.+Zhaoauthor=H.+Maoauthor=P.+A.+Baxterauthor=Y.+Huangauthor=L.+Yuauthor=L.+Wadhwaauthor=J.+M.+Suauthor=A.+Adesinaauthor=L.+Perlakyauthor=M.+Hurwitzauthor=N.+Idamakantiauthor=S.+R.+Policeauthor=P.+L.+Hallenbeckauthor=R.+L.+Hurwitzauthor=C.+C.+Lauauthor=M.+Chintagumpalaauthor=S.+M.+Blaneyauthor=X.+N.+Li&title=Intravenous+injection+of+oncolytic+picornavirus+SVV-001+prolongs+animal+survival+in+a+panel+of+primary+tumor-based+orthotopic+xenograft+mouse+models+of+pediatric+glioma&doi=10.1093%2Fneuonc%2Fnot065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Intravenous injection of oncolytic picornavirus SVV-001 prolongs animal survival in a panel of primary tumor-based orthotopic xenograft mouse models of pediatric glioma</span></div><div class="casAuthors">Liu, Zhigang; Zhao, Xiumei; Mao, Hua; Baxter, Patricia A.; Huang, Yulun; Yu, Litian; Wadhwa, Lalita; Su, Jack M.; Adesina, Adekunle; Perlaky, Lazlo; Hurwitz, Mary; Idamakanti, Neeraja; Police, Seshidhar Reddy; Hallenbeck, Paul L.; Hurwitz, Richard L.; Lau, Ching C.; Chintagumpala, Murali; Blaney, Susan M.; Li, Xiao-Nan</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Cary, NC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1173-1185</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Seneca Valley virus (SVV-001) is a nonpathogenic oncolytic virus that can be systemically administered and can pass through the blood-brain barrier.  We examd. its therapeutic efficacy and the mechanism of tumor cell infection in pediatric malignant gliomas.  Methods: In vitro antitumor activities were examd. in primary cultures, preformed neurospheres, and self-renewing glioma cells derived from 6 patient tumor orthotopic xenograft mouse models (1 anaplastic astrocytoma and 5 GBM).  In vivo therapeutic efficacy was examd. by systemic treatment of preformed xenografts in 3 permissive and 2 resistant models.  The functional role of sialic acid in mediating SVV-001 infection was investigated using neuraminidase and lectins that cleave or competitively bind to linkage-specific sialic acids.  Results: SVV-001 at a multiplicity of infection of 0.5 to 25 replicated in and effectively killed primary cultures, preformed neurospheres, and self-renewing stemlike single glioma cells derived from 4 of the 6 glioma models in vitro.  A single i.v. injection of SVV-001 (5 × 1012 viral particles/kg) led to the infection of orthotopic xenografts without harming normal mouse brain cells, resulting in significantly prolonged survival in all 3 permissive and 1 resistant mouse models (P < .05).  Treatment with neuraminidase and competitive binding using lectins specific for α2,3-linked and/or α2,6-linked sialic acid significantly suppressed SVV-001 infectivity (P < .01).  Conclusion: SVV-001 possesses strong antitumor activity against pediatric malignant gliomas and utilizes α2,3-linked and α2,6-linked sialic acids as mediators of tumor cell infection.  Our findings support the consideration of SVV-001 for clin. trials in children with malignant glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX3fv8LCBY07Vg90H21EOLACvtfcHk0liL3G98IAR-QA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlGnu7%252FL&md5=6858de67b09b9f9ae585cfe721b3afd1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fneuonc%2Fnot065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fneuonc%252Fnot065%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DH.%26aulast%3DBaxter%26aufirst%3DP.%2BA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWadhwa%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DJ.%2BM.%26aulast%3DAdesina%26aufirst%3DA.%26aulast%3DPerlaky%26aufirst%3DL.%26aulast%3DHurwitz%26aufirst%3DM.%26aulast%3DIdamakanti%26aufirst%3DN.%26aulast%3DPolice%26aufirst%3DS.%2BR.%26aulast%3DHallenbeck%26aufirst%3DP.%2BL.%26aulast%3DHurwitz%26aufirst%3DR.%2BL.%26aulast%3DLau%26aufirst%3DC.%2BC.%26aulast%3DChintagumpala%26aufirst%3DM.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26aulast%3DLi%26aufirst%3DX.%2BN.%26atitle%3DIntravenous%2520injection%2520of%2520oncolytic%2520picornavirus%2520SVV-001%2520prolongs%2520animal%2520survival%2520in%2520a%2520panel%2520of%2520primary%2520tumor-based%2520orthotopic%2520xenograft%2520mouse%2520models%2520of%2520pediatric%2520glioma%26jtitle%3DNeuro.%2520Oncol.%26date%3D2013%26volume%3D15%26spage%3D1173%26epage%3D1185%26doi%3D10.1093%2Fneuonc%2Fnot065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span> In  <span class="citation_source-book">Macromolecular Crystallography, Part A, Method Enzymology</span>; <span class="NLM_contrib-group">Carter, C. W.,  Jr.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">276</span>, pp  <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+Carter&author=R.+M.+Sweet&title=Macromolecular+Crystallography%2C+Part+A%2C+Method+Enzymology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26btitle%3DMacromolecular%2520Crystallography%252C%2520Part%2520A%252C%2520Method%2520Enzymology%26aulast%3DCarter%26aufirst%3DC.%2BW.%26pub%3DAcademic%2520Press%26date%3D1997%26volume%3D276%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser crystallographic software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lgfWt-O8eHWsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lgELhuvno-92Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgELhuvno-92Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Tomašić, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mašič, L. P.</span><span> </span><span class="NLM_article-title">Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span><span class="refDoi"> DOI: 10.1517/17460441.2012.688743</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=10.1517%2F17460441.2012.688743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=22607309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=549-560&author=T.+Toma%C5%A1i%C4%87author=L.+P.+Ma%C5%A1i%C4%8D&title=Rhodanine+as+a+scaffold+in+drug+discovery%3A+a+critical+review+of+its+biological+activities+and+mechanisms+of+target+modulation&doi=10.1517%2F17460441.2012.688743"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation</span></div><div class="casAuthors">Tomasic, Tihomir; Peterlin Masic, Lucija</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">549-560</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Rhodanine-based compds. have been assocd. with numerous biol. activities.  After many years of research in drug discovery, they have gained a reputation as being pan assay interference compds. (PAINS) and frequent hitters in screening campaigns.  Rhodanine-based compds. are also aggregators that can non-specifically interact with target proteins as well as Michael acceptors and interfere photometrically in biol. assays due to their color.Areas covered: The authors review the recently reported biol. activities of rhodanine-based compds.  Furthermore, the article provides details of their synthesis and occurrence in compd. libraries through high-throughput screening (HTS) and virtual high-throughput screening (VHTS).  Addnl., the authors provide the reader with possible mechanisms of non-specific target modulation, anal. of the crystal structures of enzyme-rhodanine complexes and a comparison of rhodanine and thiazolidine-2,4-dione moieties.Expert opinion: The biol. activity of compds. possessing a rhodanine moiety should be considered very critically despite the convincing data obtained in biol. assays.  In addn. to the lack of selectivity, unusual structure-activity relationship profiles and safety and specificity problems mean that rhodanines are generally not optimizable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorolVH32PdC7Vg90H21EOLACvtfcHk0lgELhuvno-92Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWmtLw%253D&md5=a02e78c0c7788aaeb044f3753c901117</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1517%2F17460441.2012.688743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2012.688743%26sid%3Dliteratum%253Aachs%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DT.%26aulast%3DMa%25C5%25A1i%25C4%258D%26aufirst%3DL.%2BP.%26atitle%3DRhodanine%2520as%2520a%2520scaffold%2520in%2520drug%2520discovery%253A%2520a%2520critical%2520review%2520of%2520its%2520biological%2520activities%2520and%2520mechanisms%2520of%2520target%2520modulation%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26spage%3D549%26epage%3D560%26doi%3D10.1517%2F17460441.2012.688743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XRX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XRX','PDB','4XRX'); return false;">PDB: 4XRX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XS3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4XS3','PDB','4XS3'); return false;">PDB: 4XS3</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00684">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_13000"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00684">10.1021/acs.jmedchem.5b00684</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Compound synthesis and characterization</p><p class="last">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings spreadsheet</p><p class="last">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_001.pdf">jm5b00684_si_001.pdf (966.95 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00684/suppl_file/jm5b00684_si_002.csv">jm5b00684_si_002.csv (2.1 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00684&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00684%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-17%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00684" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a560c6cf23d88","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
